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Vulval lichen sclerosus (LS) and high-grade intraepithelial neoplasia (VIN 3) are two 
common and distressing diseases.  Significant morbidity is caused by symptoms of 
persistent pruritus and surgical treatment of skin areas suspicious of malignancy.  The 
risk of developing cancer in a background of LS and VIN 3 is poorly defined.  The 
methods currently available for clinical assessment of the vulva are limited.  There is 
abundant research on the application of the LASER Doppler technique - laser Doppler 
Flowmetry (LDF) - showing changes in perfusion within the small blood vessels of the 
skin as a useful parameter for more accurate disease classification.  There is also 
research on immunohistochemical microvessel density (MVD) studies showing 
increases in blood supply in tissues prone to develop cancer or as a prognostic marker of 
cancer outcome.  The Laser Doppler perfusion imager (LDPI) provides a rapid, real­
time, non-invasive and non-contact method to measure skin blood flow in an area as 
opposed to a single point by the LDF, making the LDPI more suitable for application to 
the vulva.  This thesis reports for the first time, the application of the LDPI to the vulva. 
Initially the LDPI was applied to the clinically normal vulva to study perfusion variance 
related to menstrual cycle, age and local skin temperature provocation. The application 
was then extended to vulval disease, LS and VIN 3, and validated against 
morphological differences in MVD.  The LDPI and MVD studies suggest that in VIN 3 
there is an actual increase in skin perfusion.  In LS the situation is more complex and 
suggests that the LDPI measured perfusion at a greater depth than the MVD.  Studies on 
base line perfusion variance of vulval LS to topical therapy show that there is no overall 
difference in baseline perfusion in spite of symptom improvement.  Temperature 
provocation studies suggest differences in skin blood flow response in diseased 
compared to the normal vulva.
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22CHAPTER 1 
Introduction
231.1 Introduction
The vulva is an area of specialised skin, associated with the openings of the urinary, 
genital and intestinal tract, and their various functions.  The scientific investigation of 
the anatomy, physiology and pathology of the vulva is a challenge in view of the 
considerations associated with religion, ethnicity and embarrassment.  The study of 
vulval pathology is also impaired by the differences in presentation compared to the 
same disease in better-investigated non-genital skin sites and by the confusing array of 
clinical terms used by the different specialities with an interest in the care of women 
presenting with vulval symptoms  .
During the past 30 years increasing interest in diseases of the vulva has led to the 
formation of specialist vulval clinics at several centres around the country, including the 
Royal Free Hospital (RFH)198.  The International Society for the Study of Vulvovaginal 
Disease (ISSVD), established in 1970, has facilitated standardisation of the 
nomenclature and stimulated discussion at an inter-disciplinary international level254.
1.2  Vulval disease
Vulval lichen sclerosus (LS) and high-grade vulval intraepithelial neoplasia (VIN) are 
two diseases frequently seen in a specialist vulval clinic and have an unclear potential 
for neoplastic progression.  LS, classified as a non-neoplastic epithelial disorder of the 
vulva, is the most common dermatological disease in this specialised skin, accounting 
for as much as 23% of new patients seen in the vulval clinic198,254.  Vulval LS has a 3- 
5% reported risk of malignant transformation but histological analysis of squamous cell 
carcinoma (SCC) demonstrates LS in the adjacent skin in 65 to 75% of cases63,193. 
High-grade VIN is less common than vulval LS but the reported risk of malignant
24progression varies between 5% and 87%, depending on previous treatment151’193.
Occult invasive carcinoma is present in up to 23% of high-grade VIN19;133;159;217;252:286. 
Histological studies report high-grade VIN in the adjacent skin in approximately 25% of 
women diagnosed with SCC193.  Clinically, there is concern that high-grade VIN is 
increasingly being diagnosed in young women, with implications of distortion or 
disfiguration from surgical treatment.  This was previously thought to be a relative 
increase attributed to greater clinical acumen particularly as the incidence of SCC had 
been reported to have remained static125,139.  However sub-analysis of women under the 
age of 50y by Joura et al155 indicated that these young women experienced a more than 
doubling of the incidence in invasive vulval carcinoma.  More recently MacLean194 also 
reported that the incidence of SCC showed the greatest increase in women under the age 
of 50y, which raises concern about a real increase in the incidence of high-grade VIN in 
young women.
1.3  Background to thesis
The aim of this thesis was to introduce a new physiological parameter to assess vulval 
disease.  Advances in laser Doppler technology have provided a non-invasive and non- 
contact biophysical method for measuring skin blood flow (SBF) over a wide area such 
as the vulva, within several minutes.  The ability to assess changes in SBF in vulval 
disease may pave the way towards developing more effective medical methods of 
treatment and to reduce the need for surgery, as well as identifying women with LS and 
high-grade VIN at greater risk of progression to cancer.
The significance of SBF as a potential biophysical parameter to assess disease with a 
risk of developing malignancy arises from immunohistochemical studies on 
histopathological tissue samples in a variety of cancers demonstrating a correlation
25between an increase in the microvessel density (MVD) with metastatic disease and 
prognosis for - malignant melanoma110, breast carcinoma162;339, non-small cell lung
•  i on
carcinoma  and prostatic adenocarcinoma  .  This increase in MVD is due to 
angiogenesis, the formation of new blood vessels, an essential physiological process in 
embryonic development and wound healing; it is also believed to have a critical role in 
the growth of malignant tissue beyond the limits (1-2 mm) of simple diffusion of 
nutrients and oxygen96’97.  In human pre-cancerous lesions of the colon, 3-dimensional 
(3-D) reconstruction of microvascular architecture and vascular endothelial growth 
factor (VEGF) immunostaining also suggest that formation of new blood supply, termed
1  71
angiogenesis, sets in long before the progress towards invasive phenotypes  .  Indeed, 
increased vascularisation measured by immunostaining for various endothelial markers 
has been reported in pre-neoplastic disease in a wide range of tissues: breast intra-ductal 
carcinoma36’112’339, cervical intraepithelial neoplasia80* 291, complex endometrial 
hyperplasia2, latent prostatic carcinoma104 and colorectal adenomas37.  The work by 
Dobbs et al80 on the cervix, which relates to vulva demonstrated a progressive increase 
in MVD and VEGF expression from the normal cervix through mild cervical 
intraepithelial neoplasia (CIN 1) to high grade disease (CIN 3) and invasive SCC, 
providing further support for the hypothesis that an increase in blood supply by 
angiogenesis is an early event in pre-neoplastic disease.  More recent work by Ozalp et 
al 237 and Sotiropoulou et al295 also concluded that the onset of angiogenesis is an early 
event in cervical SCC, starting in the pre-invasive stage.  Studies on the 
microvasculature in high-grade VIN show a significantly higher MVD using anti-von 
Willebrand factor (vWF) immunostain and a greater expression of VEGF compared to 
lower grade disease14.  VEGF, a leading mediator in the induction of angiogenesis, is 
reported by MacLean et al197 to be present in relatively fewer cases of VIN compared to 
vulval SCC: potentially these may be cases of VIN at risk of malignant progression.
26Angiogenesis is a complex process and techniques to observe and quantify microvessels 
histologically in sections of tissue can, in addition to being invasive, only provide an 
estimate of the final product; physiological variables such as blood flow, vascular 
permeability and interstitial pressure, which influence the relationship of angiogenesis 
to malignant transformation, are very relevant but also much more complex to
__141^337 measure  .
1.4  Objective for this thesis: 
To study the SBF in the normal and diseased vulval skin. 
1.5  Hypothesis
1.  Does the laser Doppler perfusion imager (LDPI) allow assessment of the 
microcirculation of the vulva?
2.  Is the use of the LDPI to measure vulval SBF acceptable to women with 
normal vulva?  How constant is the SBF on the normal vulva?
3.  Does the SBF in the normal vulva vary according to age and menstrual 
cycle?  How does the SBF in the normal vulva respond to temperature 
provocation?
4.  Is the use of the LDPI to measure vulval SBF acceptable to women with 
vulval lesions?  How constant is the SBF on the vulva in the presence of 
vulval lesions?
5.  Does SBF in vulval LS vary when symptomatic before treatment compared 
to when asymptomatic after treatment, and when compared to the normal 
vulva?
276.  Does the SBF in vulval LS vary during the recommended therapeutic 
regimen of potent followed by moderately topical steroids phased down to 
maintenance therapy, compared to before treatment?
7.  Is there any difference in SBF between high-grade VIN and normal vulval 
skin?
8.  Does the use of temperature provocation explain more about the SBF in 
vulval LS and high-grade VIN?
9.  Is there any correlation between the SBF measurements by the LDPI and 
MVD assessment by immunohistochemistry?
The terms SBF, skin microcirculation and skin perfusion refer to the same function and 
are interchanged in the thesis.
28The Vulval Skin2.1  Anatomy, Physiology and Function of the Vulva.
2.1.1  Introduction
The vulva forms the external female genitalia.  In the lithotomy position it is bound 
anteriorly by the mons pubis, posteriorly by the anus, and laterally by the genito-crural 
folds (Figure 2.1).  The vulval skin is comprised of the mons pubis, the labia majora and 
minora, the vestibule and the clitoris as shown in Fig. 2.1.  In this thesis the area of 
study includes the inner labia majora (i.e. part of the inter-labial space and which is not 
covered with hair) and labia minora, clitoris, clitoral hood and perineum, which are 
affected by LS and VIN.  The genito-crural fold and natal cleft are not studied in this 
thesis although LS, in particular, may extend laterally into these areas.
Figure 2.1  Structure of the vulva
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302.1.2  Anatomy
The mons pubis is a rounded fibro fatty subcutaneous pad, covered with coarse hair, 
forming a cushion over the symphysis pubis205;219;340.  It extends over the perineum in 
an elliptical fashion to form the labia majora.  The labia majora are two large, 
longitudinal folds of skin enclosing the vulval cleft and consisting of fibro fatty tissue 
attached to overlying skin by a smooth muscle network.  Posteriorly the labia majora 
forms a horizontal fold of skin lying behind the fourchette, termed the posterior 
commissure.  The outer-pigmented skin surface is covered by coarse hair and contains 
sebaceous and sweat glands while their moist internal aspect is smooth, hairless, gland- 
studded and usually slightly separated by protrusion of the labia minora.
The labia minora are richly innervated thin, delicate, smooth, pigmented fat-free and 
hairless skin with “free” sebaceous glands opening directly onto the skin surface.  The 
core of each fold of labia minora consists of loose connective tissue permeated by a fine 
elastic network, some smooth muscle fibres and extensive vascular spaces forming 
erectile tissue. The labia minora lie between the labia majora and enclose the vestibule. 
Anteriorly the labia minora bifurcate into the prepuce and the frenulum, enclosing the 
clitoris.  Posteriorly the labia minora fuse to form a transverse fold behind the vaginal 
opening, the fourchette.
The vestibule extends anteroposteriorly from the frenulum of the clitoris to the 
fourchette and laterally from the hymenal ring to Hart’s line on each labium minus. 
Hart’s line is the junction between the smooth, nonkeratinised epithelium medially and 
the slightly papillated, keratinised epithelium of the more lateral labia minora.
Localised within the vestibule are the openings of the vagina, urethra, the ducts of the 
Bartholin’s glands and the minor vestibular glands.
31The clitoris is an erectile body consisting of two corpora cavernosa beneath the clitoral 
hood and a glans distally, visible between the bifurcations of the labia minora.
The perineal skin lies between the fourchette and the anal margin while the natal cleft 
forms the skin fold posterior to the anus.
2.13  Physiology
2.13,1  Blood supply
The arterial supply to the vulva is from the internal iliacs by way of the internal 
pudendal artery and the external iliacs by way of the branches of the femoral artery 
provided by the superficial and deep external pudendal arteries205;219;340.  These vascular 
systems extensively communicate by anastomosis, which explains why ischaemia of the 
vulva is impossible even with bilateral blockage of the internal iliac arteries, and 
account both for its capacity to bleed profusely and to heal with remarkable ease.  An 
extensive intercommunicating venous plexus leave the vulva accompanying the arterial 
supply.  Venous drainage is mainly via the internal pudendal veins draining into the 
internal iliac veins and the external pudendal veins which pass to the great saphenous 
veins, to reach the femoral and subsequently the external iliac veins.  The deep dorsal 
vein drains the clitoris, through the vesicle plexus and into the internal iliac veins.
322.1.3.2  Lymphatic supply
The major lymphatic drainage from the vulva is to the medial horizontal group of 
superficial inguinal lymph nodes2051 2 19;340.  There is additional drainage by the 
superficial external pudendal lymphatic vessels, to the superficial femoral nodes.  The 
region of the clitoris is drained by the deeper lymphatic nodes, which pass directly to 
the deep femoral nodes and to the external iliac nodes.  The relevance of regional lymph 
drainage is in the management of malignant disease.
2.1.3.3  Nerve supply
The nerve supply of the vulva is derived from the sacral (S) and lumbar (L) plexuses, 
namely the pudendal nerve from S2, S3, S4, perineal branch of the posterior cutaneous 
nerve of thigh from S3, genital branch of the genitofemoral from LI, L2, the 
ilioinguinal from LI and the anterior hypogastric branch of the iliohypogastric nerve 
from (thorax) T12-L1.
There are specialised nerve endings of myelinated and unmyelinated nerves in the labia 
majora and minora and the clitoris.  Encapsulated nerve endings called Meissner’s 
corpuscles and Merkel’s discs subserve touch.  Pacinian corpuscles abound and respond 
to pressure induced by venous engorgement.  Ruffini corpuscles and Dogiel-Krause 
corpuscles vary greatly in size and shape and may respond to changes of temperature 
stimuli associated with sexual activity.
The cutaneous nerves convey all modalities of common sensation -  touch, pain, itch, 
warmth and cold, as well as complex sensations such as wetness.  In addition, these 
cutaneous nerves carry post-ganglionic sympathetic nerves that are motor to sweat 
glands, pilomotor units and the adventitia of the microvasculature.  No parasympathetic
33fibres participate in this cutaneous innervation233. The sensory component of the 
parasympathetic innervation of the perineum mediate the sensation of distension from 
the anal canal and the vagina while the motor component extensively innervates the 
vessels in the external genitalia and is responsible for vascular engorgement of the 
vaginal erectile tissue88.
2.1.3.4  Age and hormones
The labia majora and minora undergo changes in relation to puberty and menopause. 
The labia majora are practically absent in the young child and then develop primarily by 
the deposition of fat with the heralding of puberty.  The presence of pigmentation and 
hair on their lateral surfaces establishes the labia majora as well defined structures. The 
pigmentation of the labia minora also becomes more obvious during adolescence.  After 
the menopause the labia majora becomes less prominent with gradual decrease in 
subcutaneous fat with increasing age and there is loss of hair follicles causing thinning 
of labial hair18.
Jones147 examined the histology in normal vulva from postmortem tissue, using radial 
biopsies extending from the vaginal margin, through the labia minora, extending to the 
lateral margin of the labia majora. The keratin and epithelial layer are thin at birth, 
thicken after menarche reaching a maximum during reproductive years and finally start 
to thin after the menopause.  The keratin layer increases in thickness from the medial to 
the lateral aspect of the vulva.  The rete pegs change following the trend of the epithelial 
and keratin thickness, with their length and number reaching their maximum during the 
reproductive era and slowly reducing after the menopause.  Harper and McNicol119 
examined biopsies from the labium majus between the upper third and the lower two 
third, reported similar findings as Jones147 on the rete pegs and epithelial thickness.  In
34contrast to Jones147, Harper and McNicol119 noted very gradual thickening of the keratin 
layer throughout life.  Erickson and Montagna88 reported less well developed rete ridges 
in the labia majora compared with the labia minora and the most well developed long 
and slender rete ridges in the clitoris, suggesting the difference reflected the mechanical 
demands made in each area.  There is a scarcity of information on the microanatomical 
structure of the vulva and comprehensive information including all structures of the 
vulva is limited to studies of cadaveric tissue specimens.  The research reports88’119’147 
described above are excellent but artefacts related to the method of collection of tissue 
specimen could be responsible for the differences in reports.
The vulval skin changes with puberty and menopause suggest steroid hormone 
influence on its development.  This is however not supported by immunohistochemical 
study assessing the frequency of oestrogen receptors in the epidermis of the vulva, 
which show a low concentration, when compared to the vagina and to non-genital 
skin195.  Other studies comparing normal, dysplastic and malignant tissue also report a 
low concentration of oestrogen receptors in the vulval skin146,234.  Although the 
discrepancy between immunohistochemical hormone receptor studies compared with 
clinical physiological impression may be due to sensitivity and specificity of the assays 
used, these consistent research findings have implications for the use of topical 
oestrogen cream for the treatment of vulval conditions.
352.1.4  Function of the vulva
The general functions of this specialised skin are as with other skin, to maintain 
integrity of the body by providing a waterproof covering, detecting sensory stimuli, 
absorption and excretion of liquid, and acting as a barrier against microorganisms.  In 
addition the vulva has specialised functions related to its role in reproduction.  The 
vulva has erectile tissue in the labia minora, the clitoris and the vestibular bulbs on 
either side of the vaginal opening which are richly supplied with blood vessels forming 
a network of plexuses and anastomosis, as described in section 2.1.3.1.  These vulval 
erectile tissue are capable of vasocongestion and resolution decongestion within 
minutes55;258.  Menopause and old age result in a gradual loss of this physiological 
response to sexual stimulation due mainly to loss of erectile tissue particularly in the 
labia minora.
362.2  Structure of skin and organisation of the microvasculature
2.2.1  Histology
All the structures of the vulva are cutaneous and consist mainly of keratinised stratified 
squamous epithelium (Figure 2.2a) 341;347.  The vestibule is also cutaneous but the 
epithelial covering is not keratinised (Figure 2.2b).
Stratified squamous epithelium has four histological layers: - a basal layer or stratum 
germinativum resting on the basal lamina, a spinous or prickle-cell layer which forms 
the bulk of the epidermis, a granular layer and a homy/keratin layer or stratum comeum. 
The outer tough and protective keratin layer of the stratum comeum is continuously 
shed and replaced by progressive movement and maturation of cells produced by 
mitosis in the basal layer.  These epithelial cells become flatter and broader, finally 
loosing their nucleus to form keratin.
Beneath the avascular epidermis is the dermis, which consists of the papillary and 
reticular parts.  The papillary dermis projects upwards interdigiting with the epidermal 
rete ridges.  The papillary connective tissue is composed of fine collagen fibres with 
reticular and elastic fibres, running at right angles to the surface240.  The reticular dermis 
below the papillary dermis is composed of coarse collagen fibres lying parallel with the 
surface and thick elastic fibres that prevent the dermal collagen from being 
overstretched240.  The exact position of the deep dermal boundary between the dermis 
and the subcutaneous fat beneath is less well defined147.
37Figure 2.2a: Photomicrograph of keratinised stratified squamous epithelium in the
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Figure 2.2b:  Photomicrograph of stratified squamous epithelium of the mucous 
membrane from the vestibule. There is no keratinisation or granular zone 
(Magnification x40)
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38The skin appendages are very well vascularised in man compared to other primates191. 
The mons pubis, outer labia majora and the perineum are covered by hair bearing skin 
and contain sebaceous glands, apocrine and eccrine sweat glands.  The inner labia 
majora and labia minora are non-hair bearing skin richly provided with sebaceous 
glands opening directly onto skin forming tiny elevations on the skin surface, referred to 
as Fordyce’s spots. These areas are devoid of apocrine and eccrine sweat glands.
2.2.2  Skin blood supply
Musculocutaneous vessels branch off blood supply to the deep muscles and continue 
peripherally to form the main supply of the skin40.  A few direct cutaneous vessels 
perforate the muscle and go straight to the skin, travelling parallel to the surface of the 
skin.  These major vessels perforate the subcutaneous fat and supply the arterioles and 
venules of the skin microcirculation to form two important plexus in the dermis: an 
upper horizontal network in the papillary dermis from which nutritive capillary loops of 
the dermal papilla arise and a lower horizontal plexus in the reticular dermis at the 
interface between the dermis and subcutaneous fat.  The lower horizontal plexuses 
connect directly with the upper horizontal plexuses and also provide lateral tributaries 
that supply the hair bulbs and sweat glands.  There are some interconnections among the 
ascending arterioles and descending venules within the dermis, but these two horizontal 
plexuses represent the physiologically important areas in the skin.
392.2,2.1  Papillary dermis
The microvessels in the mid to upper dermis or the papillary dermis vary in diameter 
from 10 to 35pm but most are in the 17 to 22pm range.  The microvasculature between 
the ascending arteriole and the descending collecting venule could be divided into the 
following seven segments (Figure 2.3): arteriole of superficial plexus, terminal arteriole, 
arteriole and venous side of the capillary loop, postcapillary venule, venules of the 
superficial plexuses (upper and deep components interconnected by vertical shunts). 
Vessel classification by morphology of vessel wall is more reliable than measurement 
of vessel diameter, which tends to widely overlap between the different vascular 
segments and are influenced by the type of fixative used to prepare tissue45,127,351.
40Figure 2.3  Diagram of the segmental arrangem ent of the 
m icrovasculature in the papillary dermis (adapted from Higgins et a l127)
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The endothelial tube of the arterioles which most likely function as part of the resistance 
vessels in the skin is surrounded by two layers of smooth muscle cells -  inner 
longitudinal and outer spiral, a subendothelial elastic lamina and a homogenous 
basement membrane.  The diameter of the arterioles progressively decreases as it 
transcends to the beginning of the capillary bed by gradual disappearance of the two 
layers of smooth muscle cells to form the terminal arteriole.  The terminal arteriole has a 
single-cell layer with less well-developed dense bodies and fewer filaments compared to 
the smooth muscle cells, and circumferential arms almost completely encircle the 
endothelial tube.
41The next microvascular segment, the arterial capillary is surrounded by pericytes which 
replace the single cell, have contractile protein and form tight junctions with the 
endothelial cells through breaks in the homogenous basement membrane.  As the 
capillary is traced around the hairpin loop the basement membrane progressively begins 
to develop lamella within its homogenous framework until a segment is reached in 
which the basement membrane in the entire vascular wall is multilaminated, forming the 
venous capillary.
The venous capillary connects with the postcapillary venule, whose external diameter 
progressively increases.  The endothelial tube is surrounded by two to three layers of 
pericytes in contrast to a single layer in the venous capillary, and the basement 
membrane is multilaminated, as in the venous capillary.
The majority of vessels in the papillary dermis are postcapillary venules, the 
physiologically most reactive segment of the microcirculation.  Here inflammatory cells 
migrate from the vascular space into the tissues, and endothelial cells often develop 
intercellular gaps that result in increased vascular permeability in response to acute 
inflammation.
422.2.2.2  Reticular dermis
The microvessel diameters in the reticular dermis in the mid to lower dermis are wider 
ranging from 40 to 50pm, although rarely a vessel as large as 100 pm can be found42. 
The walls of the arterioles and venules are thicker with smooth muscle cells or pericytes 
present as four to five layers in contrast to one to two layers in similar vessels of the 
superficial plexuses.
2,2.23  Regional differences
There are no structural differences in the vessel structure of the skin in different body 
regions, although there are regional differences in vessel density.  The capillary density 
in the papillary dermis is significantly higher than in the reticular dermis240.  There have 
been several studies comparing regional differences in capillary density, although none 
of these included the genital skin.  Pasyk et al240 recorded the highest dermal capillary 
density on cadaver histological sampling in the head-face followed by chest/back area, 
upper extremities, abdomen/buttock and the lower extremities -  thigh and lower leg.
The calf and shin area had the lowest density.  Park et al  also reported a relative 
decrease in blood flow from the thorax/arm to the thigh/lower leg, measured using the 
laser Doppler flowmetry (LDF) in supine subjects.  Previously, other workers in the late 
1950’s220 observed a correlation between the thickness of the epidermis and dermis, and 
alteration in papillary dermal vasculature.  When the dermis was thin, as in the skin of 
the thigh and the calf, there were fewer capillaries and scant vascular bed, while areas 
with thicker epidermis and well-developed rete ridges, had capillaries present in each 
rete ridge.  Although there have been no studies on the vulval skin capillary density, 
based on the information available on the blood supply to the vulva described in Section
2.1.3.1  above, it is likely that vulval skin has relatively higher blood supply compared to
43the surrounding skin although the ratio of difference between vulval and non-vulval 
skin may change after the menopause.
Structures resembling arteriovenous (A-V) communications have only been identified 
within the skin microvasculature of the digits, nose and ears  ’
442.2.3  Application of optics to assess SBF
Current understanding of the biophysics of the cutaneous microvasculature is attributed 
to work by Braverman et al41, correlating LDF signals with histological examination. 
There are two aspects to skin blood flow -  the spatial and temporal heterogeneity.
2.2.3.1  Spatial heterogeneity
The LDF gathers signals from a depth of only 1-1.5mm below the surface of the 
epidermis, therefore excluding the capillary blood supply to the sweat gland and hair 
follicles as these structures are 3-5mm below the skin surface.  Most of the 
microvasculature contained in the papillary dermis is 1  to 2 mm below the epidermal 
surface.  The LDF signal showing high amplitude red cell flux waves exhibiting 
vasomotion corresponded to an underlying ascending arteriole and low amplitude waves 
without vasomotor activity corresponded to venular predominance 43.  Braverman et al44 
constructed separate topographic maps of LDF signal for flux and concentration of 
moving red blood cells (CMRBC), obtained simultaneously.  Sites of high flux and high 
CMRBC indicated the presence of an underlying ascending arteriole and its paired 
descending venule.  High flux, low-CMRBC sites indicated arteriolar predominance; 
low flux, high CMRBC sites indicated venular predominance; and low-flux, low- 
CMRBC sites denoted relative avascular areas.  These LDF studies have demonstrated 
that the ascending arterioles are spaced randomly at intervals of 1.5-7mm, thus 
explaining the basis for spatial heterogeneity of LDF measurements43.
Each ascending arteriole divides into four to five branches to form a portion of the 
upper horizontal plexus and is accompanied by a post capillary venule that is formed 
from the confluence of 8 to 10 branches within the upper plexuses.  In 3-D the vascular 
unit resembles an umbrella (Figure 2.4): the paired ascending arteriole and descending
45venule represent the handle.  The arteriolar and venular branches form the umbrella 
proper, with the arterioles being predominant in the centre and the venules predominant 
in the periphery41.
Figure 2.4  Diagrammatic representation of computer reconstruction of vessels 
present in the papillary dermis (adapted from Braverman et al 41)
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462.2.3.2  Temporal heterogeneity
The phasic (vasomotor) variation in red cell flux amplitude detected in the LDF signal 
is greatest over the ascending arteriole and its immediate branches, suggesting that these 
vessels are the morphological site for the generation of vasomotor activity in the skin40. 
The putative sphincter, formed by the single cell with circumferential arms replacing the 
smooth muscle cells of the ascending arterioles, encircling the terminal arteriole, before 
transcending into the capillary, may be the origin of the vasomotion detected by the 
LDF.  When a single arteriolar site is monitored continuously for 1  to 2 hours, the red 
cell flux changes from minimum to maximum and vice versa at intervals of 12 -20 
minutes at some sites and 70-90 minutes at other sites, thus explaining in part the 
temporal heterogeneity of LDF measurements.
Simultaneous measurement of vasomotion over paired arteriolar sites confirms 
synchronicity suggesting central regulation of vasomotion  .  Quantification of 
vasomotor waves by spectral analysis demonstrates that the beat-to-beat rate of the 
cardiac cycle varied around two means, one related to the sympathetic tone and the 
other to parasympathetic tone and respiratory rate.  When a patient is tilted quickly 
from the supine to erect position the sympathetic tone is accentuated at the expense of 
the parasympathetic tone presumably because of baroreceptor generated increased 
sympathetic tone.  Bemardi et al23 demonstrated regional differences in sympathetic 
tone with significant reduction in responses in the human forearm.
472.3  Conclusion
The vulval skin has many histological similarities with skin in other sites and some 
differences related to its specialised physiology and function. More studies are required 
to clarify differences in histological features of the human vulval structures to variables 
such as age and cyclical hormone and, their influence on blood supply and flow.
Section 2.2.3 suggests that optical methods such as the LDF have the potential to further 
improve our understanding of vulval skin microvasculature in the presence and absence 
of disease, adding another dimension to the assessment of the vulval skin.
In the next chapter vulval LS and VIN, and their association with cancer are reviewed 
followed by the techniques currently available in clinical and research practise to assess 
the vulval skin.
48Review of vulval diseases -LS and 
high-grade VIN and the assessment 
of the vulval skin
493.1  Introduction
The aim of this chapter is to review vulval LS and high-grade VIN.  The clinical 
presentation of these diseases with diagnosis, aetiology and the relationship with 
malignant disease are discussed.  This is followed by a description of the methods used 
for assessment of the vulval skin in the clinical setting and the special techniques 
utilised in research.
3.2  Vulval Lichen sclerosus (LS)
LS is important because it is one of the most common dermatological diseases of the 
vulva and has a small but definite association with the development of squamous 
carcinoma of the vulva 60:63;193;198;209.  It is an inflammatory disease of unknown cause 
and incompletely characterised pathogenesis.  The definitive diagnosis of LS is made on 
histological examination of biopsy specimens126.
The earliest description of this ‘persistent pruritic white vulval lesion’ was by Robert 
Weir in 1875.  Henri Hallopeau coined the term ‘lichen sclerosus’ in 1887. The typical 
histological features of LS was first formally described in 1892 by J Darier192’256.  Since 
the first description of this disease a confusing array of clinical terminology has arisen
109
which has impaired communication of research findings  .  When the ISSVD was 
established in 1970 one of their main tasks was to standardise the nomenclature for 
vulval disease.  The latest classification for nonneoplastic epithelial disorders is shown 
in Table 3.1255.
50Table 3.1  Nonneoplastic epithelial disorders (NNED) of the vulval
skin and mucosa255
Lichen Sclerosus
Squamous cell hyperplasia (formerly hyperplastic dystrophy) (SCH) 
Other Dermatoses
The clinical and histopathological application of this classification is still lacking in 
practicality.  In a study by Ambros et al5  and another by O’Keefe et al230 there was good 
agreement among pathologists on the histological diagnoses of LS, whereas the term 
squamous cell hyperplasia (SCH) was infrequently used and instead lichen simplex 
chronicus (LSC) was the more common rendered diagnosis.  The authors dispute the 
position of SCH below LS in the classification because it is relatively rare in isolation. 
The symptom of pruritus in LS leads to chronic rubbing, which can cause superimposed 
LSC.  To identify LSC separately from SCH in the absence of squamous cell carcinoma 
is problematic63.  Scurry et al274 confirmed the presence of SCH and indicated that the 
diagnosis should be with LS.  However Scurry et al274 also admitted to difficulties in 
histological differentiation between LSC and SCH particularly with end-stage LS when 
the classical feature of oedematous-hyaline layer is lost.
513.2.1  Presenting symptoms
LS can affect both sexes at all ages and skin sites but the typical patient is a middle aged 
woman with anogenital involvement, who may have suffered the symptoms without 
accurate diagnosis for many years  .  The most common complaint is severe and 
intractable itching (pruritus vulvae), followed by soreness, particularly during 
micturation.  Superficial dyspareunia is also common and is caused by narrowing of the 
introitus, and splitting of the skin at the fourchette during sexual intercourse.  A few 
women may complain of vulval pain (vulvodynia).  In the detailed study by Lorenz et
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al  itching was the most frequent (98%) symptom followed by irritation (60.5%), then 
burning and dyspareunia (-25%), tearing (-14.8%), bleeding and Assuring (-9%).
Occasionally the patient is asymptomatic and is referred because of the incidental 
finding of a white lesion at routine clinical examination245.  When young girls are 
affected, difficulty with defecation and micturition are common, in addition to itching24.
3.2.2  Examination findings
LS lesions present as white or slightly pink polygonal papules that coalesce into plaques 
giving the appearance of being “splashed with whitewash” on fine “cigarette paper” 
wrinkling of the cutaneous surface of the vulva and perineal region (Figure 3.1a-d).
52Figure 3.1a-d Clinical photographs of vulval LS
Figure 3.1a
Figure 3.1a -  This patient (72y) presented 
with a 20y history of vulval pruritus and 
soreness.  On examination there was pallor 
with  ‘cigerette paper’ crinkly appearance. 
Note the loss of labia minora (more on the 
left than right) with midline fusion partially 
occluding the clitoris.  The adjacent 
“mask” has been positioned prior to LDPI.
Figure 3.1b
Figure 3.1b - This child (5y) 
presented with several months of 
vulval pruritus and painful 
micturition.  Note the shiny smooth 
pallor with some ecchymosis.
53Figure 3.1c - This patient (54y) presented 
with a 2y history of vulval pruritus.  There is 
partial resorption of labia minora and 
narrowing of introitus with midline fusion 
partially occluding the clitoris.  There is 
scratch damage causing ecchymosis on right 
inner labium minus.
Figure 3.1 d - This patient 
(61y) presented with a 
long history of untreated 
LS associated with a short 
history of a non-healing 
ulcerated lesion on the left 
inner labium majus, which 
proved to be SCC on 
biopsy.
Figure 3.1d
Figure 3.1c
54Some areas develop a chalky white, parchment-like hyperkeratosis of the vulval skin. 
The vulval architecture is modified in more advanced disease where there is absorption 
and loss of the labia minora, midline fusion burying the clitoral structures and 
eventually narrowing of the vaginal introitus.  On gross morphology whiteness with 
crinkling are the most common features (87.7%) followed by thickening and fissuring 
(-30%), hyperaemia, phimosis, ecchymosis, erosions (-20%), thinning, agglutination, 
excoriations, tissue bridge (-13%), tearing and oedema (~4%)189.
There is usually symmetrical involvement of the inner parts of the vulva - labia minora 
and inner aspect of labia majora (100%), and clitoris (70%)189.  In more extensive 
disease the perineal (68%) and perianal areas (32%), including natal cleft (32%) are 
affected giving the appearance of “figure 8” or “hourglass” distribution of the disease. 
Occasionally there may be extension of disease into the genito-crural folds (8.6%).  The 
presence of associated extra-genital lesions varies between 3.7% and 18% 145,174’208’209
During the symptomatic phase of the disease there is intense itching, usually associated 
with haemorrhagic bullae, telangiectases, erosions, purpura and oedema, which may be 
localised or generalised.  During this active stage of the disease painful fissures also 
appear at the fourchette, perineal midline and in other natural skin creases.  Fissures at 
the fourchette are precipitated or exacerbated by sexual intercourse.
55SCH (Figure 3.2) is a difficult clinical diagnosis and is usually found in a background of 
LS.  The skin surface appears thick with keratin overgrowth (hyperkeratosis) and 
fissured, with a dull red sheen as opposed to the glazed whiteness of LS.
Figure 3.2  Clinical photograph of vulval SCH
This patient (28y) presented with 
a 5y history of superficial 
dyspareunia and splitting at 
fourchette.  Biopsy demonstrated 
squamous cell hyperplasia.
563.2.3  Histological findings
The epidermal layer in LS (Fig 3.3) is classically hyperkeratotic (thickening of the 
stratum comeum), thinned with shortening or even disappearance of the rete ridges such 
that the basal layer is arranged along a horizontal line.  Hyperkeratosis is always present 
forming a thick multilayered keratin often greater in depth than the epidermis.  Keratotic 
follicular plugging is also a common feature.  The cells in the basal layer may show 
hydropic degeneration and when confluent form a subepidermal bulla. These epithelial 
changes are variable and not diagnostic126145.
Figure 3.3  Photomicrograph of vulval LS (Magnification x40)
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57The more characteristic changes in this disease are seen in the dermis.  There is a broad 
homogenous zone of subepithelial collagen hyalinisation with a deeper band of chronic 
inflammatory infiltrate.  This diagnostic feature within the dermis of LS may be so 
scanty as to become invisible in places leading to false negative diagnosis when relying 
on a single punch biopsy126.
Electron microscopy studies show that in early LS the elastin fibres are not destroyed 
but are pushed downwards by the subepidermal homogenous zone caused by deposition 
of acid mucopolyscaharide214.  Whereas in advanced disease elastin fibres are destroyed 
and replaced by a hybrid of elastin-like substance and microfilaments originating from 
collagen most likely produced by dysfunctional fibroblasts145,214.  The vulval dermal 
fibroblasts contain proteases, which are capable of inducing in vivo fragmentation of 
dermal elastic fibres107.  Computer-supported 3-D reconstruction of the papillary 
capillaries and superficial vascular plexus in non-genital LS show progressive
*  •  167 disruption and disintegration of the capillary wall resulting in vessel reduction
58In SCH (Fig 3.4) there is hyperkeratosis, acanthosis (increase in depth of the prickle-cell 
layer) and parakeratosis (retention of nuclei within the homy layer).  Marked acanthosis 
results in elongation and distortion of the architecture of the rete pegs forming clubbed 
and pointed configurations of the lower border of the epidermis.  Parakeratotic 
thickening of the homy layer is more likely to be associated with the presence of VIN, 
than hyperkeratotic thickening123.  In the subepithelial dermis there is an inflammatory 
infiltrate consisting mainly of lymphocytes with some plasma cells and macrophages. 
The subepithelial collagen hyalinisation is less prominent beneath the thickened 
epidermis.
Figure 3.4  Photomicrograph of vulval SCH (Magnification xlO)
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593.2.4  Aetiology
The pathogenesis of LS is not clearly understood but several theories are being pursued.
3.2.4.1  Autoimmune disease
Autoimmune diseases such as thyroid disease, diabetes, vitiligo and alopecia areata 
have been linked with LS206’ 208.  These associations though established are weak and 
unrelated to the severity of the disease.  Familial LS is well recognised.  Genetically the 
HLA complex governs the susceptibility to inflammatory disease.  In a group of 84 
women with vulva LS there was an association with Class II antigen, in particular DQ7 
and to a lesser extent DQ8 and DQ9, of the HLA system compared with controls202. 
Carli et al  found an increase in CD la -  Langerhan’s cells at all stages of the disease 
suggesting an abnormality of the skin immunological system.  The study by Marren et 
al  demonstrating a lack of correlation between duration of symptoms and histological 
appearances, suggests a continuing inflammatory process in which activated Langerhan 
cells may be involved.  Although the presence of an abnormality within the skin 
immune system, in particular a T-cell mediated response within the dermis, is disputed 
by some researchers62,272, it is likely that the immunogentic profile in these women is 
the trigger the leads to development of LS following an innocent episode of scratching 
as a result of local irritants273.
Other genetic studies on cytokine receptors and inhibitors, which are thought to control 
inflammation, suggest that interleukin-1  receptor antagonist gene may relate to the 
severity of LS70.
603.2.4.2 Hormonal dependence
Hormonal factors could be relevant because LS is ten times more common in women 
than men and the median age is about 50 years181.  Friedrich and Kalra1 0 1  advocated the 
use of topical testosterone therapy based on low serum levels of dihydrotestosterone and 
testosterone found in these patients.  A more recent study using immunohistochemical 
staining for hormone receptors in vulval tissue biopsy specimens show that in LS 
androgen receptors are greatly reduced when compared to normal vulval epithelium129. 
In addition to this oestrogen receptors are also low in frequency on the vulva compared 
to the vagina195.  These findings support the use of neither topical oestrogen nor 
testosterone to treat vulval LS.
3.2.4.3 Infective cause
There is some interest in Borrelia burgdorferi, which has similarities with LS in the
histopathologic features of the diseased tissue. Farrell et al94 examined 16 specimens of
vulval LS using light microscope and did not find any spirochete and, the coccoid
bodies that were found appeared to be mast cells rather than bacilli. However detection
of this spirochete, by DNA (deoxyribonucleic acid) amplification with PCR
(polymerase chain reaction) suggests a geographic distribution in its association with 
T  q 7 6 ;1°2
613.2.4.4 Abnormal cell kinetics
Vulval LS appears to have a wide range of proliferative capacity and high levels have 
been associated with over-expression of wild type p53292.  When compared with normal 
vulval epithelium and non-genital LS, vulval LS appears to demonstrate altered p53
i p
expression and epidermal cell proliferation
These studies suggest that in vulval LS there may be unknown factors triggering 
damage in DNA, which in turn increases the expression of p53.  The mechanisms 
involved in the repair of damaged DNA, apoptosis when repair is not possible or the 
replacement of dead cells, may be impaired thereby triggering the pathway towards 
malignant transformation.  Vulval LS also show abnormal expression of certain 
isoforms of epidermal CD44, which are designated as markers of tumour progression93.
623.2.5  Relationship between LS and vulval carcinoma (SCC)
The association of vulval LS with squamous cell carcinoma (SCC) is clear from 
retrospective histological examination of the epithelial changes in the proximity of the 
cancer (see Table 3.2).  Up to 75% of cases with vulval SCC are associated with 
LS/SCH.  Many of the studies seem to suggest that SCH has a greater association 
compared to LS with SCC.  As discussed in Section 3.2 above, the histopathological 
differentiation between LSC and SCH in the absence of cancer is problematic5’63’230’274.
Table 3.2 reviews the literature on the reported relationship between LS and SCC. 
Differences in terminology and methodology used in these papers limits their 
comparison.  For example, Leibowitch et al182 also included clinical evidence of 
epithelial disease in the vicinity of the cancer; to avoid under-reporting as in some cases 
histopathological examination alone was insufficient.  The incidence of SCC in women 
prospectively followed up with vulval LS is in the range of 0-10% with an average rate 
of 3%123.  Hart et al123 reported 4 cases of SCC in 107 women with LS at first 
examination and 1  case after 12 years in 92 long-term follow-up patients.  Meyrick 
Thomas et al209 had 19 (5%) cases of SCC in 357 women with biopsy proven LS.  In a 
prospective study with histologically confirmed LS in 211 women and with an age- 
matched control group Carli et al60 found a cumulative risk of SCC of 14.8% (0.06% in 
the general female population) and a relative risk of 246.6.
63Table 3.2 The association of vulval LS with squamous cell carcinoma
Author No. of
cases
Normal
(%)
epithelia
LS/SCH7
(%)
*CIS
(%)
Percentage 
with atypia
Buscema et al, 
198056
98 2 (2%) 63 (64%) 33 (34%) 53%
Buscema et al, 
198056 (revised *)
83 2 (2%) 63 (75%) 18(21%) 44%
Zaino et al, 
1982355
60 2 (3%) 39 (65%) 19 (32%) 72%
Leibowitch et al, 
1990182
78 6 (8%) 48 (61%) 24 (31%) 66%
Rueda et al, 
1994263
64 7(11%) 41 (64%) 16 (25%) 29%
# CIS = high grade VIN (undifferenciated)
* Buscema et al56 suggested excluding 15 cases of carcinoma in-situ (CIS), in which invasion was 
identified as microinvasive disease.
LS/SCH7  includes the dystrophies described in the earlier papers.
64The unanswered question is whether vulval LS is a premalignant disease.  It is likely 
that the presence of LS rather than chronic tissue damage from itching and scratching is 
responsible for development of malignant disease, as other itchy conditions such as 
eczema and psoriasis do not develop cancer273.  In an elaborate study by Carlson et al63 
DNA aneuploidy was present in 33% of vulval LS compared with other inflammatory 
conditions such as acute scars and lichen simplex chronicus, which were all diploid. 
DNA aneuploidy was also more likely to be found with LS associated with SCC 
compared to those without cancer.  In the cases with DNA aneuploidy there was 
significant increase in epidermal thickness and p53 expression.  This and the discussion 
in Section 3.2.4.4 above on cell kinetics provides some answers but more studies are 
required with better data collection and standardisation of terminology and histological 
definition to define the true impact of LS in the community, and on SCC.
There is concern expressed by some that the majority of patients with SCC in a 
background of LS were previously undiagnosed, suggesting that clinical surveillance
189
may have an impact on reducing the risk of development of carcinoma  .  The 
techniques currently available for clinical surveillance are limited, particularly as the 
studies suggest that the presence of SCH and/or atypia predict the risk of LS developing 
carcinoma193’355.  As LS often involves a large area of vulval skin, adequate tissue 
sampling to identify areas at risk of malignancy requires better techniques to localise 
these suspicious skin areas to avoid unnecessary excision of wide areas of the vulva.
653.2.6  Management
Effective treatment for LS has been a challenge, mainly because of the uncertainty 
concerning the aetiology and pathogenesis of this disorder.  Therapy of vulval LS is 
usually protracted, providing symptomatic relief, without necessarily correcting the 
underlying disorder or architectural distortion.
The patient would greatly benefit from multidisciplinary input i.e. in a combined 
specialised vulval clinic with a dermatologist and gynaecologist, who have strong links 
with the genitourinary medicine and pathology departments.  Confirmation with 
histological diagnosis is recommended.  A 4 mm biopsy punch under local anaesthetic 
in the clinic can provide sufficient tissue for this purpose.  An information leaflet 
containing general information about vulval LS, its small link to malignancy, the lack of 
a cure, the need for long-term follow-up and contact with support groups is helpful.
The management of vulval LS is based on controlling pruritus with the use of potent 
topical steroids followed by maintenance therapy.  Maintenance therapy is 
recommended even if women are symptom-free.  Clobetasol propionate is a highly 
effective synthetic fluorinated corticosteroid with a high degree of glucocorticoid but 
minimal mineralocorticoid activity.  The drug is believed to contain anti-inflammatory, 
anti-pruritic and vasoconstrictive properties through the induction of phospolipase A2 
inhibitory proteins called lipocortins189.  There is concern about contact dermatitis, 
increase predisposition to infection, steroid -induced atrophy, telangiectasia, stria and 
the supression of the pituitary-adrenal axis.  In the publications presented below in this 
section of this thesis contact dermatitis was the only occasional problem and none of the 
other side effects were reported.
66Dalziel et al73 prescribed Clobetasol propionate (CP) (0.5%) for 12 weeks twice daily 
application.  On prospective review there was progressive and significant reduction of 
itch and soreness at 6 weeks and 12 weeks of therapy.  Histological parameters did not 
show epidermal atrophy but there was significant reduction of hyperkeratosis and 
epidermal basal cell liquefaction.  In the dermis there was significant reduction of the 
intensity of dermal inflammatory infiltrate and hyalinisation of collagen.  On 
retrospective chart review by Lorenz et al189 and on prospective observation by Sinha et
7on
al  the complete/partial remission rate for symptoms was ~ 94% and no response rate 
~ 5%.  Gross morphology showed some improvement with complete remission in 31%, 
partial remission in 46% and no change in 22%189.  Previous studies have reported good 
response rates to topical testosterone but in view of the more recent comparative studies 
and unpleasant side-effects, this treatment is not recommended13.  Bracco et al39 have 
also shown significant improvement in symptoms, gross morphology and histological 
features with CP compared to testosterone, progesterone and a cream based placebo 
preparation. Topical testosterone causes elevation of serum levels and androgenic side- 
effects were reported in 4 of 10 patients - enlargement of clitoris (x3), alteration of 
voice (x2) and dramatic increase of libido (x 1)156.
The clinical impression is that CP does not cure vulval LS but controls symptoms of 
pruritus.  Therefore in the long-term, after the initial “short and sharp” sustained 
treatment for 12 weeks with highly potent steroids, women are advised to continue with 
moderately potent steroids such as clobetasone butyrate.  This is phased down to once 
or twice weekly application over a period of several weeks and maintained indefinitely 
to prevent recurrence of symptoms34,74,290.  Carli et al6 1  found modification of the 
immunohistochemical parameters activating the skin immune system and recommended 
the use of maintenance therapy in the hope that better disease control will reduce
67scarring and discourage malignant change.  Topical testosterone for long-term treatment 
is unsuccessful with a high rate of discontinuation of treatment due to exacerbation of
„34;59;67 symptoms
Squamous hyperplasia is a controversial disease entity clinically and histologically5’230. 
Clark et al69 reported poorer symptom response with SCH (48%) compared with LS 
(62%) with graduated topical steroids and suggested that this disease may have a 
different underlying pathogenesis. Zorlu et al357 reported very high success rates of 
100% for histological reversal and symptom relieve with topical fluorinated steroids. 
Cattaneo et al66 also reported similarly high success rates for symptom relief and gross 
morphology.  These extremely good results could be related to the pathological 
diagnostic dilemma between LSC and SCH5;230 as discussed in Section 3.2.
Other treatment options include topical or systemic retinoids and cyclosporins, which 
may be considered in women with refractory symptoms  ’  .  Surgery to remove the
diseased skin is not recommended as a rule because of a high recurrence rate and the 
associated morbidity3.  However surgery does have a role in counteracting the effects of 
scarring such as dissection of buried clitoris, division of fused labia and enlargement of 
a narrowed introitus. The treatment of the narrowed introitus includes topical therapy 
and the use of dilators to prevent recurrence, in addition to surgery245.
683.3  High grade vulval intraepithelial neoplasia (VIN 3)
High-grade VIN (VIN 3) is an important disease as the rate of diagnosis has markedly 
increased particularly among young HPV (Human papilloma virus) - positive 
womenI5,72,75,125,137,163;215’282.  However the potential for increase in the vulval cancer 
incidence in young women is controversial137’139’149’207.  The overall incidence of vulval 
cancer in England is on the increase194.  MacLean194 reports that although women over 
the age of 75y account for more than 50% of the cases with vulval cancer, women under 
the age of 50y have demonstrated a doubling of the percentage contribution from 
6%(n=47) in 1979 to 12% (n=103) in 1998.
In 1986 the ISSVD defined two categories of VIN (Table 3.3)255.
Table 3.3  Vulval Intraepithelial Neoplasia255
Squamous
VIN 1  (mild)
VIN 2 (moderate)
VIN 3 (severe)
Non squamous
Paget’s disease 
Melanoma in-situ
69Table 3.3 shows that the grade classification system is similar to CIN but unlike CIN, 
no biological continuum has been shown for VIN57,173.  Although there are vague 
suggestions of a continuum when comparing the mean age of diagnosis of VIN 1, VIN 
2 and VIN 3 in the presence of HPV138,215, we should be cautious against drawing 
parallels between VIN and CIN .
VIN is different from CIN. VIN is a symptomatic disease unlike CIN.  VIN is found in 
only 20-30% of vulval SCC (Table 3.2) while CIN is present adjacent to >90% of 
cervical SCC148.  HPV has been identified in most cases of VIN 3, much less in vulval 
SCC and none in normal vulval biopsies in contrast to 80-90% of CIN 3 and invasive 
disease and in about 15% of normal cervical biopsies134’148.  The embryological origins 
of the squamous epithelium and the microenvironment of the cervix and the vulva are 
also very different  .
3.3.1  Clinical profile
Many reports define two cohorts of women with VIN 3 -  the older and younger 
woman137’138’143.  The older (>40y) woman usually has unifocal disease and is HPV 
negative.  The younger (<40y) HPV positive woman tends to be a cigarette smoker with 
multifocal and multicentric disease125’185’215 265’323.  Exogenous and in particular 
endogenous immunocompromise such as the use of medication in renal transplant and 
the presence of retrovirus disease, respectively, is associated with VIN 3 in even 
younger women which tends to be resistant to treatment172,179’331,349.
70The terminology for VIN was recently reviewed and modified to reflect the morphology 
of the disease rather than simply drawing parallels with CIN (Table 3.4).
Table 3.4  Modified terminology for VIN285
Main group Sub-group Previous category
Low grade VIN VIN 1.
High grade VIN
Usual type
•  Warty
•  Basaloid
•  Mixed
VIN 2 and 3.
Differentiated VIN of simplex type
Unclassified
Pagetoid type or cannot be 
classified in the above 
categories.
Low grade VIN represents HPV effect and has considerable inter- and intra-observer 
variations, and so is not reproducible.  High grade VIN has good interobserver 
histolopathologic reproducibility.  High grade VIN of the usual type occurs in young 
women and is associated with HPV and vulval cancer.  High grade VIN of the 
differentiated type (dVIN) is less common, seen in older women is relation to LS and/or 
SCH and is also associated with vulval cancer.  The high grade VIN of the usual type 
and differentiated type also reflect the clinical profile of the disease described above.
713.3.2  Clinical appearance
There is no pathognomonic clinical (Figure 3.5 a-d) or colposcopic feature for VIN 3 or 
for the presence of underlying early stromal invasion252’350.  High index of suspicion and 
histology is the key to diagnosis53,163'289.  The appearance of VIN 3 tends to vary with 
patient age, skin colour and location of the lesion within the vulval and perianal
co
regions  .  The most common sites are the lower one third of the inner labia minora and 
fourchette72.  The hairy area becomes involved usually as part of multifocal disease143. 
On the keratinised vulval skin white lesions are the most frequently seen and are due to 
hyperkeratosis215.  On the mucosal surface subclinical macular lesions are best 
examined using a colposcope and 5% acetic acid.  Recalcitrant and abnormal appearing 
condylomata acuminata may show VIN 3 on histology.
When VIN is suspected colposcopic examination with a magnification of at least 7.5x 
after application of acetic acid solution and directed biopsies is recommended to 
confirm diagnosis75,163.  Colposcopic examination of the vulva is far more complicated 
than examination of the cervix because it is impossible to see the subepithelial blood 
vessels especially in areas of the vulva covered by opaque keratinised epithelium19.  The 
application of acetic acid is helpful to delineate multifocal disease.  Vascular patterns 
are frequently absent within well-defined plaques of acetowhite epithelium caused in 
part by associated hyper- and para-keratosis.  However the presence of abnormal 
vascular pattern, specifically widely spaced capillary punctation and rarely, mosaism, is 
highly suggestive of underlying invasive carcinoma143.
72Figure 3.5a-d  Clinical photographs of high-grade YIN (YIN 3)
YIN 3
YIN 3
Figure 3.5a -  The vulva (45y) is 
distorted by previous excision therapy 
for VIN 3. The raised red areas caused 
pruritus and biopsy showed VIN 3 on 
histology.
VIN 3
Warty 
VIN 3
Figure 3.5c - (Age 48y) Previous 
excision of vulval warts. Presented with 
symptomatic pigmented areas, which 
confirmed VIN 3 on histology.
Figure 3.5b -  (Age 59y) The 
left labia minora was previously 
excised for VIN 3.  Recurrent 
pruritic symptoms presenting as 
a white area which on biopsy 
demonstrated VIN 3.
i
Figure 3.5d (Age 27y) Mildly 
symptomatic pigmented areas 
(VIN 3 on histology) in the 
perineum managed with topical 
steroids.
733.3.3 Clinical symptoms
VIN 3 is a symptomatic disease and the most common presenting symptom is vulval 
pruritus, followed by burning or pain and dysuria75’215’282.  About 20% of women 
diagnosed with VIN 3 are asymptomatic and the lesions are detected incidentally during 
clinical examination or other procedures.  The number of asymptomatic women 
diagnosed with VIN 3 is reportedly higher in genito-urinary medicine clinics72’137’ 215. 
The concept of vulval self-care is slow to evolve and even in the presence of symptoms 
there is delay in presentation.
3.3.4 Histopathology
The stratified layers of cutaneous squamous cells lose their normal orderly stratified 
architecture and show lack of progressive maturation from the basal layer to the more 
superficial layers (Figure 3.6a).  Nuclear pleomorphism, hyperchromatism and pyknosis 
occur in conjunction with abundant mitotic activity.  Abnormal mitotic figures can 
extend throughout the epithelium (Figure 3.6b).  Hyperkeratosis, parakeratosis and 
dyskeratosis are also observed.  Acanthosis and broadening of the rete pegs may be 
evident.  Skin appendages specifically sweat glands and hair follicles are involved in 
more than 50% of cases.
74Figure 3.6a  Photomicrograph of high-grade VIN -  usual type (VIN 3)
(Magnification x20)
Figure 3.6b  Photomicrograph of high-grade VIN -  usual type (VIN 3) showing 
abnormal mitosis (Magnification x60)
Triploidy
Abnormal
mitosis
75High-grade VIN is subdivided into three different categories based on histology -  usual r
type (basaloid, warty, mixed), differentiated and unclassified - in the proposed modified 
categorisation of VIN  .  The most common is the high grade usual type - basaloid, 
warty, mixed - variety with abnormal cells affecting the full thickness of the epithelium 
(VIN 3) and associated with HPV133’306.  Differentiated high-grade VIN is infrequently 
diagnosed as an isolated finding and is usually found adjacent to SCC, often in 
association with LS115’308.  Differentiated high-grade VIN has a low incidence of HPV, 
is possibly missed as the abnormal cells are found deep within the epithelial folds  ’
The patients included in the investigations in this thesis had high-grade VIN of the usual 
type - basaloid, warty, mixed (VIN 3).
763.3.5  Natural history of VIN
The diagnosis of VIN 1  and 2 is variable but on the increase due either to a real increase 
in incidence or to greater awareness125;138;159.  These lesions, particularly VIN 1  are 
thought to be the result of reactive cytology associated with vulval inflammatory 
disorders19,53.  Immunohistochemical techniques could be developed to differentiate 
between hyperplastic change and dysplasia89.
Angiogenesis, a phenomenon describing the formation of a new blood supply from 
existing blood vessels, is considered to be a key switch in tumour growth.  In SCC there 
is a significant correlation between strong expression of the angiogenic factor VPF 
(vascular permeability factor) / VEGF (vascular epithelial growth factor) and a high 
microvessel count with poor survival rates232.  In VIN the presence of VEGF and MVD 
is significantly lower in VIN 1  and 2 compared to VIN 314.  This suggests that VIN 3 is 
the relevant precursor of invasive cancer and that VIN 1  and 2 are low-grade disease.  It 
is of concern that VIN 2 and 3 tend to be classed as high-grade disease as in CIN 
because of histological difficulties in differentiating between these conditions246. 
Pathologists have rightly endeavoured to reduce this confusion by developing 
immunohistochemical techniques to better differentiate VIN 2 and VIN 3 323.  As
'J/LC
recommended by Sarhanis et al  and in view of the implications of treatment it is 
recommended that may be VIN 1  and 2 be considered low-grade disease.  This 
suggestion however does contradict the recent proposed modified classification for 
VIN285 in Table 3.4.
The malignant potential of VIN 3 is not disputed but the risk of progression to invasive 
disease is controversial.  Histological review of excised invasive vulval SCC specimens 
demonstrates the co-existence of VIN in 20-34% of cases (Table 3.2).  Occult invasive
77carcinoma is present in up to 23% of VIN 3 (Table 3.5).  The previous discrepancy 
between the frequency of diagnosis of VIN 3 and the age-adjusted incidence of 
SCC125;139;282 is now showing the expected cohort effect of an increase in the number of 
women diagnosed with vulval cancer particularly in women under the age of 50y155,194 .
78Table 3.5 Reported progression, recurrence and occult invasive disease rates for VIN
Study group N FU Progression with 
treatment
Recurrence Occult disease
*Sideri et al, 19992*6 52 6m-7y 12%
Modesitt et al, 1998217 59 7m-8y 2.3% 23.2%
Junge et al, 1997159 61 22y 0% 10%
Herod et al, 19961 2 5 133 15y 7% 65% with laser 
25% with excision
Ben David et al, 19962 1 102 12y 29%-excision
55.8% - laser vaporisation
Hording et al, 19951 3 3 73 23y 4% 16%
Jones et al, 19941 5 1 75 - treated 
(8 -  untreated)
6m-32y 5.3% treated 
(87.5% untreated)
21.3% - in treated group.
*Babero et al, 19931 6 58 31m 5% 11%
Hoffman et al, 19921 3 0 18 6m-5y 5.5% 16%
*Babero et al, 1990,:> 60 16% -surgical treatment - 
VIN 2,3
5% -medical treatment -  VIN 1,2
Shafi et al, 1989i82 46 lOy 6.5%
*Basta, 19891 9 71 >5y 7% - VIN 3 T16% - VIN 2 and 3 5.6%
Rettenmaier et al, 1987252 48 4m-
7.25y
2.6% 23% complete margins 
32% incomplete margins
19%/
Crum et al, 19841 1 41 10% t22%
*Includes VIN land 2, as well as VIN 3  *  Radical surgery better cure rate compared to conservative surgery
N = number of subjects 
FU = Follow-up
79The true natural history of high-grade VIN has not been systematically studied and 
therefore remains unanswered.  The thought-provoking studies from the New Zealand 
experience reported by Jones and McLean in 1986 and, Jones and Rowan in 1994 show 
that the risk of progression of untreated VIN 3 to invasion is as high as 87% in the 
presence of multicentric disease in a background of HPV in the older woman150’311.  In 
view of these reports there are serious ethical issues impeding acceptance of a 
prospective study of VIN 3.  As with cervical neoplasia, it is not possible to clinically 
differentiate lesions at increased risk of progression, although immunohistochemical 
studies such as the expression of VEFG may provide some pointers in the future197. 
Compared to the cervix, repeat excision of the affected vulval region increases 
morbidity more significantly.  There is therefore a great need for the development of 
techniques to allow more accurate diagnosis and follow-up, particularly if conservative 
medical therapy for VIN 3 is to be developed.
In the older woman wide excision is recommended because of higher progression rate 
and possible presence of occult invasive carcinoma16.  In the very young (15-27y) 
asymptomatic women, particularly in the presence of pregnancy, spontaneous
1  O
regression occurs and therefore observation with close follow-up should be the rule 
In young women, particularly if asymptomatic, with multifocal disease, observation 
with close follow-up is recommended to detect recurrence125.  In up to 10% of patients 
with VIN 3, invasive vulval cancer will develop despite adequate treatment and follow- 
up (Table 3.5).  This underlies the need for close long-term surveillance.
803.3.6  Treatment
Treatment is usually indicated on confirmation of a diagnosis of VIN 3, particularly in 
the presence of vulval symptoms.  There is now a trend towards less radical surgery 
with close follow-up to reduce morbidity by conservation of the vulval architecture and 
function  ’  .  There are broadly two modes of treatment -  the excisional and ablative
methods.
Excisional treatment when compared to ablative techniques has the advantage of 
providing a specimen for histological examination to exclude microinvasive disease and 
for inspection of the margins.  Accurate diagnosis of the depth of invasion in the 
presence of invasive disease is critical to determining the requirement for nodal 
dissection and cure rates.
Ablative techniques using CO2 laser seem to have a higher recurrence compared to 
excisional methods  ’  ’  .  There is also concern about the depth of treatment in the
presence of disease in the skin appendages, particularly hair follicles on the initial 
biopsy22.  In non-hairy areas preservation of sebaceous glands is important to maintain 
lipid secretion, which acts as a water barrier and maintains skin suppleness, thus 
preventing dry skin and severe dyspareunia283.  Therefore ablative methods after 
adequate biopsies to exclude early invasive disease is recommended for mucosal areas 
particularly the periuretheral and periclitoral areas while excisional method for hairy 
areas because of the depth of destruction required and closure of defect is eased by the 
presence and mobility of subcutaneous tissue35,125,163.
81In-spite of careful choice of the combination of treatment modality, recurrence of 
disease is common and very variable -  64%21; 11% (VIN 1,2,3)16; 22%72,16%130, 
16%(VIN 2,3)15.  Young women with multifocal HPV positive disease have a higher 
recurrence rate which could be due to new disease or inadequate treatment21’159’217.  The 
status of the margin is an important factor in the rate of recurrence, with reports of a 
three fold increase in half the mean time when the margin is incomplete159’217’252.
•  917
Modesitt et al  also commented on the difficulty in obtaining negative margins due to 
microscopic disease extending beyond acetowhite changes.  In these women 
development of disease at other lower genital tract sites is also frequently observed, and 
the future risk for lower genital tract invasive cancer is increased, so life-long vigilance 
is important21.
Medical treatment such as corticosteroid, testosterone, and P-interferon have been used 
to treat VIN 1  and VIN 2 particularly in young women15’16.  The cure rate with medical 
treatment for VIN 1  in young women is as high as 85%15.  The results of medical
10^* 1  Al
treatment for VIN 3 are unreliable compared to surgery  ’  , although currently there
is growing interest in imiquimod 5% cream which is an immune response 
modifier201’325.  Todd and Luesley315 reviewed the literature and reported that although 
there was a pressing need for Nonsurgical interventions, none of the Nonsurgical 
treatments reviewed resulted in optimal outcomes.  This may be partly due to the 
medical professional’s anxiety of disease progression in the presence of high grade 
disease, as there is currently no clinical technique that can assess disease status reliably 
without the need for invasive investigation i.e. surgery.
823.4  Assessment of the vulval skin
In many societies the importance and frequency of vulval disease is underestimated 
because this subject is a source of embarrassment.  Women with symptoms tend to 
delay seeking medical advice, sometimes suffering in silence for many years before 
presentation.  As many women perceive the assessment of the vulva as a source of 
embarrassment, the examiner should do everything possible to minimise this 
understandable anxiety.
Multidisciplinary clinical input -from a closely linked team of gynaecologist, 
dermatologist and genitourinary physician greatly facilitates the consultation20 305.  A 
committed pathologist is invaluable to the team as accurate histopathological diagnosis 
is much more relevant to the vulval skin compared to other skin sites because of the 
confusing nature of the clinical presentation of vulval skin disease.  Clinically, history 
followed by examination, are as always the preliminary investigative tools.
3.4.1  History
Turner and Marinoff317 provide a good review on history taking for vulval disease. 
Pruritus is the most common complaint followed by pain, which may be associated with 
superficial dyspareunia.  Occasionally the woman may have noticed a lesion on the 
vulval skin.  The history should include information on the general health status of the 
patient and a complete gynaecological and obstetric review.  The history provides clues 
to the site of disease and puts into context the presenting symptoms with other disease 
and lifestyle factors.
833.4.2  Clinical Examination
Privacy is essential, and the presence of an experienced nurse who can talk to the patient 
and allay anxiety during the examination is invaluable.  Examination of the vulva is 
described in detail by MacLean and Reid196 and includes inspection of other skin areas. 
Dermatological diseases of the vulva when compared to other skin sites are influenced 
by the location of this specialised skin in a constantly warm and moist area.
Colposcopy with colpophotography of the vulva aided by application of 5% acetic acid 
and 1% toludine blue helps demarcate areas of disease and follow-up
•  *•  50; 170;250 examination
Colposcopic examination of the subepidermal vessels in the vulva is more difficult 
compared to the cervix because the presence of keratin increases reflection and 
interference by hair.  Not all areas of acetowhite epithelium represent neoplastic change, 
such as VIN.  The acetic acid precipitates nucleoprotein to reflect more light giving the 
white appearance.  Other causes of increased nucleoprotein include infection and tissue 
repair following scratching or coital friction.  Toludine blue is a nuclear stain, which is 
retained in any tissue where the more superficial cells are nucleated, for example in VIN 
350 71.  Although there are some criticisms of this technique, toludine blue is useful to 
define the areas of abnormality that should be further assessed, including clear 
demarcation of areas requiring biopsy157.
843.4.3  Investigation
The main investigative tool is histological examination^ a skin biopsy.  In research 
several non-invasive bioengineering techniques have been applied to study various 
parameters of the normal vulval skin.  The same research parameters can be developed 
to assess diseased skin, such as is studied in this thesis, the application of a laser 
Doppler technique to measure vulval skin blood flow.
3,4.3.1  Biopsy and histological examination
Histological examination is usually needed to confirm diagnosis.  Outpatient biopsy of 
vulval lesions can be performed after infiltration with local anaesthetic, using a 4 or 6 
mm Stiefel disposable sterile biopsy punch204.  3% citanest (prilocaine 30mg/ml) plus 
octapressin (felypressin 0.03 iu/ml), contained together within a 2.2 ml cartridge is 
injected via a dental syringe and a 27-gauge needle.  A healthy 70 kg adult can tolerate 
up to 600 mg of prilocaine (that is 20 ml) without developing features of toxicity.  Once 
anaesthesia is established the punch is pushed with a twisting action through the skin, 
the resulting plug carefully moved out of the wound with fine dissecting forceps and the 
base of the plug cut with a scalpel blade or stitch cutter.  Ferric sub-sulphate (Monsel 
solution) or a silver nitrate stick is applied to the hole to secure haemostasis.  Larger 
areas of skin biopsy can be excised with scalpel under local or general anaesthesia 
depending on the extent of biopsy, and sutured to achieve haemostasis.
The skin biopsy is transferred to the pathology laboratory in a fixative such as formal 
saline.  Specimens for immunofluorescence and electron microscopy require special 
transport medium, which need to be pre-arranged with the laboratory.
853.4.3.2  Percutaneous absorption
Percutaneous penetration of topical application of drugs is generally limited by the 
stratum comeum and differences in regional penetration may be as great as hundredfold. 
Labelling the topical drug such as l4C -hydrocortisone and measuring the amount 
excreted in the urine can assess the percutaneous absorption.  The absorption of 1 4C 
hydrocortisone by the labia majora is 7.7% compared to 1.3% in the volar forearm and 
6% on the face49.  This is however much less than the scrotal skin (42%), which is 
homologous to the labia majora.  The absorption was higher in the premenopausal 
compared to the postmenopausal women for both the volar forearm and the vulva.  The 
kinetics of percutaneous penetration in the vulva showed a rapid absorption followed by 
a slow decrease whereas in the volar forearm it was a plateau. Topical testosterone also 
showed a higher absorption rate on the vulva compared to the volar forearm but there 
was no age related difference235.  These marked regional differences could be attributed 
to variations in the thickness of the stratum comeum or the number and size of hair 
follicles and other appendages or skin blood flow.
863.4.3.3  Transepidermal water loss
The stratum comeum provides an interface to retain water.  Water diffuses from viable 
dermal tissues through the stratum comeum to the external environment as a result of 
the gradient that exists.  The rate at which it diffuses across the stratum comeum is 
called transepidermal water loss (TEWL) -  an index of the efficiency and integrity of 
the stratum comeum.  Damage to the barrier by skin disease or physical or chemical 
trauma result in increased TEWL from baseline values.  At baseline the vulva appears to 
be far more permeable to water than the forearm47.  However in some vulval studies 
there was periodic bursts of markedly increased water loss which was not demonstrated
Q A
in the forearm  .  This is attributed to increased emotional sweating characteristic of the 
vulva due to the increased number of eccrine sweat glands on the external surface of the 
labia majora, at the site of these studies.
3.4.3.4  Stratum corneum water-holding capacity
Stratum comeum water content is a function of at least two properties: (1) 
hygroscopicity (i.e. ability to take up water) and (2) ability to retain water.  The lipids 
within the stratum comeum of the vulva are relevant to barrier function and
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delipidisation increase TEWL equally in pre- and post-menopausal women  .
873.4.3.5  Sensitivity to irritant activity
Vulval skin was significantly more reactive thaij forearm to certain irritants48.  Increased 
subjective complaints of burning and stinging may be related to the nerve receptors in 
the genital region having lower threshold to stimuli, reflective of its role in sexual 
response.  However other irritants which produce marked clinical signs of dermatitis on 
the forearm, only produce subtle sub-clinical changes on the vulva detectable only by 
modem bioengineering instruments such as relative capacitance85.  Therefore potential 
substances to be used on the vulva should be tested on the vulva rather than on the arm 
or the back.
3.4.3.6  Mechanical trauma
Stripping of the stratum comeum results in relatively less change in barrier function 
compared to the forearm, probably since the epidermal barrier is physiologically 
reduced at the vulva343.  The post-traumatic regeneration of the epidermal barrier is 
accelerated at the vulva compared with the forearm.  This suggests a higher basal 
epidermal cell turnover of vulval skin.
3.4.3.7  Skin bloodflow
The mean basal blood flow through labia majora measured with the LDF was twice that 
of the forearm (P<0.003)83.  Nicotinate-induced erythema is less intense and lasts 
shorter in the vulva compared to the forearm, probably due to dumping effect by higher 
basal blood flow83.
883.5  Conclusion
Vulval LS and VIN 3 cause significant morbidity and risk mortality when there is 
development of carcinoma.  There is a definite but poorly defined risk of progression to 
cancer.  However the majority of women with these diseases do not develop cancer but 
will require careful monitoring and excision of suspicious lesions for diagnosis and 
treatment.  Excision of large areas of vulval skin distorts the external genitalia causing 
significant morbidity.  Currently there is no reliable non-invasive technique to monitor 
disease progress and to accurately identify malignant disease.  If such a technique were 
to allow objective measurement of disease progress, in particular, to reliably detect the 
point as close as possible to the transition form pre-malignant to malignant disease, 
there would be greater clinician confidence in conservative monitoring and use of 
medical treatment, reducing the need for disfiguring vulval surgery.
Currently the only non-invasive technique for the assessment of the vulva comprises of 
the colposcope, particularly when pre-invasive disease is suspected, to Study the 
morphology of the sub-epidermal blood vessels.  The presence of keratin on vulval skin 
impedes the reliability of vulval colposcopy.  The flow of blood within these sub- 
epidermal vessels could provide a further parameter in VIN 3 and LS to monitor serial 
changes in disease progress, including response to conservative medical therapy and to 
identify skin areas at risk of malignant invasion.  In the next chapter the methods 
available to study SBF are reviewed.
89CHAPTER 4
A critical review of biophysical 
methods available for the assessment 
of the vulval skin microcirculation
90Interest in the measurement of the skin microcirculation started in the 1930’s, when 
many of the principles underlying the techniques currently available were conceived. 
The advent of microprocessors and microcomputers in the 1960’s and 1970’s was the 
key to the rapid progress in technology during the past few decades.  Table 4.1 shows 
the non-invasive methods for the clinical study of the skin microcirculation.
Table 4.1  Non-invasive methods for the clinical study of blood flow in small 
vessels
Blood flow 
parameter
Direct technique Indirect technique
Temperature •  Thermography -  temperature gradient
•  Heat clearance
Oxygen
content
•  Tc P02 -  O2 diffusing through skin
•  Reflectance Spectrophotometry -  
haemoglobin or blood content and O2 
saturation
Physical 
movement of 
blood
Capillaroscopy -  
movement of 
RBC
•  Photoplethysmography -  blood volume 
flow
•  LASER Doppler -  movement of RBC
RBC - red blood cell
Tc P0 2 -transcutaneous oximetry
O2 - Oxygen
Invasive techniques include clearance of radioactive material and dye dilution such as 
dynamic fluorescent capillaroscopy.  Table 4.2 (a-e) describes the features and 
application of these techniques in more detail.  All these techniques have been 
extensively applied to measure SBF to study pathophysiology and/or to directly monitor 
skin disease or indirectly as a marker of systemic diseases such as diabetes.
91Table 4.2  Biophysical methods for measuring skin blood flow -  Date of Proposal and Principle.
Methodology
Date of 
proposal
Principle
Radioactive clearance 1948353 Rate of disappearance of a radioactive isotope in perfused skin is determined by the rate of SBF.
Heat clearance
1 9 3 3 2 0 2 Rate of change in temperature with time of a well-insulated probe on the skin surface is related to the rate of SBF.
Skin temperature 
- Thermography
19311 1 1 Heat generated by the body is dissipated as infra-red emission (heat) through the skin by changing skin perfusion318.
Transcutaneous oximetry 1972244 Surplus oxygen from superficial papillary capillaries diffusing towards the skin surface is proportional to the rate of SBF.
Reflectance
Spectrophotometry
19357
The relative absorption (RA) value at specific wavelengths of white light projected onto the skin surface is proportional to 
the haemoglobin content in the tissue160.
Capillaroscopy
1950’s  1 2 4 Microscopy used to directly observe capillaries (x5-xl00) and the movement of RBC (x250-xl000) within capillaries in
t
the papillary dermis.
Photoplethysmography 1937348
Near infra-red light radiated onto skin and the emerging amount of reflected light at the skin surface is inversely 
proportional to the blood volume271.
Laser Doppler
1972 25V  
1975  3 0 0
A monochromatic coherent laser light is shifted in frequency according to the Doppler effect when scattered by moving 
red blood cells in tissues.  The Doppler broadening or change in frequency is proportional to the product of the red cell 
velocity and their concentration.
92Table 4.3  Biophysical methods for measuring skin blood flow -  Methodology; Units of measurement, direct or indirect measure of  SBF and remarks.
Methodology Method Unit of measurement Direct or indirect Remarks
Radioactive
clearance2 8 1
The radioactive isotope of an inert gas dissolved in saline solution introduced 
intradermally or by the epicutaneous technique. The amount of isotope 
remaining at the injection site is monitored using a scintillation counter.
Absolute units: 
ml/g/min*
Indirect Isotope clearance curve is 
biexponential353.
Heat Clearance
A well-insulated probe with good skin contact using contact liquid is required. 
Several variations of the technique include steady-state heat clearance1 3 2 ,2 1 2 in 
which time taken either for a heated probe or a disc with an annulus to reach 
thermal equilibrium is measured, conductivity7 9 in which the power to maintain 
a temperature differential between central disc and the annulus is measured and 
transient heat clearance2 2 7 measures time taken for probe to reach equilibrium 
with skin temperature.
Absolute units: 
ml/g/min*
Arbitrary units for 
thermal conductivity: 
KT4 cal/cm°C.sec
Indirect fThe depth response 
depends on the sensor 
geometry313.
Skin temperature 
- Thermography
Skin temperature is measured at a single point or a continuum of points over an 
extended body surface area displaying a thermal image (thermography) of the 
spatial distribution of temperature U1, which can be enhanced by 
thermostimulation for diagnostic purposes77.
Qualitative analysis of 
right versus left side 
temperature 
differences: °C.
Indirect tThermographic changes 
can be result of disease in 
deeper organs77’318.
Transcutaneous 
oximetry 2 2 4 ;2 4 4
The skin surface is heated to 44°C to reduce the barrier effect on oxygen 
diffusion and to arterialise the blood in the capillaries underneath the electrode. 
The oxygen solubility in blood is reduced and its disassociation curve is shifted 
to the right.  An electrode reduces the oxygen diffusing through the skin 
surface and an electric current is generated, which is converted into a partial 
pressure measurement.
Arbitrary: mmHg Indirect Skin heating arterialises 
superficial capillaries319.
fThe depth of measurement from the skin surface is not clearly defined.  *Depends on the tissue-blood partition coefficient.
93Table 4.3 (-continued)  Biophysical methods for measuring skin blood flow -  Methodology; Units of  measurement, direct or indirect measure of SBF and remarks.
Methodology
Method Unit of 
measurement
Direct or 
indirect
Remarks
Reflectance
Spectro­
photometry
The backscatter from white light projected onto skin is diffracted by a spectrometer and 
the RA at specific wavelengths provides a measure of the different skin elements184.  In 
the context of skin perfusion the RA of haemoglobin at wavelength 569pm in the visible 
region and 800pm in the near infrared region measures the microvascular red cell volume; 
and the RA of deoxygenated haemoglobin is used to measure oxyhaemoglobin160;200;328, an 
index of tissue oxygenation.  Interference from melanin is mainly in the ultraviolet region, 
less in the visible region and non-existent in the near infra-red region221.
Arbitrary 
units: RA units
Indirect fThe depth of 
measurement depends on 
the sensor wavelength and 
geometry.
Capillaroscopy1 2 4
White light with magnification and video recording facilities allow for real-time imaging 
and for retrospective analysis.
Qualitative
and
quantitative
Direct Nutritive papillary 
capillaries -  morphology 
and function studied.
Photoplethysmo­
graphy
Infrared radiation from sensor collected by photoelectric detector either in reflection mode 
or transmission mode. 90% of the reflected light originates from the tissue substance,  10% 
from venous blood volume (quasi DC signal - slowly changing venous portion) [DC-direct 
current] and about 0.1% from arterial blood volume (AC signal - pulsating arterial signal) 
[AC-altemating current]271.
Qualitative / 
quantitative 
analysis of 
waveform271.
Indirect Changes in blood volume
/
in the cutaneous and 
subcutaneous vascular 
plexuses271.
Laser Doppler
Monochromatic coherent laser light is transmitted to the skin and a photoelectric detector 
collects the backscatter containing the Doppler frequency information, which is converted 
to a voltage output, giving an arbitrary value of perfusion90’91.
Arbitrary: flux 
or perfusion 
units
Indirect fThe longer the 
wavelength the deeper the 
penetration of the laser 
light41142.
fThe depth of measurement from the skin surface is not clearly defined.
94Table 4.4  Biophysical methods for measuring skin blood flow -Advantages and Disadvantages
M e th o d o lo g y A d v a n ta g e s D is a d v a n ta g e s
R a d io a c tiv e
c le a ra n c e
•   Q u a n tita tiv e  m e a s u re   i f  K e ty ’s  p r in c ip le  a p p lie d .
•   C a lib ra tio n  n o t re q u ire d .
•   R e p r o d u c ib le " .
•   B ie x p o n e n tia l c u rv e  a llo w s  s e p a ra te  a s s e s s m e n t o f  
p e rfu s io n  w ith in  th e   s u p e rfic ia l p a p illa ry  c a p illa rie s  
a n d  th e  d e e p  re tic u la r  v e s s e ls 353.
•   In v a s iv e , p a in fu l  a n d  tim e -c o n s u m in g .
•   R e p e a ta b ility   lim ite d  b y  tim e  ta k e n  fo r  tis s u e  s ta b ilis a tio n  a n d  th e r e f o r e  d is c o n tin u o u s  a n d  n o t re a l 
tim e .
•   R is k  o f  ra d ia tio n  e x p o s u re .
•   L o c a l c h a n g e s   in  p e rfu s io n  a t  in je c tio n   site .
•   R e q u ire m e n ts  o f  K e ty ’s p rin c ip le  n o t p r a c tic a l  in  c o m p le x  tis s u e  s u c h  a s   s k in 212.
H e a t C le a ra n c e •   Q u a n tita tiv e  m e a s u re   if  K e ty ’s p r in c ip le  a p p lie d .
•   C a p ita l  c o s t a n d  ru n n in g  e x p e n s e   is   lo w .
•   S im p le  to  u s e .
•   A llo w s   s e ria l  re a d in g s   fro m  th e  s a m e  s ite .
•   E x a c t d e p th  o f  m e a s u re m e n t  is n o t c le a r51.
•   T im e  c o n s u m in g  (~ 8  to  2 0  m in ) a n d  th e re fo re  d is c o n tin u o u s   a n d  n o t re a l tim e .
•   C o n trib u tio n  to  h e a t flo w  b y  tis s u e  c o n d u c tio n  c a n n o t b e  s e p a ra te d   fro m  c o n v e c tio n  b y  b lo o d  flo w .
•   R e q u ire m e n ts  o f  K e ty ’s p r in c ip le  n o t p ra c tic a l  in  c o m p le x  tis s u e  s u c h  a s   s k in 212.
•   S k in  c o n ta c t re q u ire d .
S k in  te m p e ra tu r e   - 
T h e rm o g ra p h y
•   P a in le s s  a n d  w e ll to le ra te d .
•  N o n - c o n ta c t te c h n iq u e .
•  N o t in flu e n c e d  b y  s k in  p ig m e n ta tio n .
•   L a rg e   s k in  a re a  a n a ly s e d .
•   T e le th e rm o g ra p h y  c a n  p ro v id e  re a l tim e  c o n tin u o u s  
m e a s u re .
•   A c tu a l d e p th  o f  s k in  c o n trib u tin g  to  th e  e m itte d  h e a t is  n o t c le a r  b u t is  lik e ly  to  b e  l^ rg e 32,114.
•   T im e  c o n s u m in g  w ith  a  to ta l  im a g in g  tim e  o f  u p  to  3 0  m in 111.
•   V e ry  e x p e n s iv e .
•   O n ly  v a lu a b le   fo r q u a lita tiv e  a s s e s s m e n t o f  th e rm a l g ra d ie n ts .
•   T h e rm o s tim u la tio n  m a y  b e  n e e d e d  to   id e n tify  p a th o lo g y 77.
•   T h e rm a l d iffu s io n  to   le v e l o u t th e  te m p e ra tu re  d iffe re n c e s  re d u c e s   s e n s itiv ity   fo r a s s e s s m e n t o f
121 *270*280
s p a tia l  v a ria tio n  o f  s u p e rfic ia l  s k in  b lo o d  flo w   ’  ’
95Table 4.4 (-continued)  Biophysical methods for measuring skin blood flow -  Advantages and Disadvantages
M e th o d o lo g y A d v a n ta g e s D is a d v a n ta g e s
Transcutaneous
oximetry
• Capital cost and running expense is low.
• Measurement depth is likely to be limited to the nutritive 
capillaries in the papillary dermis253’299.
•  Calibration and data collection excessively delicate and time consuming253.
•  Maintenance tedious -  re-site probe every 4h to  8 h to avoid skin bums244.
•  Care with choosing skin site and application of probe to avoid false low or high 
values158.
•  Many variables influencing measurement such as capillary density, skin metabolism 
and oxygen consumption, skin thickness, blood viscosity, haemoglobin concentration, 
haemoglobin affinity for oxygen and oxygen permeability of the vessel wall and skin, 
make interpretation of a single value complex  ’
•  Methodology alters the physiological state of the skin by heating the skin to 44°C and 
arterialising the papillary capillaries117’322.
•  Skin contact required.
/
Reflectance
Spectrophotometry
•  Quantify haemoglobin content and oxygenation in the 
superficial dermis.
•  Real-time.
•  Fast response times (2ms) to obtain a single spectrum,  .'. 
relatively insensitive to movement artefact
•  Near-infra red spectroscopy is not influenced by 
melanin.
•  Exact depth of measurement is not clear.
•  Single point measurement so multiple readings required to assess spatial 
heterogeneity, which is time consuming.
•  Skin contact required.
96Table 4.4 (-continued)  Biophysical methods for measuring skin blood flow -  Advantages and Disadvantages
M e th o d o lo g y A d v a n ta g e s D is a d v a n ta g e s
Capillaroscopy •  Real-time
•  Direct visualisation of nutritive capillaries in papillary 
dermis in-vivo under physiological conditions.
•  Expensive
•  Non-contact technique.
•  Limited access as skin surface perpendicular to microscope objective, with a large part 
of the capillary loop in the horizontal plane required, such as in the nail fold of finger.
•  Limited by skin translucency and pigmentation.
•  Increase in magnification reduces the observation area and the number of capillaries 
available for observation.
•  Depth of measurement is not clear.
•  Does not provide quantitative measure of capillary blood flow.
•  Repeatability depends on equipment performance, in particular its ability to produce 
uniform epi-illumination across the field of interest.
Photoplethysmography •  Not expensive
•  Rapid and clinically convenient method which can be 
used at the bedside and procedure takes 2  min to 
complete at each skin site180.
•  Technique requires skin contact2 9 7
•  Delay in detecting some blood flow changes such as venous obstruction when 
assessing the viability of venous flap3 2 6
•  Reduced sensitivity for skin microcirculation as the signal reflects the changes in 
blood volume in the cutaneous and subcutaneous vascular plexuses.
Laser Doppler •  Simple to use
•  Real time measure with instant response to blood flow 
changes
•  LDF provides a continuous record at a single point.
•  LDPI can assess spatial heterogeneity in an area of skin 
without contact335.
• Depth of measurement not clear.
• LDF requires skin contact.
• LDPI is expensive
• When comparing LDPI output between different subjects measurement of relative 
changes to provocation tests is advocated rather than measuring absolute values.
97Table 4.5  Biophysical methods for measuring skin blood flow -  research and clinical application
M e th o d o lo g y R e s e a r c h   a p p lic a tio n C lin ic a l a p p lic a tio n
Radioactive
clearance
• Previously used as gold standard against which new techniques 
studied. Now rarely used because of invasiveness and also 
improved understanding and advances of the other non-invasive 
techniques n3;301.
• Used with other non-invasive techniques to study blood flow within 
the arterio-venous anastomosis (AVA), using the fast component of 
the biexponential curve to measure capillary blood flow211.
•  Viability of various types of venous flaps by Wolff et al 346.
•  To determine level of amputation in critical limb ischaemia by Harrison et
aj 120; 12 2
Heat Clearance
• SBF in hand in Raynaud’s Phenomenon by Roussel et al262.
• Age related physiological changes in blood flow within AVA by 
Midttum210.
• Pre and post-menopausal changes in regional SBF in the areola of 
normal breast by Nitzan et al227.
•  Thermal conductivity to differentiate between deep partial thickness and full 
thickness burn by Dittmar et al7 9
•  Regional SBF with pressure index to measure specific vascular resistance in 
diabetic and non-diabetic patients with peripheral vascular disease by Nitzan et 
al2 2 8
Skin
temperature - 
Themography
• The dynamic balance between the thermoregulatory and 
haemodynamic processes during exercise by Zontak et al356.
• Thermal inertia during application of local vasoconstrictor and 
vasodilator on the forearm by Huang & Togawa136.
• Static area and dynamic area telethermography in management of chronic 
orofacial pain, temporomandibular joint disorders and inferior alveolar nerve 
deficit111.
• Thermostimulation in the diagnosis of melanoma and identification of an irritant in 
allergic contact dermatitis77.
• Dermothermometry in conjunction with capillaroscopy for detection of subclinical 
changes within skin microvasculature in medical professionals exposed to ionising 
radiation52.
98Table 4.5 (-continued)  Biophysical methods for measuring skin blood flow -  research and clinical application
Methodology Research application Clinical application
Transcutaneous
oximetry
•  Compare differences in SBF in adjacent undamaged skin and at ulcer edge in pressure 
ulcers269.
•  Used in conjunction with LDF to assess microvascular reserve in diabetes and connective 
tissue diseases such as systemic sclerosus and scleroderma by Valentini et al322.
•  Used in neonatal intensive care units to monitor Pao2253.
•  To discriminate between fast and slow healing venous ulcers 
in conjunction with capillaroscopy by Steins et al299.
•  To discriminate patients in the intermediate group suffering 
intermittent claudication who may benefit from conservative 
therapy by using provocative tests such as total occlusion of 
circulation to measure reactive hyperaemia7 8 266.
Reflectance
Spectro­
photometry
•  To investigate the skin structure, monitoring of molecules in metabolic processes and 
the evaluation of skin diseases and therapeutic results184.
•  Kakizoe et al1 6 0 studied the contribution of alpha adrenoreceptor subtypes to skin 
microcirculation in rats.
•   Hanna et al1 17 compared Tc  Po2 with the spectrometer in patients with chronic venous 
insufficiency (CVI).
•  The pulse oximetry measures blood oxygenation and is 
widely used in clinical practise for quick determination of 
respiratory and circulatory status of the patient.
•  Harrison et al1 2 0 ;1 2 2 used haemoglobin oxygenation to replace 
their ‘gold standard’ radioisotope clearance in patients with 
critical limb ischaemia to determine the level of amputation.
Capillaroscopy
•  Used to validate other techniques that are more amenable to clinical application such as 
Steins et al2 9 9 showed the presence of angiogenesis as the reason for improved Tc  Po2  
measurements in fast ulcer healers.
•  Bull et al5 4 studied skin areas predisposed to venous ulceration in healthy young adults.
•  Stucker et al3 0 3 studied a variety of microcirculatory disturbances in CVI.
•  Used with LDF to understand the differences in control of the microcirculatory 
subsystems during mental stress183, reflex sympathetic dystrophy177, systemic lupus 
erythematosis28, peripheral vascular disease (PVD).and diabetes1 5 3 154.
•  Ubbink et al319;32° discriminated the different patient groups 
with lower limb ischaemia using red blood cell velocity 
(RBCV) at peak reactive hyperaemia.
•  In women with postmastectomy ‘oedema’ capillaroscopy 
with fluorescein angiography revealed neovascularisation as 
the underlying cause260.
•  Capillary morphology in the superficial skin vessels has been 
analysed in several dermatological and general medical 
conditions29’124.
99Table 4.5 (-continued) Biophysical methods for measuring skin blood flow -  research and clinical application
M e th o d o lo g y R e s e a r c h   a p p lic a tio n C lin ic a l a p p lic a tio n
Photoplethysmo 
-graphy (PPG)
•  Lee et al1 8 0 in PVD to determine the optimum amputation level.
•  Klyscz et al1 6 9 studied arterial circulation in workers exposed to vibration.
•  Laan et al1 7 8 studied vasocongestion of the vaginal wall to sexual stimuli.
•  Assessment of leg vein function, and disturbances of peripheral arterial 
circulation271.
•  Postoperative radial forearm free flap surveillance by Stack et al297.
Laser Doppler
•   L D F
o In animal study to investigate reserve circulatory capacity in cerebral 
circulation by Barfod et al17. 
o In animal studies to detect early changes in circulatory failure in 
hypovolaemia309. 
o To detect inflammatory changes before naked eye and in 
dermatopharmacology9 1 ;267. 
o Useful in diagnosis of fibromyalgia144.
o In aetiology of peripheral neuropathy in Type 1  diabetes and leprosy by 
Abbot et al1 .
o In sepsis to demonstrate impaired hyperaemic response by Young and 
Cameron3 5 4 due to abnormal rheological properties of blood10.
• L D P I
o In patients with systemic sclerosis and Raynaud’s phenomenon by 
Seifalian et al2 7 7 and Clark et al68. 
o In breast cancer by Seifalian et al2 7 5 and Parbhoo & Seifalian238.
• L D F
o To measure skin perfusion pressure (SPP) to assess severity in lower limb 
arterial disease65’95, 
o Preferred to PPG for accurate measurement of SPP by Malvezzi et al199. 
o To assess treatment of CVI with leg elevation by Abu-Own et al4. 
o To predict post-bum non-healing wounds by Atiles et al1 1. 
o Healing of anastomosis site of low anterior resection for carcinoma116.
• L D P I
o For measurement of SPP by Tsai et al316. 
o To assess bum depth by Niazi et al225.
o In transplant surgery to measure blood flow over a wide area without 
contact to demonstrate the spatial heterogeneity, as a useful parameter of
,9;82;216;276;278;279;321  ;342 reperlusion injury  . 
o At wound margins following total elbow replacement by Ljung et al187. 
o To study ulnar artery ligation vs. resuture by Bommyr et al3 0  
o For patch testing25’248.
o To study whole area of hyperperfusion in skin reactions caused by allergy 
and exposure to ultraviolet302’352.
100Invasive techniques such as radioisotope washout are not popular because they are 
cumbersome, lengthy and uncomfortable for the patient199’ 247.  Sodium fluorescence 
also requires an interval of up to 100-min between repeated measurements because of 
high background fluorescence, so limiting its use ’   .  Proano et al  compared LDF,
Xe clearance and sodium fluorescence.  The LDF was found to be the most 
convenient method because it is non-invasive and provides continuous real-time 
measurement, although perfusion is measured in vessels deeper than the nutritive 
capillaries.  Braverman et al40’41 correlated LDF signals with histological examination of 
the organisation of the cutaneous microvasculature, and concluded that the LDF signal 
was generated mainly by the movement of RBC within the upper horizontal plexuses.
When LDF is compared to thermal clearance using probe designed to measure the same 
sample volume, the shape of the signal was the same but the absolute values were very 
different, with the LDF providing better-defined changes in perfusion due to its
A  J A  A  | A
instantaneous nature of measurement  .  LDF has a low spatial resolution in the
order of 1mm3, which is overcome by the LDPI, which has a high resolution allowing
large skin area measurement.  The LDPI used in this thesis can measure skin
0    .  #
microcirculation in an area of 12mm .  The advantage of this high resolution is
demonstrated by the LDPI measuring a significantly higher skin microcirculation in
early stage pressure sore compared to undamaged skin, while other methods with lower
resolution -  LDF, sodium florescence and skin temperature - failed to measure any
significant difference in the two skin areas270.  The LDF appears to compare well to
‘area’ measurement of temperature by Infra-Red Thermography (IR-TH).  This is
however believed to be due to similar changes in perfusion taking place in the different
135 skin perfusion compartments  .
101The main limitation of the Tc P0 2 is the need for heating the skin to obtain a discemable 
result, which suppresses the local arteriolar vasoconstriction and thereby reducing its 
diagnostic capacity.  Ubbink et al319 could not detect a clear hyperaemic response in 
addition to noting a less  pronounced postural constrictive response with Tc P0 2 when 
comparing asymptomatic and symptomatic patients with lower limb ischaemia.  Kuvers
177
et al  could not detect any differences between the different stages of reflex 
sympathetic dystrophy with Tc P0 2, although the LDF and capillaroscopy, differentiated 
these stages of disease by demonstrating differences in control of the microcirculatory 
subsystems.
Reflectance spectrophotometry (RFS) provides a non-invasive, rapid, portable and 
simple method for monitoring changes in haemoglobin content and oxygen saturation 
during disease and its treatment121’223’224.  The RFS and LDF measure different aspects 
of SBF.  RFS provides a measure of haemoglobin content within the microvasculature 
of the skin, while the LDF measures the velocity or movement of RBC.  Simonen et 
al288 reported good correlation between RFS and LDF at most anatomical sites, although 
the overall perfusion pattern was different.  The SBF measurement decreased in the 
cranio-caudal direction with the RFS while the LDF was relatively uniform across the 
body, except the head and groin were higher and the abdomen was lower.  When 
compared to the histological capillary density studies by Pasyk et al240 it is tempting to 
speculate that the signal from the RFS correspond to subepidermal papillae and the 
LDF, from the deeper microvascular plexuses of the reticular dermis.  Interestingly 
Stucker et al304 applied the LDPI to a similar study and reported significantly higher 
blood flow on the face compared to the trunk and the lowest blood flow in the buttock 
and lower limb suggesting a cranio-caudal decrease similar to that reported with the
102RFS.  The measurement of the two techniques is influenced by the skin morphology, 
blood flow and content.
The photoplethysmography (PPG) signal reflects the changes in blood volume.
Lindberg et al186 compared LDF with a modified micro PPG-laser to overcome the 
widely different optical arrangements.  The LDF principle proved to be a more sensitive 
parameter for recording more superficial skin perfusion while the PPG principle was 
more sensitive with appropriate probe geometry for measuring blood volume change 
within the cutaneous and subcutaneous plexuses186.  In order to understand the 
pathophysiology of disease and to clinically monitor disease processes, limiting the 
sample volume as close as possible to the nutritive perfusion is valuable.  The LDF 
when compared to the PPG measures a smaller microvascular volume within the 
superficial cutaneous plexuses and so meets this requirement more suitably.
The optical techniques discussed in this chapter -  laser Doppler, spectroscopy and 
photoplethysmography -  are influenced by the wavelength of light used and the skin 
optical properties8’184.  The skin optical characteristics are defined as the ability of skin 
to reflect, scatter and absorb light.  For example in the epidermis melanin content and 
distribution plays a major but highly variable role in determining the transmission of 
optical radiation through skin.  In the dermis scattering by collagen fibres is of major 
importance in determining the penetration of optical radiation.  The presence of 
chromophores such as haemoglobin and bilirubin influence light absorption.
The vulva is an area of specialised skin, which unlike other skin areas is not easily 
accessible for examination, and as a result is rarely studied.  Research of the vulval skin 
microcirculation requires the patient in the lithotomy position, which is embarrassing 
and uncomfortable.  In elderly patients restricted movement at the hip joint is common
103and reduces access to the vulval structures.  The vulva consists of overlapping skin folds 
with varied morphology, as described in Section 2.1.3.4, and so the microcirculation in 
each fold of skin would be better assessed separately.  This makes the process of 
studying the vulval skin microcirculation very delicate and precise with the important 
priority being that the technique selected should avoid lengthy examination periods.
There have been several studies on vulval skin microcirculation using the LASER 
Doppler technique.  Wilhelm et al344 and Eisner et al83 investigated the physiology of 
normal vulval skin using low resolution (1mm2) measurement with LDF on the labium 
majus at a single point to represent vulval skin perfusion.  Jackson et al140 used the LDF 
at several points on comparative sites of the vulva and so obtained a better 
representation of skin blood flow to demonstrate abnormal perfusion in vulva cancer. 
Bohm-Starke et al27 used the LDPI to demonstrate significantly increased skin blood 
flow in the most painful part of the vestibular mucosa in women with vulval vestibulitis. 
This group was able to assess the whole vestibular mucosa in each patient within 3 
minutes.
Therefore the technique most suitable for assessment of vulval skin microcirculation 
should be able to make rapid measurements in real-time over a representative area of 
skin.  The depth of measurement should be known and adjustable to limit measurement 
to the nutritive papillary capillaries in the superficial dermis in the different areas of 
vulval skin.  The technique should also be repeatable, non-invasive, affordable and 
portable.
The majority of the non-invasive techniques are able to make a rapid measurement in 
real time but tend to use a probe-based system, which requires direct contact with the
104skin surface, and only allows measurement at one point, which in the LDF has a low 
resolution of 1mm .  The value of measuring blood flow at a single point to represent 
the whole area of vulval skin, particularly considering the varied morphology of the 
vulval skin folds, is doubtful.  Comprehensive assessment of vulval skin perfusion with 
repeated single point measurements is excessively time-consuming and tedious for both 
the patient and the investigator.  Therefore the Infra-red Thermography 
(IR-T) and the LASER Doppler perfusion imager (LDPI) that can assess the 
microcirculation in an area of skin such as the vulva, without direct contact with the 
skin surface and within a short period of time to produce a colour-coded image of skin 
perfusion are most suitable.
IR-T is dependent upon the skin temperature, which is influenced by both external and 
internal factors121’135’280.  Skin heating depends on heat delivery by blood and thermal 
conductivity of the subcutaneous structures while skin cooling or heat loss occurs by 
radiation from the surface, in addition to convection by blood and tissue conduction. 
Therefore it is important that the conditions, in particular the ambient temperature, are 
very closely controlled and defined.  The signal of the IR-T is influenced by inflow 
from the superficial and deep layers of dermis and subcuticular tissue51’345.  A feature of 
skin temperature as a parameter of skin perfusion is thermal diffusion to level out the 
temperature differences between local adjacent areas of high and low flow resulting in a 
less sensitive measure of spatial differences in superficial skin perfusion
The LDPI applies the same principle as the LDF and measures the movement of red 
blood cells within the upper horizontal plexuses41’108’121.  The LDPI provides a sharper 
definition of spatial differences in perfusion compared to IR-T121,280,335.  As with other 
optical techniques, the LDPI does not easily lend itself to depth assessment because the
105exact path taken by a light photon in the skin is difficult to determine and varies with 
morphology221.  Although more or less equally expensive to the IR-T, the LDPI is more 
compact and portable.
In conclusion the LDPI is the most suitable method for use on the vulval skin because 
SBF can be measured over a wide area (12mm2) within a short period of time.  The 
advantage of representing blood flow over a specified area rather than at a single point 
is that the effect of large spatial and temporal fluctuations in tissue blood flow occurring 
in small areas is minimised.  In the next chapter, Chapter 5, the methodology of the 
LDPI is discussed on greater detail and includes validation studies.
106Method Used To Assess The Vulval 
Skin Microcirculation
1075.1  Introduction
As discussed in Chapter 4 there are many methods available to assess SBF.  The 
LASER Doppler perfusion Imager (LDPI) is a new and novel, non-invasive technique 
used for the first time on the vulva to measure perfusion264.  The LDPI is able to map 
the spatial variation of the microcirculation in an area of skin and display the 
information as a two-dimensional colour-coded image on the computer monitor335.  This 
task is performed without contact with the skin surface, thereby reducing the risk of 
spread of infection, which is relevant to assessing SBF on the external genital skin.
The aim of this chapter is to highlight the theoretical principles and instrumentation of 
the LDPI and to validate this instrument using a blood-flow model.
5.2  Basic theory and operating principles of the LDPI
LASER is an acronym for Light Amplification by Stimulated Emission of Radiation161. 
A laser beam is produced by excitation of certain materials known as active media, 
using an electrical current.  The active media in the LDPI is a mixture of helium and 
neon gases (HeNe, A,=633nm).  This is followed by amplification using optical feedback 
between a pair of mirrors located on either side of the active medium.  The laser light is 
extracted by slightly reducing the reflectivity of one mirror, allowing transmission of 
part of the light impinging on it.  LASER light has three special qualities compared to 
ordinary light - coherence, collimation and monochromaticity.
108The principle of the laser Doppler technique is based on the Doppler effect first 
described by Christian Johann Doppler, an Austrian physicist and mathematician, in 
1 8 4 2284  This phenomenon describes the change in the observer’s perceived frequency 
of waves (sound, light, water and radio waves) as a result of the relative motion of the 
source of the waves and/or the observer; the frequency increases as they approach each 
other and decrease as they move apart.
The laser beam incident on tissue is scattered in static structures as well as in moving 
red cells (Figure 5.1).  Light beams scattered in moving red cells undergo a frequency 
shift according to the Doppler effect, while beams scattered in static tissue alone remain 
unshifted in frequency.  A portion of the frequency shifted or broadened backscattered 
light is brought to impinge on the surface of a photodetector where beat notes produced 
by mixing waves scattered in different structures are formed.
Figure 5.1  Laser light transmitted to skin, by the LDPI, is scattered by 
stationary tissue elements and by moving blood cells within the microvessels.
Detector Laser
109The outermost layer of skin is the epidermis, which is free from blood vessels.  The 
superficial dermis beneath the epidermal layer is supplied with a profuse system of 
capillaries which arise from the papillae of the comeum and return to the subpapillary 
plexus, as described in Section 2.2.2.1.  The interaction between light and tissue 
involves a process of multiple scattering and absorption.  The laser Doppler technique 
measures blood flow in the very small blood vessels of the microvasculature, such as 
the low speed flows associated with nutritional blood flow in capillaries close to the 
skin surface and flow in the underlying arterioles and venules involved in regulation of 
skin temperature.  Detailed knowledge of the scattering process and depth of penetration 
is extremely difficult to obtain because factors affecting skin morphology such as 
pigmentation and changes in blood volume influence the penetration depth of light in 
tissue.
In theory, the shape of the power spectrum will for the main part be unaffected by 
variations in red cell concentration, if the velocity of the red cells and the microvascular 
bed geometry are fixed, while the magnitude of the Doppler signal increases with red 
cell concentration.  If, on the other hand, the red cell concentration and the flow 
geometry are fixed, the energy of the power spectrum will be shifted towards higher 
frequencies when the mean value of the red cell velocity distribution is increased.  Apart 
from the vascular bed geometry, red cell concentration and velocity, secondary 
parameters such as scattering in more than one moving red cell and changes in 
penetration depth due to variation in tissue morphology, may influence the power 
spectrum of the Doppler signal.
At each measuring point, a photo detector in the scanner head detects the scattered laser 
light.  The resulting photocurrent has a DC component proportional to the total back-
110scattered light intensity, and an AC component, the amplitude and frequency of which 
are dependent on the Doppler broadened laser light.  An analog or digital processor 
convert the photocurrent measured by the laser Doppler into units of Flux.
F  =  V  X  C
The flux (F) is given as the product of the average velocity of the moving red blood cell 
(V) by concentration of the moving red blood cell (C) in a given sampling tissue 
volume.
Traditionally the laser Doppler flowmetry (LDF) allowed continuous recording of 
temporal variations of perfusion at one point with time and facilitated measurement of 
perfusion at tissue sites not easily accessible to the laser beam such as internal organs 
during minimal access surgery.  However, the low spatial resolution (~lmm ) of the 
LDF does not take into account of the large spatial and temporal fluctuations in tissue 
blood flow that occur over small areas of skin, which the LDPI can minimise44.  The 
LDPI is able to integrate tissue perfusion over a specified area and provide a valid 
measure of in vivo tissue perfusion98.  Other limitations associated with the LDF 
include limitation of some applications such as open wound sites and movement of the 
fibre optics during measurement resulting in artefacts that may make interpretation of 
results difficult.
The basic elements of the LDPI are shown schematically in figure 5.2 and a colour- 
coded image of the hand is shown in figure 5.3.
111Figure 5.2  Block diagram of the LDPI
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Figure 5.3  Colour-coded perfusion image of the hand.
4 1125.3  Instrumentation
The LDPI used for this thesis was the PIM  1.0 by Lisca Development AB, LinkOping, 
Sweden.  This imaging system consists of a source of laser and a scanning head (Fig 
5.4a-d).  The source of laser is a low power (2 mW) HeNe laser (>* = 633 nm).  The 
scanning head houses the optical scanner and the detector unit.
Figure 5.4a  The PC controls the optical scanner, processes the photocurrent 
from the detector to form a signal proportional to skin perfusion and generates a 
colour-coded image on the monitor.
113The optical scanner consists of two mirrors controlled by two stepping motors, which 
direct the HeNe laser beam sequentially, in a raster fashion at up to 4,096 points.  The 
area of tissue covered is  120 x  120 mm  , in a time period of about 4 min.  This 4 min 
period includes the time required for the beam to remain stationary at each measurement 
point to calculate the perfusion parameter (~35 ms) and a certain time for movement 
(~15 ms) to the next measurement point.  A Personal Computer (PC) controls the 
stepping motors.
Figure 5.4b  The imaging system consists of a source of laser and a scanning 
head.
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114Figure 5.4c-d The scanning head houses the stepping-motor which controls the 
mirrors moving laser beam over the measuring site, and a detector unit that 
collects the backscattered Doppler shifted light.
Figure 5.4c
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115The detector unit consists of a photodiode positioned at the same distance as the 
incident light from the measuring site, detecting the backscattered light.  This 
photodetector neither senses the actual light wave frequency nor discriminates between 
the positive and negative frequency shifts.  The detector only notes the absolute 
differences in frequencies between the frequency shifted beam and the portion of the 
unshifted light in the backscatter.  An alternating electric signal is then produced at a 
frequency equal to the difference between the two incoming wave frequencies.
The PC controls the optical scanner, processes the photocurrent from the detector to 
form a signal proportional to skin perfusion and generates a colour-coded image on the 
monitor.  The PC also provides an efficient means of data storage for retrospective 
analysis.
The colour-coded image is 64 by 64 pixels and the resolution for each pixel is ~2 mm2. 
The colour of each pixel on the image reflects the value of the perfusion at the 
corresponding measurement site.  Six colours are used to give an overview of the 
perfusion and its spatial variation in the skin (Figure 5.5).
116Figure 5.5  Colour coding of the LDPI image.
The highest of the captured perfusion values is set at a 100%, and the other values are 
scaled relative to highest value.  A pixel coded in dark blue corresponds to a low 
perfusion value (less than 16% of the highest), while a pixel coded in red corresponds to 
a high perfusion value.
PERFUSION
[%] [Volts]
■ 0-16 0.00 - 0.46
□ 16-32 0.46 - 0.93
□ 32-48 0.93-1.39
□ 48-64 1.39-1.86
□ 64-80 1.86-2.32
□ >80 >2.32
117Light blue and dark blue colours represent low flux corresponding to low blood flow 
and red and orange represent high flux, which correspond to high blood flow. The 
colour coding procedure is performed in relative or absolute mode336.  In relative mode 
the entire span of the perfusion values is divided into six intervals.  The highest of the 
captured perfusion values is set at a 100%, and the other values are scaled relative to 
highest value (Figure 5.5).  A pixel coded in light blue corresponds to a low perfusion 
value (less than 16% of the highest), while a pixel coded in red corresponds to a high 
perfusion value.  The relative mode is preferable when the maximal dynamic range is 
desirable to compare adjacent areas within a single perfusion image.  In absolute mode 
the highest and lowest perfusion values are selected before colour coding and 
presentation. The absolute mode is useful when different perfusion images are to be 
compared or when single extreme values are to be excluded in the presentation.  All 
data collected are stored in ASCII code, which facilitates transfer of data to other 
systems
5.4  Image Analysis
Each pixel in the image generated by the LDPI contains a numerical value representing 
the mean blood flow within an area of ~2 mm  of skin.  The images are analysed using 
representative regions of interest (ROI) identified by means of markers and framed 
according to the chosen number of measurement sites to be analysed.  In this thesis two 
software programmes were used for image processing -  VIEW (Moor Instruments Ltd.) 
in MS-DOS for the validation studies on the LDPI and LDISOFT Version 1  (Lisca 
Development AB, Sweden) in a Microsoft ®  Windows program for the clinical studies. 
For the purpose of this thesis the main difference between the two programmes was the 
type of markers used to frame the ROI.  The LDISOFT software, unlike the VIEW 
software, allowed markers to frame irregularly shaped ROI, which was necessary for
118analysis of vulval skin perfusion images. The image analysis programme computed the 
mean within framed ROI, in flux units.  The mean values were then exported to Excel 
(Microsoft Inc. USA) for further processing of data sets before statistical analysis by 
SPSS and ANOVA.
Black paper was used to localise or provide a mask for the measurement site to 
standardise the viewing area of the LDPI and to provide reference points on the image. 
As the black paper was strongly light absorbent it ensured zero background noise at the 
margins.  Localising the measurement site in this way also reduced the scanning time at 
sites such as the vulva where the shape of the measurement site of interest on the skin 
does not fit neatly into the LDPI measurement-site-reduction-scales.
The images are converted to TIFF format and exported to Microsoft Word or 
PowerPoint® (Microsoft, USA) for printout or slide presentation.  The images can also 
be captured directly from the computer monitor by camera for slide processing and by 
the LDISOFT software for printout.
5.5  Calibration
Currently there is no comparative gold standard technique to assess skin 
microcirculation.  The validity of a universal calibration factor is questionable because 
of the presence of unknown variables such as RBC distribution within tissue and the 
variation in skin morphology affecting the optical properties of the skin or the pathway 
taken by light particles through skin.  The LDPI system used in this thesis has been 
validated using a blood flow model, as described in Section 5.6.  In vitro models are 
useful to study new devices under controlled conditions but are not analogous to human 
skin.
119The LDPI technique provides excellent and reproducible resolution of spatial variation 
compared to visual assessment and standard LDF estimation as demonstrated in studies 
of trauma response  ’  .  Temporal fluctuations in the microcirculation observed on the
LDF monitor that occur as a result of periodic events such as vasomotion and, 
respiratory and heart synchronous wave patterns are eliminated by the LDPI44’334. 
Temporal resolution of the LDPI may be limited by the scanning time period of the 
measurement site, which can be up to 4 minutes, although in a study of irritant trauma 
response Stucker et al302 reported good temporal reproducibility.  Temporal resolution 
with the LDPI can be improved by reducing the measurement site to produce shorter 
imaging times.
1205.6  Validation of the LDPI with a blood-flow model
The LDPI apparatus was evaluated using a simple blood flow phantom simulating skin, 
which allowed independent control of a specific parameter while the other variables 
remain constant7'9.  In vitro experiments was selected because in vivo evaluations are 
limited by the variations in the vascular geometry at different sites and the difficulty in 
controlling factors regulating changes of the perfusion parameter.
5.6.1  Aim
To investigate the LDPI signal response to the following variables which could affect 
the interpretation of the perfusion parameter.
I.Distance between the laser detector and the measurement site
II.Blood flow rate
III.Haemodilution
IV.Partial pressure of oxygen (P0 2) of the circulating blood
V.Movement of the measurement site
VI.The degree of geometric distortion generated by the LDPI
5.6.2  Materials and methods
5.6.2.1 LDPI -  PIM 1.0 by Lisca Development AB, LinkOping, Sweden
5.6.2.2 Blood-Flow Model
The flow model or perfusion fluid circuit (Figure 5.6) consisted of a glass beaker 
containing out-dated human blood placed on a shelf with adjustable height.
121Figure 5.6  Blood flow Model
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An anti-coagulating agent had been previously added to the blood.  The blood was bubbled 
with oxygen (95%) and placed on a magnetic stirrer to ensure a supply of homogenous 
oxygenated blood, which was carried by a hydrostatic pressure gradient through a 
polyacetal tube to the imaging site.  The imaging site consisted of polyacetal tube arranged 
in series and covered by micropore tape to simulate the optical properties of skin.  The 
blood emptied into a small beaker placed on a weighing scale, which allowed 
measurement of blood flow rate by fluid collection.  Flow measurements were performed 
over an area of 110 x 40 mm2, which was localised by a perimeter of strongly light- 
absorbent black-coloured material.  This ensured zero background noise at the margins and 
that the same area was scanned on each occasion.  For each experiment LDPI signal was 
recorded six times.
Although this blood-flow model simulates skin, it is not analogous with skin.  In skin 
tissue the number of RBCs per unit volume is likely to vary according to the presence of
122arterio-venous shunts (high RBC concentration), the orientation of the capillaries and the 
thickness of the avascular epidermis.
5.6.2.3  Experiments
5.6.2.3.1  EFFECT OF DISTANCE BETWEEN THE LASER DETECTOR AND 
THE MEASUREMENT SITE ON LDPI SIGNAL
The distance between the LDPI head and the imaging site was varied between 20 mm and 
200 mm in steps of 20 mm by adjusting the height of the LDPI head relative to the 
imaging site.  The flow rate was monitored by blood collection and this was constant at 
1.23 pis'1  during the experiment.
The LDPI was positioned at a distance of 160 mm from the imaging site during the 
subsequent experiments as this was found to be the optimal distance.  The results are 
described in section 5.6.4.1.
5.6.2.3.2  ACCURACY OF LDPI READING MEASURING BLOOD FLOW VS TRUE 
FLOWRATE
The blood flow rate was varied by altering the height of the shelf supporting the
beaker of blood (1 litre).  The flow rate was measured by calculating the weight of 
blood collected in the glass beaker situated on the weighing scale, in micrograms per 
second (figs'1 ).  This was converted to micro litres per second (pis*1 ) by calculating the 
average weight of 1  ml of used blood, by sequentially adding each ml and recording the 
weight for up to 10 ml.  The range of the blood flow rate validated was 0 to 5.89 pis'1.
1235.6.23.3  THE EFFECT OF REDUCTION OF RBC CONCENTRATION BY 
HAEMODIL UTION ON LDPI SIGNAL
Replacing 10 %, 20 % and 30 % of volume of blood in the beaker with physiological 
saline solution diluted the red blood concentration.  The LDPI reading was recorded for 
blood flow rates of 1.3,2.0 and 3.4 pis"1  for each haemodiluted solution.
5.6.23.4  CHANGES IN THE PARTIAL PRESSURE OF OXYGEN (Po^) ON LDPI 
SIGNAL
The P0 2 of the blood in the delivering beaker was increased by gradually increasing the 
pressure of oxygen (95 %) bubbled into the blood.  The range of P0 2 validated in this 
experiment was 10.7 kPa to 66 kPa.  During the time of the experiment the blood flow 
rate was monitored by fluid collection and remained constant at flow rate of 3.9 pis"1.
5.6.23.5  EFFECT OF MOVEMENT OF THE IMAGING SITE
The blood flow phantom was placed on a movable platform attached to a motor with a 
frequency regulator.  This resulted in a regular and continuous vibratory type movement 
of the imaging site during the scanning procedure.  The range of movement frequency 
validated was between 15 cycles per minute (0.3 Hz) to 78 cycles per minute (1.3 Hz). 
The blood flow rate was constant at 3.4 pis'1 .
1245.6.23.6  ASSESSMENT OF GEOMETRIC DISTORTION
A sheet of white paper with black lines drawn across was found to be more appropriate 
for the assessment of geometric distortion generated by the LDPI because of the 
contrast produced by the complete absence of backscatter from the black lines compared 
to the small backscatter detected from the white surface.  The black line was 2 mm thick 
and the gap (white) between the black lines was 15 mm broad.  Total area scanned was 
about 9.5 mm2.  This sheet of paper was scanned with the direction of the laser beam 
initially moving along the black lines and then perpendicular to the black lines, to assess 
vertical and horizontal axis geometric distortion, respectively.
5.6.3  Data Analysis
The VIEW software was used to calculate the mean LDPI value from one representative 
region (7x7 pixels) at an identical site on each image.  Each experiment was repeated 
six times and the average of these readings were taken as the LDPI value.  Statistical 
analysis was performed using the ANOVA: single factor; p <0.05 was considered 
significant. To estimate the reproducibility of the LDPI measurements, the coefficient of 
variability (SD/mean) [SD - standard deviation] was calculated.
1255.6.4  Results
5.6,4.1  Effect of distance between the laser detector and the imaging site on LDPI signal
Figure 5.7 shows a progressive increase in LDPI signal up to 160 mm distance between the 
laser head and the imaging site.  There was approximately a 7% error in flux measurements 
within 10 mm of the 160 mm point.  The percentage error was much greater with a further 
increase, compared to an equivalent decrease in distance from the 160 mm position.
Figure 5.7  Mean LDPI reading vs. distance between the laser detector and the
imaging site at flow rate of 1.23 pis'1.
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126S.6.4.2 Accuracy of  LDPI signal measuring bloodflow vs. true  flow rate
There was a significant correlation (r=0.99, p<0.001) between the actual flow rates using 
fluid collection, for the range of 0 to 4.89 pis'1 , and the LDPI signal as shown in figure 5.8. 
The best-fit straight line for the data is described by the equation: Y = 215X + 452, where 
Y is the LDPI signal in flux units and X is the fluid collection in pis'1.  The reproducibility 
of LDPI readings for flow rate had a coefficient of variability in the order of 2% to 5%.
Figure 5.8  Relationship between blood flow rates determined by timed fluid 
collection and mean flux determined by the LDPI.
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1275,6.43 The effect of reduction ofRBC concentration by haemodilution on LDPI signal
Figure 5.9 shows reduction of the LDPI signal with decreasing RBC concentration by 
dilution of 10 %, 20 % and 30 % of the blood volume with physiological saline solution at 
constant blood flow rates.
Figure 5.9  Relationship between blood flow rate and LDPI reading with 
haemodilution of 10%, 20% and 30% by volume with physiological saline solution.
X
3
O )
c
3
S.
CL
O
1600
1400
1200
1000
800
600
400
200
0
o 10% haemodilution - y = 239x + 703 
■ 20% haemodilution - y = 248x + 584 
m 30% haemodilution - y = 238x + 480
Fluid (blood) collection (pis*1)
128S.6.4.4  Changes in the partial pressure of oxygen (P0 2) on LDPI signal
The LDPI signal was independent (r=0.05, pO.OOl) of changes in P0 2 of the blood 
circulating the flow phantom as shown in Figure 5.10.
Figure 5.10  Response of LDPI to changing pressure of oxygen supplied to the 
blood.  Blood flow rate was constant at 4pls_ 1 .
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129S.6,4.5 Effect of movement of the imaging site on LDPI signal
In figure 5.11 movement of the imaging site resulted in a significant (p<0.001) increase in 
the LDPI signal.  At 15 cycles per minute or 0.3 Hz (respiratory movement) and 60 cycles 
per minute or 1  Hz (heart movement) the LDPI compounded the flow measurement by 8% 
and 44%, respectively.
Figure 5.11  Effect of the speed of movement of the imaging site (blood-flow 
model) on LDPI reading at constant blood flow rate of 3.4J11S*1.
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1305.6.4.6 Assessment of  geometric distortion of image generated by the LDPI
Figure 5.12 demonstrates the lack of geometric distortion in the horizontal axis and a 
small distortion ranging from  1.6 % to 3 % in the vertical axis of the image generated 
by the LDPI.
Figure 5.12  Diagrammatic representation of image distortion by LDPI -  the
vertical dotted lines indicate the actual position of the black lines imaged on the white 
sheet of paper.  The solid vertical line shows the distortion in this axis arising as a result 
of the crescent shaped pathway taken by the laser beam during raster fashion scanning. 
There is no image distortion in the horizontal axis.
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1315.6.5  Discussion
The LDPI was able to map the spatial variation of perfusion over a wide area of this simple 
blood-flow model without surface contact and within a short period of time. The flow 
model simulates some of the optical properties of skin but is not an anatomical analogue of 
the skin microcirculation.  With this limitation in mind the model was useful to evaluate 
the LDPI signal against several parameters influencing measurement of the 
microcirculation.
The manufacturer’s recommended distance between the laser head and the imaging site is 
150 mm to 200 mm.  We found the optimal distance at 160 mm, with approximately a 7% 
error between 140 mm to 170 mm.  The lower range of 140 mm is slightly lower than the 
manufacturer’s recommendation of 150 mm.  In this experiment a further increase in the 
distance between the detector and the imaging site from 170 mm to 200 mm resulted in a 
higher percentage increase in the error with decreasing LDPI signal.  This could be due to 
a wider spread of the area of backscatter signalled from the moving RBCs, not detected by 
the photodiode.  These findings differ from that of Kemick & Shore1 6 6  who report a 
progressive increase in LDPI output with increasing distance up to 200mm.  Then reason 
for this variance is not clear but could be related to differences in the design of the flow- 
model or LDPI settings.
Clinically this difference in detection of the backscattered signal by the photodiode of the 
LDPI is not a problem when measuring perfusion from surfaces with a flat contour, such 
as the dorsum of the hand.  In this clinical situation all measuring points on the skin surface 
are at the same distance from the detecting photodiode.  If the skin surface had an irregular 
contour, such as the breast or the vulva, the investigator needs to be aware of the source of 
error introduced by the different distances between the measurement points and the LDPI
132head.  In this thesis, studying the vulval skin perfusion, care was taken to ensure that all 
measuring points on the imaging site was within 140mm to 170mm from the laser head, to 
keep any error in measurement to a minimum.
There was a significant correlation between the blood flow rate, measured by fluid 
collection, ranging from 0 to 5.89 pis'1 , and the LDPI signal.  The increase in LDPI signal 
with blood flow rate is due to the increase in the magnitude of the Doppler shift detected 
by the photodiode.  However we observed a saturation limit for the detection of flow rate 
at 4.04 pis'1  (Fig. 5.8), which may be due to limitation of the manufacturer setting of the 
maximum detectable Doppler shift frequency231.  This does not cause a problem in clinical 
practice as the maximum blood flow in the microcirculation is within this range106.
The LDPI signal is dependent on the concentration of the moving RBCs as well as its 
velocity.  Reduction in the concentration of the RBCs by haemodilution was detected by 
the LPDI signal and there was a good correlation with flow rate measured by fluid 
collection.
LDPI readings were found to be independent of P02 in the range of 10.7 kPa to 66 kPa of 
the blood supplied to the flow phantom.  We accept that the range of P02 investigated 
extends into that experienced during oxygen therapy.  However we note that the LDPI 
readings were independent of the P0 2 over this wide range.  The question of whether this 
could be extrapolated to the narrow range of P0 2 experienced in the clinical situation, 
between the capillary blood in the arterial end (P02 =12 kPa) and the capillary blood in the 
venous end (Po2= 2 kPa), remains to be answered.  Evaluation of the LDF signal for 
changes in the P0 2 in the range of 5.3 kPa to 16 kPa showed a minor but insignificant 
influence on flux measurements226.
133Regular and continuous vibratory type movement of the imaging site significantly 
increased the LDPI signal during the scanning procedure.  This is attributed to the 
photodiode detecting a Doppler shift from previously static measuring points.  Clinically 
this is relevant when measuring superficial tissue blood flow during surgery from organs 
such as the heart or the liver.  The heart moves regularly to an intrinsic rhythm set at 60 to 
80 beats per min. and the liver moves with movement of the diaphragm during respiration. 
At 0.3 Hz  (15 cycles per minute simulating respiratory movement) and 1  Hz (60 cycles 
per minute simulating heart movement) the increase in LDPI measurement was estimated 
at 8% and 44%, respectively.  In fact any movement of measuring site on poorly stabilised 
tissue -  intermittent, random or cyclical -  increases the recorded LDPI signal.  This also 
includes clinical situations involving young children and neonates.
There is a small degree of geometric distortion in the vertical axis but no distortion in the 
horizontal axis.  This geometric distortion, which has never been reported, is most likely 
due to the crescent shaped pathway taken by the laser beam during scanning in a raster 
fashion.  The resulting small image distortion does not affect measurement of the skin 
microcirculation and is unlikely to be of clinical significance.
The LDPI used in this thesis when validated with a blood-flow model was a reproducible, 
non-invasive technique that enabled mapping of the spatial variation of blood flow over a 
wide area, without surface contact, and within a few minutes.  The LDPI signal is 
independent of tissue oxygenation in the range of 10.7 to 66 kPa and the image displayed 
on the computer monitor has only a very minor degree of image distortion in the vertical 
axis, which is unlikely to be of clinical significance.  These results of the experiments to 
validate the LDPI demonstrate that this technique would be suitable for use on the vulval 
skin.
134In the next chapter the LDPI is used on the normal vulva bearing in mind the effects of 
the distance between the laser head and the measuring site, and the movement of the 
measuring site during scanning on the LDPI signal.
135Assessment of normal vulval skin 
microcirculation
1366.1  Introduction
There is very limited information on the microcirculation of the specialised vulval skin. 
This is most likely due to anatomical access and the availability of suitable biophysical 
technology.  The vulva also consists of several skin structures with varied 
morphology8 8 1 1 4 7 , each requiring individual representation for the study of skin blood 
flow.  Several workers have successfully applied the LDF to study real time vulval
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perfusion  ’  *   .  The LDF provides single point (1mm ) measurement and requires
direct skin contact risking spread of infection.  There are large spatial and temporal 
fluctuations of SBF within small areas, which can be minimised by measuring perfusion 
in an area of skin41;168;176;307.  The LDF can measure SBF in an area but a low resolution 
of 1mm  makes this technique time consuming.  The LDPI however can measure skin 
perfusion over a specific area of interest without contact to produce a two-dimensional 
colour-coded image of the spatial variation of perfusion166’336.  These features of the 
LDPI are more suitable for measurement of vulval skin microcirculation compared to 
the LDF.
6.2  Aim
In this chapter the aim was to use the LDPI on women with normal vulva to find out if 
this technique was acceptable to women and to study the short-term reproducibility of 
vulval SBF.  The study was then extended to observe the effect of age, menstrual cycle 
and recovery from local skin temperature change on vulval skin microcirculation.
1376.3  Materials and methods
6.3.1  Study Population
This study was carried out in 28 healthy female volunteers, recruited from health care 
workers and patients admitted for routine surgery such as hysterectomy, hysteroscopy, 
diagnostic laparoscopy and sterilisation, all clinical conditions unrelated to diseases of 
the vulva.  Care was taken to ensure that the women of reproductive age were not on 
hormonal contraception and that the postmenopausal women were not taking any 
hormone replacement therapy.  10 women with a mean age of 25.5 ± 5.23 years (mean 
± SD) were entered for the study on cyclical change in vulval skin perfusion, 10 women 
with a mean age of 59.6 ± 10.5 years were entered for the study on recovery of vulval 
perfusion from local skin temperature challenge and 19 women, including the latter 
group, were entered for the study on variations in vulval skin perfusion related to age. 
The women gave informed consent to the study, which was approved by the Ethics 
Committee at the RFHSM (Royal Free Hospital and School of Medicine).
In 12 other cases the procedure was unsuccessful because the subjects did not attend 
further assessment for cycle change, did not tolerate the lithotomy position for the 
duration of the investigation or the images acquired were inadequate for assessment.
1386.3.2  Measurement procedure
The women were examined in the lithotomy position (Figure 6.1a + b).
Figure 6.1a  Diagrammatic representation of the use of the LDPI on the vulva
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Figure 6.1b  Clinical photo of the assessment of vulval perfusion with the LDPI
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139Each woman was acclimatised for 10 minutes in the examination room with ambient 
temperature at 22-23°C.  The blood pressure, core (oral) temperature, skin temperature 
and pulse rate were measured with the subject in the lithotomy position and before the 
LDPI examination was commenced.  The local skin temperature was recorded with a 
thermocouple attached on the external surface of the right labium majus, just outside the 
area of interest -  the labia minora, inner surface of the labia majora, the clitoral hood 
and the clitoris, and the perineum. The external surface of the labia majora was 
excluded because the presence of hair interferes with imaging.  The vulval area was 
localised with a perimeter of strongly light-absorbent black material, which in addition 
to providing a marker to identify and orientate the perfusion image, also reduces the 
total data acquisition time to approximately 2.5 minutes (Figure 6.1b).  The LDPI head 
was placed approximately 160 mm from the measuring area, with care taken to ensure 
that the laser head was parallel with the skin as best as possible.  This can be 
problematic considering the location and uneven topography of the vulva.  A colour 
photograph of the vulval area was taken separately to correlate with the image, during 
analysis at a later date.  An adjacent area of normal non-genital skin on the medial 
surface of the thigh, away from the vulva was also imaged, as a control area for the 
cycle study.
6.3.3  Reproducibility
The reproducibility was analysed by the sequential scanning mode to produce six and 
eight replicate images in two women with normal vulva.  Non-genital skin was also 
studied with six replicate images of the medial surface of the thigh.
1406.3.4  Cyclical change of vulval perfusion
10 women with a mean age of 25.6 ± 5.23 were imaged once a week throughout the 
cycle.  The menstrual cycle was orientated retrospectively by recording the first day of 
the imaged cycle and that of the subsequent cycle with the assumption that the luteal 
phase is fixed at two weeks.  In this group the menstrual cycle length was 28 ± 1.5 days. 
The volunteers in this group consisted of only health care workers who were more 
conveniently placed to provide the commitment of serial perfusion images.  Volunteers 
from the general public were recruited unsuccessfully due to the required frequency of 
attendance.  Image data set was complete for 8 volunteers and incomplete for two 
volunteers. One of these volunteers failed to attend on one and the other, on two 
occasions.
6.3.5  Age related variations of vulval perfusion
19 women were available for vulval skin perfusion imaging in this group.  The women 
were arbitrarily divided into three groups -  premenopausal under the age of 50 years, 
young postmenopausal between the ages of 50 to 70 years and old postmenopausal were 
aged more than 70 years.  The study group consisted of six premenopausal women aged 
32 ± 11 (mean ± SD) years, six “young” postmenopausal women aged 60.3 ± 6.5 years 
and seven “elderly” postmenopausal women aged 75.8 ± 7 years.  The use of 
antihypertensive drugs was prevalent in the postmenopausal group.
1416.3.6  Local skin temperature challenge on vulval perfusion
In 10 women with a mean age of 59.6 ± 10.5, the vulva was imaged at normal skin 
temperature and after provocation of local skin temperature change.  The local skin 
temperature was first increased by gently applying a hot pack on the vulval surface for 
approximately 3 minutes.  The hot pack consisted of disposable towels soaked in ‘hand- 
hot’ water and placed in a polythene bag to prevent wetting the skin surface while at the 
same time effectively conducting the heat to the skin.  The skin temperature was cooled 
in a similar way using a cold pack which consisted of crushed ice wrapped in three 
layers of disposable towels, which was then placed in a polythene bag and held gently 
against the vulval skin.  Care was taken to ensure that the skin temperature returned to 
the previous baseline after warming the skin and before starting to cool the skin.  The 
procedure was well tolerated by the women.  The change in temperature was recorded 
using a thermocouple and was between 4 and 6 °C above during hot provocation and 
below during cold provocation compared to the baseline temperature.  The LDPI was 
performed after removal of the pack and there was a small drop (~1°C) in temperature 
during the 2.5 min scanning procedure.
6.3.7  Image analysis
The colour of each pixel on the image reflects the value of the perfusion at the 
corresponding measurement site.  Six colours are used to give an overview of the 
perfusion and its spatial variation in the vulval skin.  Light blue and dark blue colours 
represent low flux corresponding to low blood flow and red and orange represent a high 
flux, which correspond to high blood flow.  The colour coding is described in detail in 
Chapter 5, Section 5.3 and Figure 5.5336.
142The images were stored in a PC for later advanced analysis with an Image-processing 
software LDISOFT Version 1  (Lisca Development AB, Sweden) in a Microsoft ®  
Window program. The images were manually correlated with the clinical photographs 
and regions of interest (ROI) were framed for calculation of the mean baseline skin 
blood flow in flux units for the following vulval areas: clitoral hood, clitoris, right and 
left labia minora, right and left inter labial space, and the perineum.  A control area 
selected on the medial surface of the thigh was also imaged and analysed.
The mean skin blood flow of all framed ROI was recorded on Excel (Microsoft Inc. 
USA) spreadsheet and transferred to SPSS statistical software package for data set 
evaluations.
6.3.8  Statistical analysis
The results are expressed as mean ± SD.  The percentage differences for each week of 
the menstrual cycle with respect to the remaining three weeks were compared with 
Wilcoxon Signed Ranks Test.  The same statistical test was used to analyse the variation 
in base-line perfusion after local skin temperature challenge.  Probability values of less 
than 0.05 were regarded as significant.  Short-term reproducibility of the LDPI 
measurement was determined by calculating the coefficient of variability (SD/Mean).
1436.4  Results
Hypertension was the most commonly treated medical disorder in this study group 
particularly among the postmenopausal women. Table 6.1 shows the age and mean 
arterial blood pressure for all the subjects in this study.
144Table 6.1  Sub-group analysis of the age (years ± standard deviation), systolic blood pressure (sBP)(mmHg±SD), diastolic blood 
pressure (dBP) and mean arterial pressure (MAP)
Cycle Pre­
menopausal
(<50y)
Young Post­
menopausal
(55-69y)
Old Post­
menopausal
(> 70 y)
Local skin
temperature
challenge
Week 1 Week 2 Week 3 Week 4
Subject
numbers 1 0 1 0 9 8 6 6 7 1 0
Age (years) 25.6 ±5.23 25.6 ±5.23 26.2 ±5.1 26.8 ± 5 32 ± 11 60.3 ± 6.5 75.75 ±7.14 59.6 ± 10.5
Arterial
blood
pressure
(mmHg)
sBP 117 ± 10.9 113.9 ±9 115 ± 16 120.7 ± 4.5 131 ±25 145 ± 17.6 150 ± 19.5 142 ± 20
dBP 67.22 ± 8 6 8 . 6 ±  1 0 65.33 ± 10 71.43 ±4.76 80 ±  1 1 87.5 ± 18.9 79.29 ± 18.8 8 6 ±18
MAP 83.81 ± 8.4 83.7 ±8.1 81.89 ±8.79 87.86 ±4.16 97 ± 15 106.5 ± 16.5 99.43 ± 12.88 105 ± 18
1456.4.1  Reproducibility
The coefficient of variation for normal vulval baseline perfusion was between 5% and 
7%, and that for non-genital skin was 1% (Table 6.2).  A coefficient of variation of 10%
£7 or less is considered satisfactory  .
Table 6.2 The mean Flux, standard deviation (SD) and coefficient of variability 
(CV) in normal vulval skin and non-genital skin (thigh)
Normal vulva Normal vulva Thigh
Mean Flux SD Mean Flux SD Mean Flux SD
Image 1 0.69 0.4 1.05 0.48 0.52 0.11
Image 2 0.71 0.45 0.98 0.43 0.53 0.12
Image 3 0.66 0.37 0.93 0.41 0.52 0.1
Image 4 0.75 0.38 0.91 0.39 0.54 0.13
Image 5 0.69 0.39 0.91 0.39 0.53 0.12
Image 6 0.72 0.38 0.86 0.36 0.53 0.11
CV 5% 7% 1%
Figure 6.2 (a + b) is a photograph of a normal vulva and the colour-coded image of the 
skin perfusion.
146Perineum
Clitoral region
Figure 6.2a
Figure 6.2a-b Clinical photograph (Figure 6.2a) and LDPI image (Figure 6.2b) of a 
normal vulva in a 25y old. Note a region of relatively high blood flow in the clitoral area
Figure 6.2b
1476.4.2  Cyclical change of vulval perfusion
Cyclical change in perfusion was analysed by comparing the differences in perfusion for 
each week compared to the other three weeks.  Wilcoxon signed ranks test did not show 
any significant cyclical difference in vulval skin perfusion during the menstrual cycle. 
However bar chart representation (Figure 6.3a-d) of differences in perfusion between 
weeks 1  to 4 of the menstrual cycle, show a possible increase in perfusion in week 2, 
during the follicular phase.  In Figure 6.3b all areas of the vulva consistently showed a 
higher perfusion on week 2 compared to the other three weeks.  The non-genital skin on 
the medial surface of the thigh also showed a similar perfusion pattern to the vulval 
skin.
148Figure 6.3a  Percentage change in vulval SBF during week 2, 3 and 4 
with reference to week 1   of the menstrual cycle
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Figure 6.3b  Percentage change in vulval SBF during week 1. 3 and 4 
with reference to week 2 of the menstrual cycle
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Figure 6.3c  Percentage change in vulval SBF during week 1, 2 and 4 with 
reference to week 3 of the menstrual cycle
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Figure 6.3d  Percentage change in vulval SBF during week 1. 2 and 3 with 
reference to week 4 of the menstrual cycle
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1506.4.3  Age related variations of vulval perfusion
Statistical analysis was not done for this comparison because the number of subjects 
was small and the large variations in base-line perfusion between subjects.  The mean 
values and standard deviations were plotted on a graph shown in figure 6.4.  There 
appears to be a trend with the “young” postmenopausal women having a higher baseline 
vulval skin perfusion, while the “elderly” postmenopausal women had lower perfusion 
compared to the premenopausal group.  The premenopausal women were not studied 
during the same week of the menstrual cycle as the findings in Section 6.4.2 did not 
show any significance difference in vulval SBF with the menstrual cycle.
Figure 6.4  Comparison of vulval skin baseline perfusion in premenopausal, 
‘young’ postmenopausal (< 70y) and ‘elderly’ postmenopausal (> 70 years) woman
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1516.4.4  Vulval perfusion after local skin temperature challenge
The response of vulval skin perfusion following local skin temperature challenge was 
analysed by comparing the differences in perfusion to the baseline.  Figure 6.5 shows 
the mean value and 95% confidence interval of change in vulval skin perfusion 
measured after hot and cold provocation.  Wilcoxon signed ranks test does not show 
significant differences in skin perfusion to warm and cold local temperature challenge in 
all areas of the vulva except for a minor difference in the left labium minus and clitoris. 
The 95% confidence interval is wide suggesting a wide variability of this parameter in 
the general population.
Figure 6.5 Change in normal vulval baseline perfusion in response to hot and cold 
provocation
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1526.5  Discussion
This preliminary study does not show significant differences in baseline vulval skin 
perfusion with age and the phase of the menstrual cycle.  Local skin temperature 
challenge with hot and cold packs also does not show significant differences in the 
baseline perfusion during the recovery phase, in the normal vulva, except for a minor 
difference on the left labium minus and clitoris following hot provocation.  The age and 
temperature challenge graphs (Figures 6.4 and 6.5) show a wide 95% confidence 
interval suggesting a large variation within the normal population.  However there are 
subtle trends of vulval perfusion, which may prove to be significant with larger subject 
numbers.  The reproducibility of the LDPI apparatus in the short term (within minutes) 
is good.
Age related changes in baseline skin perfusion are influenced by the thickness of the 
epidermis, density of the microvessels and the blood flow velocity. The keratin and 
epithelial layer of the vulva is at its maximum thickness during the reproductive years 
and gradually thinning after the menopause147.  This is attributed to depleting oestrogen 
levels with the menopause, although immunohistochemical studies show a very low 
frequency of oestrogen receptors suggesting that oestrogen may not be as influential in 
the vulval skin as is commonly believed195.  Capillaroscopic studies show a striking loss 
of dermal papillary loops but no quantitative change in the upper horizontal vessel 
plexus in the older woman compared to younger subjects in the forehead and the 
forearm165.  In contrast the LDF and LDPI did not show any difference in baseline 
perfusion with advancing age and this was attributed to the greater penetration of the 
laser beam, thus giving information from vessels deeper than the dermal papillary loops 
i.e. horizontal plexus and arteriovenous anastomosis (AVAs)  ’  ’  .  Heat washout 
studies however do show decreased blood flow rate in AVAs with increasing age in the
153finger and toe pulps attributed to a combination of increasing stiffness of the AVAs, 
reduced metabolic rate and presumably endothelial changes210.  The microvessel 
structure, including the presence of AVAs in the vulval skin is not known and so, the 
above reported findings of age related changes in the non-genital skin microvasculature 
should be cautiously extrapolated to the specialised vulval skin.  The trend of the data in 
Figure 6.4 could be the result of an initial decrease in epidermal thickness with ageing, 
thus increasing the depth of penetration of the laser beam in young postmenopausal 
women, followed by an actual decrease in microcirculation in the elderly 
postmenopausal women.  Although none of the postmenopausal women in this group 
were on hormone replacement therapy, the effect of postmenopausal hormone therapy is 
difficult to predict as immunohistochemical evidence  suggest sparcity of oestrogen 
receptors in the vulval skin compared to vaginal skin.  In general oestrogens protect 
against skin ageing by increasing the collagen content and skin thickness327.
The phase of the menstrual cycle does not alter the base line perfusion in the pulp of the 
big toe but significantly increases perfusion in the luteal phase in the vaginal and rectal 
mucosa87.  The vulval skin is unique compared to the regions studied by Emmanuel et 
aj87;i47;i95  observation in this thesis of a higher (not significant) baseline vulval 
perfusion during the follicular phase (week 2) of the menstrual cycle is similar to that 
found in the cervix and the endometrium, and thus requires further study105,140.
The measurement of skin perfusion over a wide area such as the vulva, in response to
recovery from local skin temperature challenge is problematic because of the practical
difficulties of maintaining a constant vulval skin temperature during the 2.5 minutes
imaging time.  The irregularity of the vulval skin surface may also cause different levels
of exposure to temperature change as the pack is placed gently to avoid local pressure
154altering the skin perfusion.  A perfusion imager that is able to stabilise the skin 
temperature as well as measure perfusion would be valuable to perform this provocation 
test more reliably.  Our results did not show significant differences in baseline vulval 
perfusion following local skin temperature challenge except during hot provocation in 
the left labium minus and clitoris.  This difference in response in the left labium minus 
and clitoris compared to the remaining vulva is unclear but it is of note that on cold 
provocation the mean response also resulted in a higher SBF compared to the remaining 
of the vulva.  It is of interest that the other vulval structures and the perineum showed a 
greater decrease in mean blood flow to cold compared to mean increase in SBF to hot 
provocation (Figure 6.5).  A larger study is required to elaborate on these observations, 
which appear to suggest AVAs or a similar structure may be predominant in the vulva 
as contributors to the noticeable vasoconstriction during cold challenge175.  Cold 
challenge decreases heterogeneity of skin perfusion while hot challenge appears to have 
the opposite effect242.  Hot challenge tends to increase perfusion variable until 44 °C 
when the maximum increase is achieved  .
This preliminary work is limited by the small numbers of women recruited and the lack 
of standardisation for confounding variables such as smoking, eating, medical diseases: 
controlled hypertension, drug history including hormone replacement therapy and time 
of the day.  The 95% confidence intervals were wide resulting in a large overlap of 
perfusion values.  This wide variation may be a reflection of the degree of intrinsic 
heterogeneity of normal skin perfusion41’336 and the effect of confounding factors86.
This feature could also be attributed to the skin attempting to maintain normal perfusion 
within the narrow temperature challenge applied in this thesis.  Future work with larger 
numbers and better standardisation could contribute valuable information on the 
microcirculatory physiology of this specialised area of skin.
155The use of the LDPI apparatus to study vulval SBF is acceptable to women and has a 
good short-term reproducibility for assessment of vulval and non-genital skin perfusion. 
The data suggests that menstrual cycle and age do not affect the perfusion parameter. 
The response of vulval perfusion during recovery from local skin temperature challenge 
is more complex, and demonstrates a wide variation in this parameter.
In the next chapter the LDPI is used to study skin microcirculation in women with 
vulval LS and YIN 3.
156CHAPTER 7
Assessment of diseased vulval skin 
microcirculation
1577.1  Introduction
Vulval LS and VIN 3 require long-term follow-up for symptom control and to provide 
surveillance for early detection of malignant change as described in Chapter 3.
Currently the available techniques for examination of the vulva as discussed in Chapter 
3 are limited for early diagnosis of malignant change.  In particular the colposcope, 
useful on the cervix, has limited application on the vulva.  The presence of keratin on 
the vulva reduces the penetration of ordinary light necessary to study the morphology of 
the superficial vessel pattern, as seen in the cervix.
7.2  Aim
In this chapter the LDPI was used in vulval disease.  The vulval skin perfusion in LS 
and in VIN 3 was compared with that in normal women.  In women with LS the study 
differentiated women before and after treatment with successful symptom relieve.  The 
purpose of this study is to develop a further parameter to objectively monitor women 
with LS and VIN 3, and perhaps pave the way to develop a new technique to identify 
cases at high risk of malignant change.
7.3  Methods and materials
The LDPI instrumentation is described in Section 5.3 and application to the vulva in 
Section 6.3.2.  Vulval image analysis is discussed in Section 6.3.7.
1587.3.1  Study population
The study population consisted of 31 women before and after treatment of vulval LS 
(58 ± 13.8y), and 11 women with VIN 3 (45 ± 12y) recruited from the Vulval Clinic 
based at the Royal Free Hospital.  The women gave informed consent for the study, 
which was approved by Ethics Committee at the RFHSM.
7.3.1.1 Normal women
The control subjects (n=19; 50 ± 20y) were healthy women with normal vulval skin 
recruited from patients admitted for unrelated gynaecological surgery and from hospital 
staff as described in Chapter 6, Section 6.3.1.
7.3.1.2 Clinical profile of women with LS
The women with vulval LS were almost all new patients to the vulval clinic with 
symptoms between six months and 22 years.  The main presenting symptoms were 
vulval pruritus and soreness, while many of the younger women also complained of 
superficial dyspareunia.  Most of the women had received some form of treatment in the 
past -  topical oestrogen cream, anti-fungal preparations, topical steroids of varying 
potency and duration while two patients also had had a simple vulvectomy. The courses 
of topical steroids used by these women were either of much lower potency and/or of 
inadequate duration compared to our regimen. These patients were diagnosed on clinical 
examination, although 23 patients had histological diagnosis in the past. We did not 
perform any biopsy for the purpose of this study, as this would have interfered with 
blood flow measurements.
15920 women were referred by the family practitioner, five were in-house referrals and six, 
tertiary referrals.
The women in this study received potent topical steroids (clobetasol propionate 0.05%, 
fluocinolone acetonide or triamcinolone) for 8 to 12 weeks followed by moderately 
potent topical steroids (clobetasone butyrate 0.05%) gradually reduced to once or twice
1 0ft
a week  . The patients included in this study showed good response with significant, 
and often complete resolution of symptoms.  Women with thick hyperkeratotic areas 
excluded themselves as their response to treatment was brief with repeated exacerbation 
of symptoms requiring excision biopsy.  The vulval architecture at presentation 
appeared to vary with the duration of disease and intensity of symptoms.  After 
commencing treatment and with resolution of symptoms, evidence of active disease due 
to pruritus resolved but the architectural changes related to resorption of the labia 
minora, obliteration of the interlabial sulci and phimosis of the clitoris remained the 
same as before treatment.
These women were seen and examined for the purpose of this study at referral and 
serially throughout their course of treatment.  The women had not received any topical 
treatment for at least three weeks before the first pre-treatment examination of LDPI. 
The post-treatment examination of LDPI was done when patients were symptom free 
and at least two weeks into the second phase of treatment with moderately potent 
topical steroids.  The results of serial examination during the two phases of treatment as 
measured by the LDPI are presented in Chapter 8.
1607.3.1.3 Clinical profile of women with VIN 3
The women with VEST 3 consisted of only one patient referred by the family practitioner, 
while two were in-house referrals and eight, tertiary referrals. The duration of the 
disease varied between three and 11 years, with all the women having previously 
received excision or laser ablative treatment. The main presenting symptoms were 
pruritus, soreness, ulceration and superficial dyspareunia. These women were seen and 
examined for the purposes of this study only at referral. All these women had 
histological confirmation of the diagnosis.
In this study the women with vulval disease (LS & VIN 3) were not standardised for 
medical history, smoking or use of hormonal preparations for contraception (one 
woman with VIN 3) or replacement therapy. Anti-hypertensive therapy was prevalent in 
the older women in the LS group.  Smoking (>10 cigarettes a day) was prevalent in the 
women with VIN 3.  Smokers were advised not to have a cigarette for at least three 
hours before the examination.
1617.3.2  Reproducibility
The reproducibility was analysed by the sequential scanning mode to produce six and 
eight replicative images in two women with vulval LS and one, with normal vulva.
7.3.3  Statistical analysis
The results were expressed as mean ± SD for each area of genital and non-genital skin. 
Differences between the mean values of the different groups of subjects for each skin 
area were assessed by Kruskal-Wallis’ test (a non-parametric one way analysis of 
variance).  Paired and unpaired data were compared with Wilcoxon signed ranks’ test 
and Mann-Whitney UTest, respectively.  Probability values of less than 0.05 were 
regarded as significant.  Reproducibility of the LDPI measurement was determined by 
calculating the coefficient of variability (SD/Mean).
7.4  Results
Table 7.1 shows the age, body temperature, skin temperature on the right labium majus, 
heart rate, mean arterial blood pressure and body mass index of all the subjects in the 
study.
162Table 7.1  The age, body temperature, skin temperature on the right labium 
majus, heart rate, arterial blood pressure ( sBP=systolic blood pressure, 
dBP=diastolic blood pressure and MAP=mean arterial pressure) and body mass 
index (BMI) of all the subjects in study
Normal VIN 3 Lichen Sclerosus
Pre-treatment Post-treatment
Subject number 19 11 31 31
Age (years) 50.1 ±20.2 44.7 ± 12.26 58.5 ± 13.8 58.5 ± 13.8
Body temp. (°C) 36.6 ±0.5 37 ± 0.2 36.45 ± 0.33 36.62 ± 0.22
Skin temp. (°C) 32.4 ±0.5 32.44 ± 0.82 32.1 ± 1.14 32 ± 1.08
Heart rate 
(beats/min)
71 ± 12 62 ±3 67.2 ± 6.5 67 ±9.1
Arterial blood 
pressure (mmHg)
sBP
dBP
MAP
142.4 ±21.4 
81.1 ± 17.4 
101 ± 17
132 ± 19 
81  ± 1 0  
98 ±3
145.94 ±24.21 
86.87 ± 11.22 
106.46 ± 13.51
137.03 ±20.67
83.03 ± 14
101.03 ± 14.74
BMI (kg/m2) 25.14 ±3.53 22.65 ± 3.34 27.83 ± 4.84 (not repeated)
Figure7.1a is a clinical photograph of a normal vulva, with corresponding colour-coded 
perfusion output by the LDPI in Figure 7.1b. Figures 7.2 and 7.3 show vulval LS and 
VIN 3, respectively.
163Perineum
Clitoris
Figure 7.1a Figure 7.1b
Figure 7.1a-b Clinical photograph (Figure 7.1a) and LDPI of normal vulva (Figure 7.1b).  There is a region of increased 
perfusion around the clitoris
164clitoris
Figure 7.2a  Figure 7.2b
Figure 7.2a-b Clinical photograph (Figure 7.2a) showing vulval LS.  There is pallor, absorption of labia minora, partial 
phimosis and excoriation on the left labium minus.  The LDPI image (Fig7.2b) shows a high perfusion area on both the 
right and left labia minora.
165clitoris
Figure 7.3a
Figure 7.3a-b Clinical photograph (Figure 7.3a) showing a large area of VIN3 in the left anterior inter-labial space, 
anterior left labium minus, clitoral hood and the perineum.  The LDPI image (Figure 7.3b) shows high perfusion areas 
corresponding to regions of suspected VIN 3, which was later confirmed on biopsy.
Figure 7.3b
1667.4.1  Reproducibility
Vulva - The coefficient of variation for normal vulval baseline perfusion was 6% and for 
vulval LS between 1% and 4%.  A coefficient of variation of 10% or less is considered 
satisfactory reproducibility87.
Thigh - The total inter-patient variability for the control non-genital area on the thigh for 
the four groups was 5%.  The intra-patient variability for patients with LS serially 
followed up during treatment with topical steroids was between 7% and 22%.  This 
could be attributed to the area scanned on the thigh, which was not identical in location 
on each follow-up and the small number of images (n= 6 to 9 images in each of 8 
patients) analysed compared to the inter-patient (n=71 images) variability group.
7.4.2  Comparison between normal vulva and vulval lichen sclerosus
The mean ± SD of vulval skin perfusion (flux values) in normal women, and in women 
with LS before and after treatment is compared graphically in figure 7.4. There was no 
significant difference in perfusion values between the normal women and those with 
untreated LS for all the areas of the vulva and perineum.  After treatment with topical 
steroids, vulval LS had significantly lower perfusion values compared to their pre­
treatment values (except for the perineum).  Post-treatment vulval LS also had 
significantly lower perfusion values compared to normal women (except for the 
perineum and clitoral hood). Table 7.2 shows the P values for these comparisons.
167Figure 7.4  Graph comparing the vulval perfusion in normal women, and in 
women with LS, before and after treatment with topical steroids
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Table 7.2  P values for vulval flux of selected regions of interest (ROI) in 
normal vulva, untreated LS and treated LS.
ROI
Normal vulva vs 
Untreated LS vs. 
Treated LS 
(Kruskal- Wallis 
Test)
Normal vulva 
vs.
Untreated LS 
(Mann- 
Whitney Test)
Normal vulva vs. 
Treated LS 
(Mann- Whitney 
Test)
Treated LS vs.
Untreated
LS
(Wilcoxon Signed 
Ranks Test)
Clitoris 0.011 0.549 0.05 0.005
Clitoral-hood 0.014 0.195 0.182 0.005
Right labium minus 0.02 0.971 0.002 0.015
Left labium minus 0.005 0.944 0.007 0.005
Right inter-labial 
space
0.01 0.8 0.021 0.006
Left inter-labial 
space
0.001 0.495 0.002 0.001
Perineum 0.026 0.110 0.10 0.147
Thigh 0.729 0.649 0.444 0.646
1687.4.3  Comparison between normal vulva and VIN 3
Figure 7.5 compares the perfusion values between normal women and VIN 3. The mean 
perfusion values were higher (not significant) for VIN 3 compared to the normal vulva 
(except for perineum).  The comparison between these two groups was impaired by the 
distribution of VIN 3, which tends to be patchy, compared to vulval LS.  Vulval LS 
usually affects the whole of the skin in the inner vulva.  A separate comparison (Figure 
7.6) between areas affected by VIN 3 and an adjacent normal area of the vulva in the 
same patient showed significantly higher perfusion in VIN 3.
Figure 7.5  Graph comparing the vulval perfusion in normal women and in 
women with VIN 3
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Figure 7.6  Graph comparing the vulval perfusion in adjacent areas of VIN 3 
and normal skin in the same woman
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VIN3 Normal7.5  Discussion
The reproducibility of the LDPI apparatus in the normal and diseased (LS) vulva using 
the ‘mean of the total vulval flux’ for each image was good-to-excellent (CV= 1-6%). 
The thigh was a good reference point for the study of variations in vulval skin perfusion 
as the reproducibility for all the women in the vulval disease group was 5% (n=71 
images) and the skin is conveniently located.  However it is interesting that the long­
term intra-individual (n=6 to 9 images in each of 8 patients) temporal heterogeneity in 
skin perfusion for the thigh (non-genital control skin area) had a poor reproducibility 
(CV=7-22%).  The latter result could be attributed to imaging a similar but not identical 
imaging site (32 by 32 pixels) on the thigh or to the small number of images analysed in 
the intra-patient variability group.  This could perhaps be overcome in future studies by 
marking the skin area.
Preliminary data of the diseased vulva in this thesis show a significant reduction in skin 
perfusion with treatment of vulval LS with topical steroids.  A short course of potent 
topical steroids on vulval LS reduces hyperkeratosis of the epidermis, in addition to 
reducing inflammation and hyalinisation of the dermal collagen73.  The laser Doppler 
technique is not sensitive to the iatrogenic blanching of the skin by topical steroids. This 
is due to venular rather than arterial vasoconstriction which cannot be recorded by flow- 
dependant techniques such as LDF and LDPI131’229.  Moreover the laser Doppler 
technique records blood flow deeper than the superficial papillary capillaries, which are 
not involved in the blanching effect.  The depth of measurement may also be influenced 
by topical preparation increasing hydration of the stratum comeum and reducing the 
scattering of the laser beam131.  The findings in this thesis therefore could be partly 
attributed to changes in the optical properties of vulval LS caused by differences in 
morphological features before and after treatment, in addition to a real decrease in the
171microcirculation incited by reduced inflammation within the dermis by topical steroids. 
The morphological features influence the optical pathway and therefore the scatter 
volume of the LDPI output.  A larger scatter volume measures a higher perfusion while 
a smaller volume, a lower perfusion.
When compared with the normal subjects, women with vulval LS had a higher mean 
base-line perfusion (not significant) before treatment which could be attributed to the 
persistent antigen-driven inflammation and thinning of the epidermis64, which may 
result in a real increase in blood flow and an increase the scatter volume of the LDPI 
output, respectively.  After good response to treatment a significantly lower perfusion 
was recorded by the LDPI in vulval LS compared to the normal vulva.  As explained 
above this is likely to be the result of both morphological changes and an actual 
decrease in perfusion.
In women with VIN 3 the mean base-line perfusion was higher (not significant) than in 
normal women.  The difference reached significance when symmetrical normal and 
diseased vulval areas were compared, as was found in vulval cancer by Jackson et al140. 
Immunohistochemical studies show a significantly higher MVD with Factor VIII- 
related antigen (F8-RA) stain and vascular endothelial growth factor (VEGF) 
expression in VIN 3 compared to lower grade disease and adjacent normal epithelium14. 
Previously, pre-invasive disease of the vulva was thought to be an uncommon clinical 
problem but over the past two decades the number of women referred with the disease 
has significantly increased, with -50% of women aged 40 years or younger125.  The 
natural history of the disease is however still poorly understood.  The recommended 
treatment is local surgical excision or laser ablation with care to preserve the normal 
appearance and function of the vulva. Conservative management is only used in special
172circumstances such as when the patient declines surgery or if the disease is 
asymptomatic, but there is no consensus on the multitude of medical therapies 
available125.
The LDPI can be used to study vulval disease and is well tolerated by the patients.  The 
SBF in the diseased vulva is also found to be constant as was the case in the normal 
vulval skin.  The studies presented in this chapter do demonstrate differences in SBF 
between normal and diseased vulva, but the extent of these differences are not reliable 
enough for precise disease monitoring or for identification of invasive disease.
In the next chapter the serial changes in vulval skin perfusion is studied during 
treatment of LS with topical steroids.
173Vulval Lichen Sclerosus -  Perfusion 
Variance to Topical Steroid Therapy
1748.1  Introduction
As described in Chapter 3, the management of vulval LS involves potent and 
moderately potent topical steroids to control the symptoms and probably disease 
progression73,74.  The examination of the vulva is subjective and mainly concerns 
identifying active disease characterised by evidence of pruritus and excluding malignant 
disease196.  As vulval LS is an inflammatory disease, changes within the 
microcirculation may provide another dimension for examination and monitoring of the 
disease process40;41.  In Chapter 7 data demonstrated that good symptom control with 
topical steroids resulted in a significant reduction in vulval skin perfusion compared to 
skin perfusion during active disease.
8.2  Aim
In this chapter the aim is to serially measure the changes in vulval skin perfusion in LS 
during topical steroid therapy using the LDPI.  In contrast to Chapter 7 when perfusion 
was measured as soon as patient achieved good symptom control and while receiving 
daily moderately potent topical steroid therapy, this chapter follows the changes in 
perfusion through treatment, until topical therapy had been phased out to maintenance 
dose.  The purpose of this study is to understand the changes in SBF during topical 
steroid treatment of vulval LS and to examine the potential role of vulval skin perfusion 
as a parameter to objectively assess the disease process.
1758.3  Materials and methods
8.3.1  Study population
The study population consisted of 39 women (57±15 years) with symptomatic vulval 
LS, recruited from the Vulval Clinic based at the Royal Free Hospital, as described in 
Chapter 7.  The age range was 23-82y, with 26% (n=10) under the age of 50y.  Twenty- 
six women were referred by the family practitioner, seven were in-house referrals and 
six, tertiary referrals.
Twenty-two patients had histological diagnosis in the past and the remaining patients 
were clinically diagnosed196.  We avoided biopsy during the study to prevent iatrogenic 
increase in perfusion.  Most of the women had received some form of topical therapy in 
the past, as described in Chapter 7, section 7.3.1.2.  Four patients also had surgery - two 
had had simple vulvectomy, one laser ablation and one a Fenton’s procedure.
We prescribed potent topical steroids (Dermovate, clobetasol propionate 0.05%,
Synalar, fluocinolone acetonide 0.025% or Tri-Adcortyl, triamcinolone acetonide) nocte 
for 8 to 12 weeks followed by maintenance with moderately potent steroids (Trimovate, 
clobetasone butyrate 0.05%)198.  Clobetasol propionate therapy was the first-line potent 
topical steroid.  Two women experienced irritation with clobetasol propionate but 
responded well to fluocinolone acetonide.  Maintenance therapy with clobetasone 
butyrate was gradually phased-out to twice a week over a period of 12 weeks.
In this study we only included patients who showed good response with resolution of 
symptoms.  Clinical features of disease improved, particularly erosions, purpura, 
erythema and ‘whiteness’.  There was no visible change in atrophy.  These women were 
seen and examined for the purpose of this study at referral and serially during treatment.
176The frequency of post-treatment examination (LDPI) varied between two and four 
weeks until twelve weeks after commencing clobetasone butyrate.
For the purpose of data analysis the LDPI measurements for the same patient was 
compared before and after treatment allowing between six and twenty-five pairs to be 
compared for each duration of treatment.
8.3.2  Statistical Analysis
The perfusion for each region of the vulva and the non-genital skin was expressed as 
mean ± 95% Cl (confidence interval).  The paired data for each treatment group were 
compared using Wilcoxon’s signed-rank’s test.  Probability values of less than 0.05 
were regarded as significant.
8.4  Results
Figure 8.1a and b show a clinical photograph with corresponding LDPI image of a 
woman with untreated vulval LS.  Fig. 8.1(c-e) shows a series of perfusion images from 
the same woman (c) four weeks and (d) eight weeks after clobetasol propionate 
followed by (e) eight weeks after clobetasone butyrate therapy.  The series of colour- 
coded perfusion images show a progressive reduction in vulval skin blood flow.
Table 8.1 shows the patient profile for each treatment pair.
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Figure 8.1a  Photo of Vulval LS
Figure 8.1a-e
Clinical  photograph  (8.1a)  of  vulval  LS  with  corresponding 
LDPI images on the next page (8.1b) before treatment followed 
by  serial  images  at  four weeks  (8.1c)  and  eight  weeks  (8.Id) 
after  treatment  with  potent  topical  steroids  -  clobetasol 
propionate,  and  eight  weeks  (8.1e)  after  treatment  with 
moderately potent topical steroid - clobetasone butyrate.
178Figure 8.1b
LDPI image for Figure 
8.1a before treatment
Figure 8.Id
LDPI image for Figure 
8.1a after eight weeks of 
potent topical steroids
Figure 8.1c
LDPI image for Figure 
8.1a after four weeks of 
potent topical steroids
Figure 8.1e
LDPI image for Figure 
8.1a after eight weeks of 
moderately potent topical 
steroids
179Table 8.1  The number of patients in each treatment pair, the age and body mass index with observations of temperature, pulse rate and
blood pressure
Treatment
type
Duration
(weeks)
Number of 
treatment 
pairs (n)
Age
(years)
Body
mass
index
Body temperature (°C) Skin temperature (°C) Heart rate (beats per 
minute)
Systolic Blood 
Pressure
Diastolic Blood 
pressure
Mean arterial pressure
(kg/m2) Pre­
treatment
Post­
treatment
Pre­
treatment
Post­
treatment
Pre-
treatment
Post­
treatment
Pre-
treatment
Post­
treatment
Pre­
treatment
Post­
treatment
Pre-
treatment
Post­
treatment
Q
O
cC
2 - 3  w 23 57.09 ± 
14.69
27.99±
4.7
36.58 ± 
0.28
36.52 ± 
0.22
32.28 ± 
0.29
31.85 ± 
1.07
68 ±7 67 ± 7 139.52 ± 
19.68
143.95 ±
16.95
83.57
±12.4
87.77 ± 
8.9
102.22 ± 
12.79
106.5 ± 
10.6
w
H
C /3
4 - 5  w 25 54.79 ± 
15.02
27.71±
4.83
36.57 ± 
0.38
36.52 ± 
0.35
32.29 ± 
1.26
31.46 ± 
1.05
66 ± 7 65 ± 8 138.36 ± 
20.57
143.63 ± 
22.45
84.14 ± 
11.46
86.17 ± 
10.6
102.48 ± 
13.63
105.32 ± 
13.24
<   S   m
a ,  2
6 - 7  w 19 56.22 ± 
16.39
27.48±
4.82
36.54 ± 
0.4
36.39 ± 
0.33
32.29 ± 
1.32
31.31
±1.21
68 ± 7 68 ± 7 150
±21.63
141.24
±28
88.5 ± 
9.64
83.65 ± 
9.27
109 ± 
12.9
102.84 ± 
15.1
H
Z
8 - 9  w 19 55.94 ± 
14.11
27.85±
4.31
36.56 ± 
0.31
36.66 ± 
0.29
31.95
±1.23
31.37 ± 
1.13
68 ± 6 66 ± 6 142 ± 
20.91
136.47 ± 
21.56
84.67 ± 
12.42
81.12
±11.78
103.8 ± 
13.42
99.57 ± 
14.14
w
H
O
On
1 0 - 11 w 18 57.35 ± 
15.03
27.86±
4.89
36.53 ± 
0.3
36.50 ± 
0.27
32.15 ± 
1.14
30.81 ± 
0.69
68 ± 7 69 ± 8 147.8 ± 
17.98
138.71 ± 
19.85
87.69 ± 
11.79
83.88 ± 
11.1
107.73 ± 
12.11
102.16 ± 
12.62
3 - 4  w 21 59.75 ± 
14.6
27.45±
4.49
36.6 ± 
0.24
36.52 ± 
0.33
32 ± 1.2 31.92 ± 
1.04
67 ± 6 67 ± 6 147.85 ± 
24.44
138.25 ± 
19.95
86.55 ± 
10.97
82.55
±10.94
106.98 ± 
14.87
101.12± 
13.22
gS
° «   a.  Q
5 -  6 w 9 56.75 ± 
16.63
30.05±
6.01
36.54 ± 
0.26
36.43
±0.37
31.74 ± 
1.73
31.40 ± 
1.19
69 ± 7 69 ±10 144.38
±21.95
133.63 ± 
18.58
88.13
±13.35
82 ± 
9.68
106.88 ± 
13.52
99.21 ± 
11.54
>; o 
H   & W  w  
H   H
•<  C /3
7 - 8  w 7 52 ± 
12.96
25.15±
3.1
36.85 ± 
0.19
36.73
±0.16
32.93 ± 
0.85
32.83 ± 
0.96
65 ± 5 66 ± 3 140.33
±20.41
136.67
±21.6
82.5
±7.58
79.17
±17.15
101.78
±11.17
98.33 ± 
18.23
04  J
W  <
G  U
9 -  10 w 6 58.8 ± 
10.4
28.18±
4.36
36.52
±0.24
36.54 ± 
0.32
31.93 ± 
0.79
31.50 ± 
0.95
65 ± 5 76 ± 18 153 ± 
18.57
149.20
±14.18
97 ± 
9.08
91 ± 
11.4
115.67 ± 
10.78
110.4
±11.48
s s 11 -  12 w 8 59.43 ± 
12.46
29.30±
5.5
36.55 ± 
0.19
36.53 ± 
0.31
31.8 ± 
0.62
32.72 ± 
1.06
70 ± 4 6 4± 5 132.86 ± 
17.29
110±
25.82
83.57
±12.82
73.75 ± 
31.98
100
±13.84
85.83 ± 
28.07
1808.4.1  Perfusion changes in the control non-genital skin site (thigh) and the vulva 
during therapy.
8.4.1.1  Thigh (Figure 8.2)
There was no significant difference in perfusion in the thigh measured before and 
during the course of treatment, except during *week (W) 4 to 5 of clobetasol propionate 
therapy (p=0.016).  During this period* perfusion in the thigh was significantly reduced 
following topical steroid therapy of the vulva.  The reason is unclear but does indicate 
that data from the vulva during this period* should be interpreted with caution.
Figure 8.2 Graph shows the change in mean base-line thigh (control skin area) skin 
blood flow with 95% confidence interval, during treatment of vulval LS
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1818.4.1.2  Clitoris (Figure 8.3)
During the course of clobetasol propionate therapy there was no change in perfusion 2-3 
weeks following therapy.  After this period there was a reduction in perfusion, although 
the levels were significant only during *W 4-5 (p= 0.006) and W 8-9 (p=0.007).
Clobetasone butyrate therapy showed a significant reduction in base-line blood flow 
until W7-8.  Afterwards the perfusion gradually increased and returned to baseline at 
W 11-12, probably reflecting the gradual reduction in the effects of topical therapy.
The clitoral area was difficult to define and correlate with the clinical photograph 
because of its size, location and in some cases phimosis by disease.
182Figure 8.3 Graph shows the change in mean base-line clitoral skin blood flow with 
95% confidence interval, during treatment of vulval LS
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1838.4.1.3  Clitoral hood (Figure 8.4)
During clobetasol propionate therapy the perfusion changes were similar to the clitoris, 
with a reduction in perfusion after W2-3.  The levels were significantly reduced during 
*W 4-5 (p=0.014) and W 8-9 (p=0.031), as in the clitoris.
Topical therapy with clobetasone butyrate showed a significant reduction in base-line 
perfusion until W 5-6, after which there was a gradual rise to the pre-treatment base-line 
perfusion, as in the clitoris.
Figure 8.4 Graph shows the change in mean base-line clitoral hood skin blood 
flow with 95% confidence interval, during treatment of vulval LS
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1848.4.1.4  Labia Minora (Figure 8.5 and 8.6)
During clobetasol propionate therapy the right labium minus (Figure 8.6) showed a 
similar pattern of perfusion change to the clitoris and clitoral hood, with a reduction in 
perfusion after W 4-5*.  The left labium minus did not show any change in perfusion 
until W 8-9 (Figure 8.5).
Therapy with clobetasone butyrate altered the base-line perfusion in a similar pattern for 
both the right and left labia minora.  There was an initial reduction in perfusion until W 
5-6 followed by a progressive rise to the pre-treatment base line by W11-12.
185Figure 8.5 Graph shows the change in mean base-line right labium minus skin
blood flow with 95% confidence interval, during treatment of vulval LS
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Figure 8.6 Graph shows the change in mean base-line left labium minus skin 
blood flow with 95% confidence interval, during treatment of vulval LS
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1868.4.1.5  Inter-labial space (Figure 8.7 and 8.8)
Therapy with clobetasol propionate showed some reduction in the base-line perfusion in 
the right inter-labial space at about *W 4-5.  There was no change in perfusion in the 
left inter-labial space.
Therapy with clobetasone butyrate produced a similar pattern in perfusion change in the 
right and left inter-labial space.  There was initially a significant reduction in base-line 
perfusion until W 3-4, followed by a return to baseline perfusion on W11-12.
187Figure 8.7 Graph shows the change in mean base-line right inter-labial space 
skin blood flow with 95% confidence interval, during treatment of vulval LS
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Figure 8.8 Graph shows the change in mean base-line left inter-labial space skin 
blood flow with 95% confidence interval, during treatment of vulval LS
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1888.4.1,6  Perineum (Figure 8.9)
Therapy with clobetasol propionate and clobetasone butyrate did not appear to produce 
any significant perfusion change in the perineal skin.  However there is a trend towards 
a reduction approaching the end of the potent topical steroid phase which continued into 
the moderately potent steroid phase before return to base line with gradual phasing 
down of frequency of topical therapy.
Figure 8.9 Graph shows the change in mean base-line perineal skin blood flow with 
95% confidence interval, during treatment of vulval LS
Perineum
150
0.715
Trlmovate Dermovate
100
0.715
0.893
0.345 50- 0.650  0.624
0.881
0.087
0.124
0.058
n«17
100 -
-150
Weeks of treatment
1898.4.1.7  Summary of results
Potent topical steroids (clobetasolpropionate 0.05%): The change in vulval skin 
perfusion during therapy with potent topical steroids is less predictable compared to 
moderately potent steroids.  There is no change in perfusion for two to three weeks after 
commencing therapy with potent topical steroids.  Afterwards there is a tendency 
towards a reduction in vulval skin perfusion.
Moderately potent topical steroids (clobetasone butyrate 0.05%): There is a significant 
decrease in perfusion for three to four weeks after commencing therapy in all the vulval 
areas, which continued until about W7-8.  The base-line perfusion then returned to pre­
treatment levels, coinciding with reduction in frequency of treatment.
8.5  Discussion
Topical steroids are now accepted as first line treatment of vulval LS314.  The treatment 
regime for vulval LS in this thesis is based on the efficacy of potent topical steroids 
shown by Bracco et al39, Dalziel et al73 and others34’67’189.  These workers reported 
significant improvement of symptoms of pruritus and soreness with a short course of 
potent steroids.  Clinically there is reported reduction in erosions, hyperkeratosis, 
purpura and thickness of plaques, while histologically, hyperkeratosis, epidermal basal 
cell liquefaction, intensity of inflammatory infiltrate and hyalinisation of dermal 
collagen improved.  Although potent topical steroids did not worsen epidermal atrophy, 
the improvement of this feature histologically in vulval LS is not as clear as the other 
features mentioned above.  Subsequent long-term control of symptoms and disease 
activity is better managed with a small amount of moderately potent topical steroids74.
190The cause of vulval LS remains elusive but tissue metabolism is not decreased despite 
the severe atrophic appearance macro- and microscopically.  Metabolic studies in the 
mid to late 1960’s demonstrated an increase in glucose metabolism257, alkaline 
phosphatase levels and adenosine triphosphatase activity218, while there was no decrease 
in radioactive phosphorus uptake164 or nucleic acid activity100.  In the last decade the 
availability of immunohistochemical techniques has shown significantly increased 
expression of p53, a guardian genome protecting against DNA damage by regulating 
cell growth, in vulval LS compared to normal vulva and non-genital LS312.  This finding 
suggests abnormalities in the regulation of epidermal proliferation, the nature of which 
is still being debated  ’  .  The skin immune system is also altered with activation of
the antigen presenting cells within the epidermis, perpetuating a continuous 
inflammatory response causing sclerosis within the dermis62’64’93.
Clobetasol propionate is a highly effective synthetic fluorinated corticosteroid with a 
high degree of glucocorticoid activity, but minimal mineralocorticoid activity.  There is 
generally a reluctance among clinicians to use potent topical steroids because of concern 
for the antiproliferative effects in a skin condition already characterised by epidermal 
atrophy118.  In addition to this, there is evidence of high penetrance of topical 
hydrocortisone in the normal vulva compared to the forearm skin49.  Histological studies 
of vulval LS before and after treatment with potent topical steroids have not qualified 
these concerns39’73.  Other side effects such as sensitivity and candidal infection have 
not been a problem in this thesis or in the studies by Dalziel et al  .  Potent topical 
steroids are believed to reduce the number and activity of inflammatory infiltrates, in 
addition to preventing phagocytic cell mobilisation to the reaction site by inducing 
vasoconstriction103.  It is believed that the anti-inflammatory, antipruritic and 
vasoconstrictive properties of the drug are achieved through inhibition of phospholipase
191A and interference with the arachidonic acid cascade.  Topical steroids also block 
histamine release following antigenic stimulation and thus reducing their effect on 
peripheral target cells and tissues.  These are valuable properties for treating vulval LS, 
which is characterised by inflammation64.
In this thesis it is reasoned that if the base-line tissue metabolism is raised in untreated 
vulval LS, with inflammation being a part of the process, then therapy using topical 
steroids, by affecting a reduction in this inflammatory response also reduce the tissue 
metabolic rate which could translate into changes in tissue blood flow amenable to 
measurement by the LDPI.  The laser Doppler technique is not sensitive to the 
iatrogenic blanching of the skin by topical steroids, as discussed previously in 
Chapter 713l;229.
The inconsistent reduction in vulval skin blood flow during potent topical steroid 
therapy is attributed to variations in disease activity within our group of women at the 
start of treatment.  This is followed by differences in response to therapy causing 
different degrees of alteration in tissue morphology, which affect the scattering 
properties of the incident laser beam.  During the second phase of therapy with 
moderately potent steroids the findings were more consistent.  This is attributed to the 
more homogenous clinically quiescent nature of disease sequel within the group of 
women at the start of this stage of treatment.  Subsequent treatment with gradually 
phased-out moderately potent steroids produced skin perfusion changes corresponding 
to the frequency of therapy.  It is of interest that the base-line blood flow returned to 
pre-treatment levels as the frequency of medication was reduced in spite of good 
symptom control, suggesting no permanent change in SBF in these cases with treated 
vulval LS.
192The site of skin studied and the nature of the disease limit this study.  The vulva has an 
irregular surface contour unique to each woman and the location is such that exposure 
depends on the degree of abduction in the lithotomy position.  The nature of vulval LS 
is such that the disease causes varying degrees of resorption and fusion of the labia 
minora, and phimosis of the clitoris altering the surface contour of the vulva. 
Histologically there is variation in the degree of hyperkeratosis, depth of the epidermis, 
extent of hyalinisation of the superficial dermis and intensity of the inflammatory 
infiltrate in the dermis.  All these macroscopic and microscopic morphological 
differences influence the scattering properties of the incident laser beam of the LDPI. 
One of the major limitations of the LASER Doppler technique is the inability to 
determine the depth of tissue sampled336, which will vary with the microscopic 
morphology.  Repeated tissue biopsy for histological studies during the course of 
treatment was avoided, as this would have interfered with the blood flow measurements 
by iatrogenically increasing the perfusion in the region of the biopsy.
In conclusion topical steroids decrease base-line vulval skin perfusion in LS while 
controlling the symptomatic and clinical sequel of the disease process.  The data also 
show that reduction in the dose of therapy causes return of base-line skin perfusion to 
pre-treatment levels although the disease continues to remain quiescent.  This is in 
concurrent with the clinical impression that topical steroids do not cure vulval LS but 
temporarily control the disease process by pruritic symptom control.  This study shows 
that there is no overall permanent change in the skin perfusion parameter with topical 
steroid therapy relieving and controlling pruritic symptoms.
193In the next chapter, Chapter 9, this investigation continues by studying the response of 
SBF in diseased vulval skin during recovery form local skin temperature challenge 
compared to findings in that of the normal vulval skin described in Chapter 6.
194Diseased vulval skin -  perfusion 
variance to local skin temperature 
challenge
1959.1  Introduction
In Chapter 6 the normal vulva did not show any significant difference in vulval skin 
perfusion from the baseline during recovery from local skin temperature provocation 
with the exception of the left labium minus and the clitoris.  Further the 95% confidence 
interval in Figure 6.5 was widely distributed.
9.2  Aim
In this chapter the ability of vulval perfusion to recover from local skin temperature 
provocation in the diseased vulva, which include LS before and after treatment, and 
VIN 3 are investigated.  The purpose of the study is to identify the presence and nature 
of any differences in skin perfusion response in these diseases compared to the findings 
in the normal vulval skin in Chapter 6.
9.3  Materials and methods
9.3.1  Study population
The study population consisted of 30 women with LS and 6 women with VIN 3 
recruited from the Vulval Clinic at the Royal Free Hospital.
All women with LS were examined before treatment.  Ten women were examined after 
completion of a course of potent topical steroids (PTS).  The preparation used was 
clobetasol propionate 0.05% [Dermovate] while fluocinolone acetonide 0.025% 
[Synalar] and triamcinolone acetonide [Tri-Adcortyl] were reserved for patients with 
adverse reaction to clobetasol propionate 0.05% (one case).  Twenty women were
196examined after their course of moderately potent topical steroids (MPTS).  The 
preparation used was clobetasone butyrate 0.05% or Trimovate.
Women with VIN 3 were examined only before treatment.
9.3.1.1  Clinical profile of women with LS
The referrals were received from the family practitioner (n=22), tertiary consultants 
(n=5) and in-house consultants (n=3).  The mean age of the ten women examined after 
PTS was 57.1± 10.5 years and mean body mass index (BMI) of 27.1 ±4.9.  In the twenty 
women examined after MPTS the mean age was 56.75±15.8 years and mean BMI of 
26.83±4.  73% (n=22) of women were postmenopausal.  All the women had received 
various forms of topical treatment in the past, as described in Chapter 7, Section 7.3.1.2. 
Three women had also received surgery: - simple vulvectomy, laser ablation and a 
Fenton’s procedure.  21 women had a histological diagnosis, while the other women 
were clinically diagnosed.  Patients requiring tissue biopsy were excluded in this study 
because of iatrogenic increase in perfusion in the region of the biopsy.  In the medical 
history there was a predominance of women on antihypertensive (n=4), thyroxin (n=2) 
and hypoglycaemic (n=5) therapy.
PTS nocte was prescribed for 8 to 12 weeks followed by maintenance with MPTS198. 
Maintenance therapy with MPTS was gradually phased down to twice per week over a 
period of eight to twelve weeks.  Only patients who showed good response with 
resolution of symptoms were included in the study.  Clinical features of disease 
improved, particularly erosions, purpura, erythema and whiteness.  There was no visible 
change in atrophy.
197The women had not received any topical treatment for at least three weeks before the 
first pre-treatment LDPI examination.  LDPI examination with temperature challenge as 
described in Section 6.3.6 was performed before commencing treatment, after 
completing the course of PTS (n=10) and MPTS (n=20).  For the purpose of data 
analysis the LDPI measurements from the same patient was compared before and after 
treatment.
9.3.1.2  Clinical profile of women with VIN 3
The mean age of the women with VIN 3 was 42±12.6 years and mean BMI of 
22.65±3.34.  They were all tertiary consultant referrals.  The symptom profile for these 
women are as described in Chapter 7, Section 7.3.1.3.  All cases had histological 
confirmation of VIN 3.  Medical history in these women consisted of previous treatment 
for VIN 3 (n=5) and CIN (n=3).  These women had multifocal VIN 3 mainly affecting 
the labia minora and interlabial sulci.  These women were examined at referral, before 
excisional biopsy.
The laser Doppler perfusion imager (Section 5.3), measurement procedure (Section 
6.3.2.) and colour-coding and image analysis (Section 6.3.7) have been described 
elsewhere.
1989.3.2  Statistical analysis
The perfusion for each region of the vulva was expressed as mean ± SD.  The paired 
data for each treatment group were compared using Wilcoxon’s signed-rank’s test. 
Probability values of less than 0.05 were regarded as significant.
9.4  Results
The data is presented in Figures 9.1 to 9.5, showing the mean with 95% confidence 
interval of the variation in vulval skin perfusion from the baseline with hot (above the 
baseline) and cold (below the baseline) provocation.
9.4.1  Vulval LS-PTS
Figure 9.1 and 9.2 compares vulval skin perfusion in LS of paired samples from 10 
women before and after good response to PTS.  The differences in subject numbers (n) 
between Figures 9.1 and 9.2 are due to differences in image quality.
Hot provocation before treatment produced an increase in vulval skin perfusion with 
significant change in the right labium minus, left inter-labial space and the perineum. 
The 95% confidence interval was similar to that in the normal group described in 
Chapter 6, Section 6.4.4 and Figure 6.5, when the changes in the scale of the y-axis is 
taken into consideration.  Post-treatment patients appear to have a more significant 
increase in blood flow to hot provocation compared to before treatment.
Cold provocation shows a narrower 95% confidence interval compared to hot 
provocation.  The cold perfusion measurements appear more significantly reduced 
before treatment compared to after treatment.
199Figure 9.1 and 9.2  Graphs show the change in mean baseline perfusion with 95%
confidence interval to local hot and cold provocation in vulval LS
before (Figure 9.1) and after (Figure 9.2) the first phase of treatment with potent
topical steroids —  Clobetasol Propionate or Dermovate 
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2009.4.2  Vulval LS -  MPTS
Figure 9.3 and 9.4 compare vulva skin perfusion in LS of paired samples from 20 
women before and after their course of MPTS.  The differences in subject numbers (n) 
between Figures 9.3 and 9.4 are due to differences in image quality.
Hot provocation resulted in a significant increase in perfusion with narrow 95% 
confidence intervals in both before and after treatment with MPTS.  During cold 
challenge there is a significant decrease in perfusion with an even smaller 95% 
confidence interval, compared to the response with PTS.
There does not appear to be a difference in response to temperature provocation in 
vulval LS before and after good response to topical therapy.
201Figure 9.3 and 9.4 show the change in mean baseline perfusion with 95% 
confidence interval with local hot and cold provocation in vulval LS 
before (Figure 9.3) and after (Figure 9.4) the second phase of treatment with 
moderately potent topical steroids -  Clobetasone butyrate or Trimovate
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2029.4.3  VIN 3
Figure 9.3 shows vulva skin perfusion in six women with VIN 3.  There is a more 
significant change with cold provocation compared to hot provocation of the right 
labium minus and interlabial sulci.  Although the number of women studied was small 
the 95% confidence interval was narrow, in particular with cold provocation.
Figure 9.5  Graph shows the change in mean baseline perfusion with 95% 
confidence interval with local hot and cold provocation in VIN 3 before treatment
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2039.5  Discussion
This chapter describes the recovery of vulval skin blood flow changes during local hot 
and cold temperature challenge of ~ 4 to 6 °C from baseline vulval skin temperature. 
Women with LS showed a slower recovery in mean baseline perfusion compared to 
normal women, before and after clinical response to treatment.  In women with VIN 3 
there was a mixed response probably reflecting the patchy distribution of disease.
This study varies from other temperature studies in that the skin blood flow change was 
measured over an area of interest and only during recovery from temperature challenge, 
rather than during the challenge33,293’294’324.  The period of warming and cooling the 
vulval skin was also short (~3 minutes), compared to the 20 to 60 minute period used in 
other studies, which was not feasible, when in the lithotomy position.  These other 
studies have also applied the LDF, which measures perfusion continuously over a single 
point (1mm ) during the period of local temperature change followed by recovery to 
baseline.  The LDPI measures perfusion only once at each point (2 mm2) while scanning 
the area of interest over a period of ~ 2.5 minutes, so disregarding any rapid changes in 
perfusion.  The perfusion perspective of the LDPI is therefore different from the LDF.
Increasing the local skin temperature increases skin blood flow but the degree of 
response depends on the final temperature of the skin surface.  Song et al  described 
an increase in skin perfusion varying between 2-fold at 35°C to almost 15-fold at 43°C 
by continuous measurement at a single point using the LDF on forearm skin.  These 
workers also reported an early decline in blood flow in spite of maintaining a raised 
local skin temperature when the temperature rise was less than 43°C.  This ‘die away’ 
phenomenon remains unexplained.  During recovery of baseline temperature after 
warming, the skin perfusion decreased with decline in temperature until 32°C, at which
204point there was a brief temporal rise in blood flow followed by further decline to 
baseline perfusion294.
The increase in skin blood flow during warming is attributed to dilatation of arterioles 
and recruitment of capillaries.  The skin vasculature and the presence of special 
structures such as AVA varies at different body sites294.  Although the vulva is 
functionally not a site for temperature regulation, there is potential for large changes in 
blood flow involving cavernous tissue within the labia minora, vestibule and clitoris.
Song et al294 also reported an increase in the amplitude of vasomotion in the warmed 
skin with a gradual return to baseline after the warming period attributed to contraction 
and relaxation of smooth muscles of the arteriolar vessel walls.  In this thesis, study of 
the normal vulva, during the first few minutes after warming, an increase in amplitude 
of vasomotion may be contributing to the wide variation in measured perfusion.  The 
normal vulva appears to be able to stabilise skin blood flow during small changes in 
local skin temperature in this study.  In vulval LS reduced variation in perfusion could 
be attributed to impaired vasomotion as a result of disease affecting the walls of the 
arteriolar vessels.  In VIN 3 the response was less marked compared to vulval LS 
probably reflecting the patchy distribution of disease and the small subject numbers. 
Abnormal skin perfusion sensitivity to warming in VIN 3 could also be attributed to 
abnormal vascular geometry and/or blood rheology in diseased areas with high baseline 
perfusion242’251.  Rheologic changes in disease include impaired red blood cell 
deformability, increased leukocyte aggregation and endothelial adherence10.  These 
changes in rheological properties may contribute to abnormal perfusion by 
compromising the effective blood vessel cross-sectional area and red cell velocity, 
which would be relevant to the laser Doppler technique as it is flow-dependant.
205Van den Brande et al324 continuously measured perfusion changes with the LDF during 
cold provocation on the normal skin of the calf in the lower limbs.  During cooling, the 
workers reported an abrupt drop in skin blood flow followed by a rapid recovery (‘cold 
vasodilatation’) in spite of continued cooling.  Vasomotion also followed a similar 
pattern with complete absence during the initial phase suggesting a reflex active 
vasoconstriction followed by a gradual increase in vasomotion with appearance of ‘cold 
vasodilatation’.  When cooling was stopped there was a hyperaemic response with more 
then doubling of perfusion above baseline during the initial period of recovery, before 
descent to the baseline.  Van den Brande et al324 also reported an almost doubling of the 
vasomotion from baseline levels during this initial period of recovery when cooling was 
stopped.
In the study described in Chapter 6, section 6.4.4, Figure 6.5 the normal vulva recovered 
rapidly with a similar cooling period and with a similar temperature change compared to 
the findings described in this chapter.  Increased vasomotion during the recovery phase 
of the normal vulva may be contributing to the wide variation in skin blood flow.  In 
vulval LS, skin blood flow remained significantly reduced after the cooling period with 
marked narrowing of the variation (95% confidence interval) in perfusion.  Abnormal 
cold reactivity in vulval LS could be attributed to the persistent absence of vasomotion 
and/or the development of abnormalities in blood rheology, such as deformity of the 
blood cells and stasis10’242, affecting blood flow.  In VIN 3 a similar response to vulval 
LS was noted after cold provocation.  VIN 3 has a significantly higher baseline skin 
blood flow as measured by the LDPI (Chapter 7) and by immunohistochemistry with 
factor VIII related-antigen vascular stain14.  In VIN 3 abnormal vasomotion activity,
206vascular geometry and blood rheology, as in vulval LS, may also be involved in 
abnormal cold reactivity242.
The role of local and central factors in the response of skin blood flow to local 
temperature change is controversial.  It is generally believed that a local axon reflex 
from cutaneous receptors mediates changes in capillary blood flow to local temperature 
change  .  There is also an efferent neural control of skin blood flow through 
sympathetic neural pathways, which have a vasoconstrictor and possibly a vasodilator 
system241.  Local metabolic and humoral factors may also affect the response of flow 
through micro  vessels in recovery from temperature provocation  .  This study does not 
allow identification of the factors altering vulval skin vascular reactivity in disease and, 
the differences between these factors in vulval LS and VIN 3.
The comparison of the results in this study with previously published material is 
difficult, because to the best of current knowledge, there are no other studies measuring 
skin microvessel reactivity with the LDPI after temperature provocation in the vulva. 
Study of vulval skin perfusion has been greatly facilitated by the availability of the 
LDPI but is still restricted by the location and poor understanding of the morphology of 
the vulva, in particular of the vascular geometry.  Improvements in techniques to change 
local vulval skin temperature over short periods and better facilities for image analysis 
will allow easier application of the LDPI to the vulva.
This study shows that in vulva LS before and after treatment, and in VIN 3 skin 
perfusion response during recovery from local skin temperature change is different from 
that of the normal vulva.  This could not be simply attributed to differences in the 
subject numbers (n) because the subject numbers in the normal group (n=10) although
207smaller than in the group with vulval LS -MPTS (n=20), was similar to vulval LS-PTS 
(n=10) and VIN 3 (n=6).  The abnormal skin perfusion response in the presence of 
vulval disease could be attributed to abnormal vessel reactivity, which may be part of 
the disease pathogenesis.  The persistence of the abnormal skin perfusion response after 
treatment of vulval LS suggests that disease pathogenesis is not filtered by the treatment 
providing symptom relief and control.
In the next chapter the morphological differences in microvessel density (MVD) using 
immunohistochemical techniques in normal and diseased vulva are compared with 
LDPI measurements.
208CHAPTER 10
Normal and diseased vulva -  
immunohistochemical microvessel 
density analysis
20910.1  Introduction
The microvasculature can be quantified morphologically by MVD (microvessel density) 
using immunohistochemical-staining techniques on tissue biopsy samples to stain and 
locate these vessels.  The vast majority of the studies on MVD have been in relation to 
the development and prediction of prognosis of pre-malignant and malignant disease, 
including in the vulva as discussed in Chapter 1.  It is clear from the discussion in 
Chapter 3 that vulval LS (Table 3.2) and VIN 3 (Table 3.5) have a definite but poorly 
defined association with the development of malignant disease, thus requiring long term 
follow-up with a frequency to contain clinical work and a quality of reliability to detect 
early changes in disease process leading to malignancy which are more amenable to 
conservative treatment and preservation of vulval structure.  The preliminary work 
presented in this thesis raises the possibility of further developing the LDPI as a new 
non-invasive and painless biophysical method to measure blood flow changes within the 
superficial skin micro  vasculature to improve the scope for objective assessment of these 
vulval skin diseases.
10.2  Aim
In this chapter the MVD in the normal vulva, vulval LS, VIN 3 and vulval cancer was 
studied, using anti-von Willebrand factor (vWF) or (Factor 8 Related antigen) F8-RA 
immunostain to compare the MVD in LS and VIN 3 with that of the normal vulva and 
vulval SCC.  The morphological findings in LS and VIN 3 were then correlated with the 
biophysical findings in Chapter 7 to understand the LDPI output.
21010.3  Materials and Methods
10.3.1  Archival tissue
Tissue specimens from cases with vulval LS, VIN 3, SCC and normal epithelium were 
obtained from the files of the Department of Histopathology at the Royal Free Hospital 
for the years 1990 to 1996.  The tissue specimens were obtained from diagnostic Stiefel 
punch biopsy, wide excision biopsy and vulvectomy undertaken for investigation or 
treatment of vulval lesions.  Ideally skin biopsy from women with LS and VIN 3 who 
were previously scanned would have provided a better study pool for comparison with 
LDPI findings.  Unfortunately there was no ethical approval for vulval biopsy for the 
purpose of this study.
There are a number of methods for fixing tissue to preserve its morphology, depending 
on tissue type and which techniques will be used after sectioning.  The most widely 
used fixatives in diagnostic hospital histology laboratories are formalin based, as 
formalin is a neutral salt employed to maintain tonicity.  In this study 10% neutral 
buffered formalin (10% w/v formaldehyde in water) was used.
After fixation was complete the fixative was poured off and processed using an 
enclosed automatic processing system (VIP 2000F/300E) programmed with the 
following schedule: 10% neutral buffered formalin, 2h, 40°C; 70% industrial 
methylated spirit (IMS), lh, 40°C; 90% IMS, lh, 40°C; absolute IMS, 3h, 40°C; xylene, 
4h, 40°C; paraffin wax, 3h, 60°C.  Tissues were embedded in paraffin wax utilising the 
Tissue-Tek III.  The cast blocks were then left at room temperature to allow the wax to 
become hard.  After the wax hardened, the cast blocks were removed from embedding 
mould and stored in a dry place at room temperature until required.
211The blocks were sectioned (5 pm) using a microtome at room temperature.  The sections 
were floated on warmed distilled water (45°C) to prevent creasing, mounted onto 2% 3- 
aminopropyltriethoxysilane (APES) coated slides (Sigma-Aldrich, Poole, Dorset, UK) 
and dried at 42°C for 30 min.  The slides were placed in the incubator at 37°C for 2 
days to firmly attach the sections to slides and were stored in a slide box and placed at 
4°C until required.  Each block had a corresponding haematoxylin and eosin (H&E) 
stained slide for histological evaluation.  A gynaecological pathologist {J C Crow 
FRCPath} reviewed the H&E slides.
Thirty-one women with LS, 13 with VIN 3, 10 with vulval SCC and 11 with normal 
vulval epithelium were included in this investigation.  The mean and standard deviation 
(mean±SD) of the age in years (y) of the women included in this study were:
LS: 55 ± 1  ly, VIN 3: 37 ± lOy, vulval SCC: 68 ± 9y and normal vulval epithelium:
49 ±15y.
21210.3.2  Immunohistochemistry
Five-micrometer thick paraffin wax-embedded sections were stained 
immunohistochemically for vWF antigen using the streptavidin-biotin-peroxidase 
complex technique.  The sections were deparaffinised in xylene and rehydrated in 
different grades of ethanol up to distilled water.  Endogenous peroxidase activity was 
quenched with a 3% v/v hydrogen peroxide (H2O2) and pre-treated with proteinase 
(bacterial protease type XXIV, P8038, Sigma-Aldrich, Poole, Dorset, 12.5mg in 100ml 
of phosphate-buffered saline [PBS], 37°C) for 15 min.  To optimise immunoreactivity, 
antigen retrieval was also tested with microwaving (sodium citrate buffer -  0.01 M 
sodium citrate pH 6.0 at 25°C) for 10 min at full power, protease digestion using 
different time intervals (10, 12, 15, 17 and 20 min) and without the antigen retrieval 
step.  Results were compared for non-specific staining, preservation of tissue and 
overall appearance.  The least background with best specific staining was obtained with 
15 min incubation in protease solution.  The tissue sections were then incubated with 
the primary antibody.  The concentration of the primary antibody was compared at 1:20, 
1:40, 1:60 and 1:80 dilutions.  Monoclonal anti-human vWF antibody, 1:40 dilution 
(M0616, clone F8/86, Dako, Ely, Cambs) was found to be optimal and was used in this 
study.  The duration of incubation was compared using several techniques - overnight at 
4° C and at room temperature in a humidity chamber for lh, 2h and 4h.  The most 
specific staining with the least background was obtained with lh incubation in a 
humidity chamber at room temperature.  This was followed by application of secondary 
antibody (biotinylated rabbit anti-mouse immunoglobulin, E0354, Dako diluted 1:200 in 
PBS-SAB [phosphate buffered saline -  bovine serum albumin] pH 7.4 with 10% normal 
human serum) for 45 min and then with streptavidin-biotin-horseradish peroxidase 
(K0492, Dako diluted 1:200 in Tris buffer Ph 7.6 [xlO]) for 30 min.  The chromogen,
2133,3’-diaminobenzidine tetrahydrochloride solution (Sigma-Aldrich) was used. 
Counterstaining of nuclei was performed with Mayers haematoxylin.
Staining consistency and reproducibility was confirmed by staining 3 different sections 
from the same block on separate days.  There was 5% variation between sections. 
Sections of human placenta were used as positive controls for each staining run.  For 
negative controls the primary antiserum was replaced with PBS.  vWF was selected as 
the immunohistochemical vascular endothelial marker because its high specificity 
provides good contrast between microvessels and other tissue components, as has been 
reported by Miettinen et al213 and Weidner337 and more recently, confirmed by our 
group6.
10.3.3  Microvessel density (MVD)
Each section was examined by light microscopy at low magnification (x40 and xlOO) to 
identify areas with the greatest density of stained microvessels (‘hot spots’).  Three non­
overlapping fields of vision with the highest number of hot spots were selected.  The 
number of stained microvessels was quantified in each section at high magnification 
(x200) using an image analysis system (Seescan Imaging, Cambridge).  The 
microvessels were point counted in frame-defined areas of the section.  The areas were 
expressed as 104 pm2 of dermal tissue.  The frame-defined areas that were examined 
varied in size between 1.2 x 104 pm2 to 4.8 x 104 pm2 (mean 3.8 x 104 pm2).  The MVD 
within the framed areas was divided by the area of the section and expressed as 
MVD/unit area, the unit area being 104 pm2.
In cases of VIN 3, LS and normal epithelium, the frame-defined areas were confined to 
the dermis, i.e. the epidermis was excluded because this structure is avascular and
214varied in thickness between the 3 histologically different tissue types.  The MVD in 
these sections was confined to the area within 200pm of the epidermo-dermal junction 
just beneath the basement membrane of the epidermis.  In cases of vulval SCC, we 
excluded sclerotic, hypocellular areas and regions immediately adjacent to benign 
disease, when determining MVD.
Any brown-staining endothelial cell or endothelial cell cluster that was clearly separate 
from adjacent microvessels, tumour cells and other connective tissue elements was 
considered as a single countable microvessel337.  Even those distinct clusters of stained 
endothelial cells that might be from the same vessel snaking its way in and out of the 
section were considered distinct and countable as separate microvessels.  The presence 
of a vascular lumen was not relied upon to define a microvessel337.  Macrovessels, 
characterised by thick muscular walls or a diameter greater than 50pm, were excluded 
from the count.
All sections were analysed by 3 independent observers (J C Crow FRCPath, Consultant 
Pathologist, K J Rolfe PhD, and myself).  There was less than 5% variation between the 
observers.
10.3.4  Statistical Analysis
The highest vessel density (HVD) and average vessel density (AVD) per unit area for 
each tissue specimen were analysed.  Non-parametric analysis was used because of the 
skewed data distribution.  The Kruskal-Wallis test analysed the differences among the 4 
groups of tissue specimens and then the Mann-Whitney U-Test was used for pairwise 
comparisons between the groups.  Probability values less than 0.05 were considered 
significant.
21510.4  Results
The anti-vWF antibody stained the vascular endothelial cells brown as shown in a 
typical field from cases of normal vulva (Figure 10.1a), LS (Figure 10.1b), VIN 3 
(Figure 10.1c) and vulval SCC (Figure 10.Id).  Tumour cells, as well as other normal 
constituents, were consistently unstained.
216Figure  10.1a
Photomicrograph of normal vulval 
skin sectioned at an angle showing 
normal distribution of microvessels 
within the superficial dermis and 
cross-section of the dermal 
papillary microvessels within 
epidermis, immunostained with 
anti-vWF (Magnification x200).
217Figure  10.1b
Photomicrograph of vulval LS 
with a sparse number of 
microvessels immunostained 
with anti-vWF, within the 
superficial dermis. 
(Magnification xlOO).
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Figure 10.1c
Photomicrograph of vWF 
immunostain in VIN 3. 
Microvessels are clearly denser 
within the sub-epithelial dermis 
compared to LS.
(Magnification xlOO).
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Figure  10. Id
Photomicrograph 
showing an invading 
tongue of vulval SCC 
surrounded by 
numerous microvessels 
in the stroma. 
(Magnification xlOO)
220The distributions of the HVD and AVD for each type of vulval tissue specimen are 
compared as scatter graphs in Figure 10.2 (HVD) and 10.3 (AVD).
Figure 10.2  Scatter graph showing the overall median (•) values, comparing the 
distribution of the HVD per unit area for normal vulva, LS, VIN 3 and SCC
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Figure 10.3  Scatter graph showing the overall median (•) values, comparing the 
distribution of the AVD per unit area for normal vulva, LS, VIN 3 and SCC
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222The Kruskal-Wallis test showed that the observed differences among the 4 groups of 
tissue specimens were highly significant as a whole (p<0.0005).  Table 10.1 shows the 
overall median for the HVD and MVD values with the lower and upper quartiles for 
each clinical group.
Table 10.1  The median MVD values (HVD and AVD) per unit area with lower 
and upper quartiles for each vulval tissue specimen
Vulval tissue 
specimen
HVD values AVD values
Median
Lower
Quartile
Upper
Quartile
Median
Lower
Quartile
Upper
Quartile
Normal (n=ll) 2.2 1.9 2.6 1.76 1.65 2.15
LS (n=31) 1.7 1.3 2.5 1.41 0.98 2.34
VIN 3 (n=13) 2.8 2.25 4.35 2.17 1.98 3.21
SCC (n=10) 6.0 5.48 7.38 4.98 4.36 6.22
n=number of cases.
The P values for the HVD* and AVD* per unit area for normal vs LS: 0.038*, 0.031*; 
normal vs VIN 3:  0.03*, 0.034T ; normal vs SCC: <0.005n; LS vs VIN 3: 0.002*, 0.004f; 
LS vs SCC: < 0.0005**; VIN 3 vs SCC: 0.006*, 0.004t.
When the two outliers were removed in the VIN 3 group (n=l 1), the normal vs VIN 3 
was no longer significant (p=0.08*, 0.09*); the LS vs VIN 3 comparison was less 
significant (p=0.013*, 0.021*) and the VIN 3 vs SCC comparison remained highly 
significant (p<0.005**)
223Vulval LS had significantly the lowest MVD per unit area within 200 pm of the 
subepithelial dermal tissue.  Interestingly, the MVD in LS was also significantly lower 
than in normal vulval epithelium.  The MVD continued to significantly increase from 
normal epithelium to VIN 3 and to vulval SCC.  This can be seen in the 
photomicrography (Figures lO.lb-c) and is demonstrated in Table 10.1. 
Morphologically there was a marked difference in the density of the subepithelial 
microvessels between LS and VIN 3.
It is worthy of note that the distribution of MVD in VIN 3 in the scatter graphs in 
Figures 10.2 and 10.3 showed 2 cases with a much higher HVD (9.16 and 9.61) and 
AVD (6.89 and 7.71) per unit area compared to the main cluster of 11 patients. 
Removing these 2 outliers made small differences in the results (Table 10.1)
22410.5  Discussion
Immunostaining to visualise microvessels for the purpose of counting can be performed 
using various vascular endothelial cell markers such as vWF, ABH blood group 
antigens, CD31/PECAM-1, CD34, CD36 and Ulex europaeus agglutinin 1  (UEA-1)337. 
von-Willebrand factor (vWF), a multimeric protein synthesised by endothelial cells and 
present in the cytoplasm of these cells in blood vessels of all sizes, is considered the 
gold standard  .  No endothelial cell marker is perfect and vWF is no exception.  The 
vWF endothelial cell marker is identifiable to a varying degree in megakaryocytes, 
platelets and lymphatic endothelial cells, but it does not have the high cross reactivity 
with stromal fibroblasts, tumour cells and plasma cells found with the other markers.  In 
fact Miettinen et al213 and more recently Amis et al6 demonstrated the best contrast 
between microvessels and other tissue components with vWF, compared to the other 
endothelial cell markers such as CD31, CD34 and monoclonal antibody BNH9.
In this study VIN 3 had a significantly lower MVD compared to vulval SCC and a 
higher MVD compared to normal vulval epithelium, which is similar to the findings of 
Dobbs et al80 on the cervix.  In Chapter 3 the new classification for high-grade VIN is 
sub-categorised into the usual type or undifferentiated (VIN 2 and 3 -  warty, bowenoid 
and mixed), differentiated (dVIN) and unclassified varieties.  VIN 3 in the patients 
presented in this thesis refers to the undifferentiated VIN 3 or usual type -  warty, 
bowenoid and mixed.  The risk of high-grade VIN (undifferentiated VIN 3) progressing 
to malignant disease is influenced by treatment125’151’193.  The reported risk varies 
between about 5% for treated disease and 87.5% for untreated disease (see Table 3.5). 
The incidence of occult microinvasive disease has been reported to be as high as 
23%217.  Microinvasive vulval disease can sometimes be visualised colposcopically by
1 7   n
the presence of abnormal vasculature  , as is frequently the case for microinvasive
225cervical neoplasia287,291, implying that changes in vascular morphology do occur during 
the process of malignant progression.  These changes in vasculature in vulval SCC may 
in fact begin during the pre-neoplastic phase (e.g. VIN 3), as demonstrated by a study 
on MVD by Bancher-Todesca et al14 and, more recently, by a study on VEGF 
expression by MacLean et al197.  This study, showing MVD significantly higher in VIN 
3 than in normal vulva but lower than in SCC, provides further support to this 
hypothesis.  It is also worthy of note that 2 patients had a much higher MVD (both 
HVD and AVD) compared to the main cluster, as shown in Figures 10.2 and 10.3.  It 
can be hypothesised that these patients could belong to a pool at greater risk of 
progression to malignant disease; this can only be demonstrated by long-term follow-up 
studies.
The LDPI findings in Chapter 7 reported a significantly higher perfusion in skin 
affected by VIN 3 compared to adjacent normal vulval skin in the same patient. 
However when normal women were compared to women with VIN 3 the perfusion was 
higher in VIN 3, although the difference did not reach significance, most likely due to 
the small number of subjects in the study.  This morphological immunohistochemical 
study also demonstrated significantly increased MVD in VIN 3 compared to normal 
cases.  These findings imply that the increased perfusion detected by the LDPI is more 
likely to be due to a real increase in blood flow, rather than an apparent increase caused 
by morphological features influencing photon pathway such as a greater depth of 
penetration resulting in a larger volume of tissue assessment, beyond the superficial 
microvessels.
LS is also believed to carry an increased risk of progression to malignancy but the MVD 
in this disease was significantly lower than in normal vulval epithelium.  Computer-
226supported 3-D reconstruction of the papillary capillaries and superficial vascular plexus 
in non-genital LS show progressive disruption and disintegration of the capillary wall 
resulting in vessel reduction167.  The findings in this immunohistochemical study 
support a similar process in vulval LS.  The immunohistochemical results could also be 
attributed to the methodology, which only targeted microvessels within 200 pm of the 
epidermo-dermal junction.  In classical vulval LS the superficial dermis consists of a 
band of acellular oedematous hyalinised tissue, which in this study was present in all 
cases.  Although the methodology of selecting hot spots would have excluded frankly 
abnormal areas with a very low number of microvessels, overall this selected group 
with classical LS may be at lower risk of progression to carcinoma.  Doldi et al8 1  
reported great variability in the expression of VEGF mRNA (messenger ribonucleic 
acid) in a very small group of non-neoplastic vulval lesions (n=8) which included only 1  
case of LS, while MacLean et al197 showed no significant difference in 
immunohistochemical expression of VEGF between vulval LS (n=25) compared to 
normal vulval epithelium (n=10).  Both this data and that of MacLean et al197 suggest 
that angiogenesis is unlikely to be a feature of classical vulval LS.  Other mechanisms 
such as p53 protein accumulation  *   , alteration in the cytokeratin profile  ’  and
presence of allelic imbalance63’243 may be the critical factors which are more relevant to 
the earlier detection of classical LS cases at high risk of malignant transformation.
Rolfe et al261 showed increased expression of cell cycle proteins (p53 and Ki67) in areas 
of squamous hyperplasia (SH) and dVIN in multiple sequential vulval biopsies taken 
from the same woman with LS who developed SCC.  The work by Rolfe et al261 
suggests that tissue specimens selected from areas with SH and dVIN may have a 
higher MVD compared to those selected exclusively from areas of classical LS.
227The interpretation of the biophysical findings in LS in Chapter 7 with respect to the 
immunohistochemical morphological findings in this chapter is more complex 
compared to VIN 3.  The LDPI measured a higher perfusion in untreated LS compared 
to normal vulval epithelium, although this difference did not reach significance.  After 
treatment, the skin perfusion in LS decreased significantly below that in normal women 
and untreated LS.  Unlike VIN 3, which is an asymmetrical patchy disease, LS affects 
the whole of the vulval skin symmetrically preventing comparison of adjacent normal 
and abnormal vulval skin areas in the same patient with the LDPI.  The LDPI 
measurements are affected by physiological and skin morphological variations between 
subjects and therefore comparison of symmetrical normal and abnormal areas in the 
patient reduces the effect of these confounding factors.  The cases studied 
immunohistochemically were selected from the archive of samples available and is not a 
systematic study of cases before and after treatment of good responders as was done 
with the biophysical method.  However it is possible that the cases studied 
immunohistochemically are more comparable to the untreated cases studied with the 
LDPI as it is a more usual clinical practice to take biopsies in symptomatic patients 
either before treatment or when resistant to treatment to confirm diagnosis.  The 
morphological study showed a significantly lower MVD while the biophysical study 
appears to show a higher (not significant) perfusion in LS compared to normal.  The 
difference in the morphological compared to the biophysical findings in untreated LS 
could be attributed to differences in the depth of tissue studied.  The LDPI could be 
studying blood flow at a much greater depth than within 200pm of the epidermo-dermal 
junction as applied to the morphological study.  Alternatively the MVD selectively 
measured the microvessels (<50pm) focused upon by identifying hot spots while the 
LDPI measures the blood flow in all the vessels with the scatter volume.
228Although vWF is specific for staining endothelial cells lining blood vessels it does not 
differentiate between proliferating and mature microvessels.  Recently, newer 
antibodies have become available which are able to detect activated/proliferating 
endothelial cells and to distinguish between newly formed immature vessels and those 
that are more established and mature332’333.  CD 105/Endodlin is a member of the 
transforming growth factor pi receptor complex that binds preferentially to proliferating 
endothelial cells that participate in tumour angiogenesis.  In cancers of the breast and 
cervix endoglin is a more specific and sensitive microvessel marker than other 
panendothelial antibodies such as vWF26’46.  It is also worth noting that angiogenesis is 
a complex process and that techniques to observe and quantify microvessels 
histologically in sections of tissue only provide an estimate of the final product; 
physiological variables such as blood flow, vascular permeability and interstitial 
pressure, which influence the relationship of angiogenesis to malignant transformation, 
are more complex to measure141’337.  The study of changes in vasculature and blood flow 
in diseases at risk of malignant change increases not only our understanding of the 
underlying pathophysiology but also provides opportunities to develop new markers to 
identify high-risk cases and to design new therapies aimed at inhibiting angiogenesis or 
selectively destroying the ‘new’ vasculature, giving rise to the possibility of medical 
rather than surgical cure109’188.
The LDPI has the potential for clinical applications for measurement of blood flow 
within microvessels, non-invasively, without contact and in real-time.  The 
interpretation of comparative studies between morphological and biophysical methods 
could be improved by a greater understanding of the structure of the vulval 
microvasculature, of the photon pathway through vulval skin, physiological variables 
such as age related changes in perfusion both in the normal and in the presence of
229disease.  Morphological studies using 3-D computerised reconstruction of the vulval 
vasculature as shown by Auer et al12 in describing changes in perfusion in psoriasis 
before and after treatment and by Konerding et al1 7 1  in colon pre-cancerous lesions, will 
greatly improve our understanding of the morphology of the vulval vasculature.
In conclusion the increase in perfusion detected by the LDPI in cases of VIN 3 is most 
likely due to a real increase in perfusion as demonstrated by the MVD findings.  In 
vulval LS the biophysical and morphological comparisons are more complex.
230Summary and future work
231In this thesis the LASER Doppler Perfusion Imager was used for the first time to study 
SBF in women with normal and diseased vulval skin.  Previously Jackson et al140 had 
used the LDF to show differences in SBF in vulval cancer compared to adjacent normal 
vulval skin.  Mapping of SBF over a specific area (12mm2) within a short period of time 
(~3min) minimises the effect of large temporal and spatial variations compared to 
manually repeated single point (1mm2) measurement, which is also time consuming and 
tedious for both the patient and operator.  In addition, as the methodology crucially 
involves the patient in the lithotomy position to obtain adequate exposure of the vulval 
skin, the technique should be as brief as possible.  For these reasons the LDPI was 
found to be a suitable technique.
Response to hypotheses posed in Section 1.5
1.  Yes, experiments with a blood-flow model demonstrated that the LDPI 
technique used in this thesis was reliable in measuring SBF on the vulva.  These 
experiments showed that the LDPI readings were optimal at a distance of
160mm between the imaging site and the laser head with a 7% error within 
10mm.  The LDPI measurements correlated significantly with blood flow rate 
and haemodilution and were not influenced by the changes in the P0 2. 
Movement of the imaging site reduced the reliability of the LDPI measurements 
but this was not a problem at the vulval skin site.  There was only minor 
geometric distortion in the vertical axis.
2.  Yes, women with normal vulva found the use of the LDPI acceptable and the 
reproducibility of the measurement of vulval SBF was good (CV = 5-7%).
2323.  Age and menstrual cycle did not show any variation in SBF, although further 
studies with larger subject numbers are required to confirm these findings. 
Recovery from local skin temperature challenge also showed little difference in 
change of baseline SBF, but the wide 95% confidence interval (Cl) again 
suggests that larger subject numbers are required.
4.  Yes, women with vulval lesions found the use of LDPI acceptable and the 
reproducibility of the measurement in the presence of skin disease was good.
5.  Women with untreated vulval LS had a higher SBF compared to normal women, 
although the results did not reach significance.  An intra-patient comparison 
between symmetrical normal and diseased skin sites was not possible in LS as 
the disease distribution is symmetrical, affecting all vulval structures.  After 
treatment and with good symptom response, there was a significant decrease in 
baseline SBF.
6.  Serial measurements of SBF in vulval LS at the commencement of treatment 
and during treatment with potent topical steroids demonstrated a gradual 
decrease in baseline SBF.  As the women achieved good symptom control and 
progressed to moderately potent topical steroids, the vulval SBF remained 
significantly below the pre-treatment baseline values.  However as the frequency 
of moderately potent topical steroid therapy was phased down to maintenance 
therapy the vulval SBF progressively increased to pre-treatment baseline levels 
in spite of good symptom relief.
2337.  In high-grade usual type VIN (undifferentiated VIN 3) the baseline SBF was 
higher compared to normal women but again did not reach significance.  An 
intra-patient comparison was possible with high-grade VIN as the disease 
distribution is asymmetrical.  When SBF in high-grade VIN (undifferentiated 
VIN 3) was compared in the same patient between ‘normal’ and diseased areas 
there was a significantly higher SBF in areas of high-grade VIN 
(undifferentiated VIN 3) compared to normal skin.
8.  The response of vulval SBF to recovery from local skin temperature challenge 
demonstrates skin perfusion differences in normal and diseased skin.  There is a 
significant increase and decrease in skin perfusion after hot and cold provocation 
compared to the response in normal vulval skin.  This may be related to 
impaired skin vessel reactivity to changes in local skin temperature.  This 
abnormality in skin perfusion persists after good symptom relief with treatment 
in vulval LS.
9.  MVD in vulval LS was significantly lower than in the normal vulva whereas the 
LDPI showed a higher, though non-significant, SBF in women with untreated 
LS compared to normal women.  This discrepancy between biophysical and 
morphological findings is attributed either to different depths of tissue 
assessment or alternatively to the LDPI measuring changes in SBF in blood 
vessels with diameter greater than 50pm while the MVD only focused on the 
blood vessels with diameter less than 50pm (microvessels).  In high-grade VIN 
(undifferentiated VIN 3) there was good correlation between the MVD and 
LDPI studies in that both techniques showed significantly higher blood supply in 
diseased tissue.
234An important clinical question for this thesis was whether the use of real-time SBF 
imaging of the vulva with LDPI had a role in improving identification of invasive 
disease within vulval LS and high-grade VIN.  The majority of women with vulval LS 
and high-grade VIN do not develop malignant disease and therefore it would be of great 
assistance to the clinician if invasive disease could be diagnosed more reliably at an 
early stage to reduce the morbidity and mortality associated with treatment of vulval 
cancer194.  This question can only be answered by a prospective trial following-up 
patients with LS and VIN 3, clinically and with the LDPI, athough logistically this 
would be a difficult study.  During this period of study none of the women presented in 
this thesis developed cancer.  The measurements made by the LDPI method require 
much refinement and a better way of measuring relative changes in blood flow, 
compared to temperature challenge used in this thesis, to more clearly differentiate the 
normal from the abnormal skin.  However this preliminary work has made some 
contribution towards the study of the vulval skin.
The LDPI is suitable for use on the vulva.  The technique is acceptable to women and 
the SBF of the vulva has a good reproducibility in the normal and diseased skin.  There 
are changes in SBF in the presence of vulval disease but a much larger subject group is 
required to compare SBF between women with normal and diseased skin (e.g. vulval 
LS).  In high-grade VIN this problem was overcome as the disease has an asymmetrical 
distribution allowing comparison of symmetrical abnormal and ‘normal’ regions in the 
same patient.  The morphological studies using MVD support the LDPI finding in high- 
grade VIN.  The situation with vulval LS is more complex and more information is 
required on the microanatomical changes within the skin microvasculature, the passage 
of light photons within the skin, and the influence of morphology on the light passing
235through skin.  LS is a heterogeneous disease and therefore it would be necessary to 
stratify subjects with different disease presentations to understand the different groups. 
The local skin temperature provocation studies suggest an abnormality within SBF in 
the diseased vulva.  The pattern of data gives the impression that in the presence of 
vulval LS (irrespective of treatment) and in high-grade VIN the SBF is less able to 
maintain normal baseline perfusion suggesting the possibility of changes within the wall 
of the blood vessels; the nature of the exact pathophysiology is not revealed by these 
studies and is very likely to be different for each disease.  More work is required before 
the LDPI could become part of routine clinical assessment of patients with LS and high- 
grade VIN.
These are questions for future work:
•  What is the exact structure of the microvasculature in the different regions of the 
vulval skin?  Although this is likely to be similar to other skin areas, it requires 
confirmation in view of the function of the vulva, which includes rapid changes 
in organ perfusion.  3D-computerised imaging has been helpful in the colon and 
for the study SBF changes in psoriasis12,171.
•  How do skin morphological factors influence the pathway of the light photons 
through the skin in the presence of disease and after iatrogenic intervention (e.g. 
after surgery or topical medical therapy)?  This information could improve 
assessment of the exact depth of penetration of the laser beam.
•  What is the correlation between abnormal vessel patterns seen on vulval 
colposcopy and SBF mapping by the LDPI?  LDPI with digital photography will 
facilitate more accurate correlation of the blood flow image with the photograph,
236allowing for a more precise and time-saving comparison between the perfusion 
and colposcopic image31.  The measuring of perfusion in regions of the vulva 
such as the vestibular glands by Bohm-Starke et al27 is greatly facilitated by 
generation of a digital photograph to correlate with the two-dimensional blood 
flow image.
•  What is the correlation between 3-D computerised study of the skin 
microvasculature and LDPI in vulval LS?  As in the study by Auer et al in 
psoriasis this type of correlation study will greatly improve our understanding of 
SBF changes within vulval LS12.
•  Other techniques such as infrared spectrophotometry, which is not influenced by 
skin pigmentation, can assess the microvascular haemoglobin content and tissue 
oxygenation, and therefore may prove more valuable in accurately predicting 
areas at risk of malignant progression.
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